Predicting the severity of radiation skin reactions in women with breast cancer by Porock, Davina
Edith Cowan University 
Research Online 
Theses: Doctorates and Masters Theses 
1-1-1998 
Predicting the severity of radiation skin reactions in women with 
breast cancer 
Davina Porock 
Edith Cowan University 
Follow this and additional works at: https://ro.ecu.edu.au/theses 
 Part of the Nursing Commons 
Recommended Citation 
Porock, D. (1998). Predicting the severity of radiation skin reactions in women with breast cancer. 
https://ro.ecu.edu.au/theses/992 
This Thesis is posted at Research Online. 
https://ro.ecu.edu.au/theses/992 
Edith Cowan University 
  
Copyright Warning 
  
 
  
You may print or download ONE copy of this document for the purpose 
of your own research or study. 
 
The University does not authorize you to copy, communicate or 
otherwise make available electronically to any other person any 
copyright material contained on this site. 
 
You are reminded of the following: 
 
 Copyright owners are entitled to take legal action against persons 
who infringe their copyright. 
 
 A reproduction of material that is protected by copyright may be a 
copyright infringement. Where the reproduction of such material is 
done without attribution of authorship, with false attribution of 
authorship or the authorship is treated in a derogatory manner, 
this may be a breach of the author’s moral rights contained in Part 
IX of the Copyright Act 1968 (Cth). 
 
 Courts have the power to impose a wide range of civil and criminal 
sanctions for infringement of copyright, infringement of moral 
rights and other offences under the Copyright Act 1968 (Cth). 
Higher penalties may apply, and higher damages may be awarded, 
for offences and infringements involving the conversion of material 
into digital or electronic form.
PREDICTING THE SEVERITY OF RADIATION SKIN REACTIONS IN 
WOMEN WITH BREAST CANCER. 
A thesis submitted in fulfilment of the requirements for the degree of 
PhD in Nursing 
School of Nursing 
Faculty of Health and Human Sciences 
Edith Cowan University, Western Australia 
Davina Porocl< RN BAppSc(Curtin) PostgradDipNursing(Curtin) MSc(Curtin) 
March 18, 1998 
USE OF THESIS 
 
 
The Use of Thesis statement is not included in this version of the thesis. 
ABSTRACT 
Skin reactions are unavoidable side effects of radiotherapy for breast 
cancer that may limit the amount of treatment a patient is able to 1eceive As well. 
the discomfort associated with the treatment may negatively affect the patient's 
quality of life and their willingness to complete a course of treatment that typically 
extends over seven weeks 
ii 
Prior literature suggests that variations in patients' tissue reactions to 
radiation may be related to individual patient characteristics. Before health c..are 
providers can intervene to prevent or minimise skin reactions. a clinical model that 
helps predict which patients will experience more skin reactions is needed. The 
purpose of the study was twofold: firstly, to test the theoretical relationships 
between factors that impair healing and the severity of radiation skin reactions: and 
secondly, to develop a model to predict the severity of radiation skin reactions in 
women being treated for breast cancer. 
The theoretical framework for the study was based on two bodies of 
knowledge, radiobiology and wound healing. This framework specified three sets of 
potential predictors of radiation induced skin reactions. These were radiation 
factors (e.g. dose, fractionation). genetic factors (e.g. personal and family history of 
cancer. radiosensitive conditions) and personal factors (e.g. age, smoking history, 
nutritional status). It was hypothesised that the severity of the skin reaction was a 
function of the relationship between these constructs. 
A sample of 126 women was recruited to the study over a 14-month data 
collection period. All the women had undergone lumpectomy and were 
commencing a standard radiation protocol of 45 Gray to the whole breast delivered 
in daily fractions of 1.8 Gray over five weeks, and a 20 Gray electron boost to the 
lumpectomy site deliver3d in daily fractions of 2 Gray over two weeks. After 
iii 
obtaining written informed consent, data on potential factors were collected by 
interview at the commencement of treatment and from the medical records. Weekly 
observations of the skin using the Radiation Therapy Oncology Group scoring 
system were recorded throughout the seven weeks of treatment. The breast was 
divided into eight anatomical sites to increase specificity 1n the final analysis T ne 
mean inter-rater reliability of RTOG scoring between the three observers was O 85 
Chi square analysis revealed that several factors were associated with a 
more severe reaction. Significant factors from the "personal construct''. included 
smoking, chemotherapy, history of skin cancer, reaction of the skin to UV radiation, 
lymphocele aspiration, condition of the lumpectomy scar at the commencement of 
treatment, weight, and the size of the breast. 
Stepwise logistic regression analysis revealed the relative risk and 
predictive value of the factors. A predictive model was developed for each of the 
eight anatomical sites of the breast for weeks three to seven of radiation treatment. 
The principal predictors were a large breast size, smoking during the treatment 
period, and having had a lymphocele aspirated on at least one occasion prior to 
radiotherapy. The results show that it is possible to predict the severity of skin 
reactions in individual patients. 
The research contributes to theory development in radiation skin reactions 
and to the practice of radiation oncology nursing. Practice implications centre on 
individualising the preparation, education and management of women undergoing 
radiation therapy for breast cancer. Further research with larger samples and using 
different anatomical sites will contribute to the development of a skin reaction risk 
assessr,ent tool for general use in radiation oncology nursing. 
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CHAPTER ONE 
INTRODUCTION 
Introduction 1 
Radiotherapy is an important non-surgical treatment for cancer that can be 
used alone or in conjunction with surgery and/or chemotherapy. It is a principal 
treatment modality in the cure of breast cancer. Effective radiotherapy treatment 
depends, in large part, on the patient's compliance and willingness to complete a 
course of treatment that typically extends over seven weeks. 
Radiotherapy for the treatment of breast cancer can be stressful for several 
reasons. Whilst adjusting to the diagnosis of cancer, the patient must commence a 
treatment that is unfamiliar and time consuming. Patients often begin radiotherapy 
with limited infomiation about the treatment, or with inaccurate infom,ation from 
sources such as other patients or well meaning people who have known someone 
who has had radiotherapy. One area of concern to patients who undergo treatment 
for breast cancer, and one fraught with misinformation, is the occurrence of skin 
reactions as a side effect of treatment. 
Skin reaction is the most common side effect of radiotherapy with as many as 
95% of patients experiencing some degree of reaction (De Conno, Ventafridda & 
Saita, 1991; King, Nail, Kreamer, Strohl & Johnson, 1985). Given that in developed 
countries such as the United States of America, Europe and Australia, at least 50% 
of all cancer patients will receive radiotherapy at some stage during the course of 
their illness (Bentzen & Overgaard, 1994a; Holmes, 1988), this represents a 
substantial number of people who can expect to experience a radiation skin 
reaction. 
The ionizing radiation used in radiotherapy causes damage to all living cells, 
both normal and malignant. Side effects from radiotherapy are caused primarily by 
Introduction 2 
damage to normal tissue. The acute side effects result from damage to cells that 
divide rapidly and frequently such as skin, bone marrow and gastrointestinal 
mucosa Some side effects for example fibrosis and loss of pigmentation, can be 
observed months or even years later. These permanent effects occur in cells such 
as connective tissues that divide less frequently. 
Acute radiation reactions of the skin are the focus of this study. Acute 
radiation reactions typically appear between 10 and 14 days from commencement 
of radiotherapy and continue to increase in severity until the completion of 
treatment. The appearance of the skin is often described as a severe sunburn with 
peeling (dry desquamation) and itching. The reaction may become more severe 
with varying degrees of epidermal loss (moist desquamation) and in very rare 
occasions, necrosis. Discomfort ranges from mildly irritating to severe pain. 
Many texts and journal articles on radiotherapy include information on 
radiation-induced side effects in normal tissue. The variation in side effects 
experienced by individuals is often raised and is explained as being dependent on 
several variables or factors. The factors are usually listed as: radiation dose; quality 
(type or energy) of radiation; time period over which the dose is administered; size 
of field (volume); anatomic location; and other factors (Casarett, 1980: Sitton, 
1992; McDonald, 1992). Holmes (1988) describes the "other factors0 as being 
previous or CO' ,current chemotherapy or surgery and individual susceptibility 
dependent on age and general health. Sitton (1992) includes poor nutritional status 
and age as factors impairing normal tissue repair and thus worsening the skin 
reaction. 
Common knowledge in radiotherapy is the role of radiation factors in 
producing variations in the expression of side effects. Without radiation, there 
would be no skin reaction and work continues on the manipulation of these factors: 
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for example, hyperfractionation protocols The advances made using knowledge of 
radiotherapy have already made a significant impact in reducing the seventy of 
radiation reactions: for example, megavoltage linear accelerators have earned the 
name "skin-sparing" machines because of their protection of the skin by the 
delivery of higher energy radiation. 
Despite advances in radiotherapy knowledge and probably because of the 
importance of tumour eradication, development of knowledge in the role of 
personal characteristics or factors has not received the same research attention. 
Now the necessity to know more about personal factors has arisen due to 
consumer pressure for knowledge about what will happen to the individual; calls for 
professional accountability for interventions and advice on the management of 
reactions; and the need for knowledge to aid decision making in respect to 
treatment choices. 
Several notable authors in the medical literature have identified the potential 
importance of personal factors, recognizing that the degree of radiation skin 
reaction experienced is not due solely to the radiation received but that particular 
individual characteristics contribute to its expression (Bentzen & Overgaard, 1994b; 
Tucker, Turesson & Thames, 1992). 
Furthermore, the need for research investigating the impact of personal 
factors on normal tis.:;ue reactions has been documented. Dische (1991) called for 
research that not only included large numbers of patients but also gathered 
detailed data about the patients in order to identify predictive factors. More 
recently, the need for prospective research focussing on the influence of gender, 
age, site and previous sun exposure on the manifestation of early skin reactions 
was suggested by Hamilton et al. (1996). These studies will be discussed in greater 
detail in subsequent chapters. 
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There has been increased interest in the medical and nursing literature on 
the individual differences in radiation skin reactions experienced by patients 
receiving radiotherapy (Bentzen & Overgaard, 1994b; Dische, 1994; Tucker, 
Turesson & Thames, 1992) This worl<. has led to the identification of factors in the 
patient that may predict the degree of skin reaction. Patient factors are those that 
impair the normal processes of tissue healing, such as smoking, infection and 
nutritional deficits. An assumption underlying this research was that by considering 
both radiation and patient factors together a clearer picture of patient-to-patient 
variation in radiation skin reactions would emerge making possible the prediction of 
individual risk. 
The Benefits of Risk Prediction in Radiation Skin Reactions 
Skin reactions are currently viewed as an unavoidable part of treatment and 
nursing management is often directed toward the palliation of skin reaction 
symptoms. Skin care guidelines given to patients usually entail a change in 
hygiene routine, restrictions in clothing and, in some cases. restriction on activities 
such as swimming. The rationale behind these guidelines is not to prevent the 
development of skin reactions. but to prevent exacerbation of the inevitable 
radiation damage. In addition, there are no studies that have described the 
proportion of patients who suffer mild, moderate or severe radiation reactions. This 
lack of information means that skin care guidelines are applied to all patients even 
though it is apparent clinically that only a small proportion of patients will develop a 
severe acute radiation skin reaction. 
Self-regulation theory specifies that when a patient is prepared for a stressful 
event, accurate concrete descriptions of the event guide the patient's coping 
mechanisms (Johnson, Fieler, Wlasowicz, Mitchell & Jones, 1997). According to 
this theory, a schema (or mental picture) is formed in anticipation of an impending 
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stressful event. Schemata are formed from various sources, including the patient's 
own experiences and new information from health professionals, family members 
or the media. Based on this schema, the patient's expectations about the nature of 
the event are formed. Patients use their interpretations of the schema to cope with 
the physical and functional aspects of the event. 
Application of self-regulation theory leads to the postulation that providing 
patients with an accurate description of what is most likely to happen to them, 
rather than what is the general rule for all patients, will help them cope and prepare 
for treatment. This hypothesis was tested in earlier research which found 
educational preparation of this kind results in a significant reduction in anxiety and 
improvement in patients' satisfaction with nursing care (Poroch, 1995). 
The development of accurate individual predictions for radiation skin 
reactions means that if the patient were likely to have no reaction or a mild 
reaction, then s/he would be reassured. The description of a mild skin reaction 
would be given and options for skin management tailored appropriately. If the 
patient were likely to have a more severe reaction then s/ha would be prepared for 
the experience and options for skin management could be discussed on the basis 
of individual need. 
Benefits to the nurse, in addition to the ability to individualise skin 
manc1gement information, would be prioritisation of care through identification of 
high-risk patients and consideration of interventions that may counteract the risk 
factors. For example, the nurse might advise the patient regarding smoking 
cessation, or nutritional needs. 
There are also research benefits associated with accurate prediction of skin 
reactions. To date, methodological problems occur when attempting to assess the 
efficacy of diffe~nt skin care guidelines or dressing materials due to the patient-to-
Introduction 6 
patient variation in severity of skin reactions. This problem makes matching 
subjects or controlling for extraneous variables virtually impossible Therefore. 1f 1t 
were possible to predict the severity of reactions, new dressings and changes to 
guidelines could be tested against the prediction. For example, if a patient was 
reliably scored as high risk, then the difference between the prediction and the final 
appearance of the skin when trying a new dressing would indicate the advantages 
(or otherwise) of the dressing. 
In summary, radiation skin reactions are a well recognised, common problem 
in the cancer patient population. To date, research has proved difficult due to the 
patient-to-patient variation in reactions. Although the benefits of predicting the 
severity of radiation skin reactions are evident, and there has been discussion in 
the literature to suggest some causal relationships, no attempt has been made to 
quantify these relationships or use them to predict patient outcomes. This study 
aimed to address this empirical gap. 
Statement of Purpose 
The principal purpose of this work was the investigation of relationships 
between personal characteristics of patients and their differing responses to 
ionizing radiation revealed by the severity of the radiation skin reactions. Sufficient 
literature and clinical knowledge were available to suggest that the degree of 
radiation skin reaction experienced by the patient is not due solely to the radiation 
received, but that particular individual characteristics contribute to the expression of 
radiation damage in nonnal tissues (Bentzen & Overgaard, 1994b; Tucker, 
Turesson & Thames, 1992). Two assumptions underscored the research: firstly 
that factors known to impair wound healing would also affect the development of 
skin reactions; and secondly that these factors had a measurable effect. 
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The findings of this study will ultimately lead to the development of an 
instrument for clinical and research use that would enable nurses to predict the 
sever :y of radiation skin reactions for individuals commencing radiotherapy. The 
research process proceeded in three phases: 
1. Development of hypotheses for testing relationships between the severity of 
radiation skin reactions and potential predictors identified from the wound 
healing and radiation oncology literature and from clinical experience. 
2. Development of the research protocol and testing of hypotheses with a sample 
of women with breast cancer receiving post lumpectomy radiation therapy. 
3. Development of predictive models and calculation of relative risks associated 
with significant predictors using stepwise logistic regression analysis. 
Organisation of the Thesis 
Chapter Two presents the conceptual framework for the study and critically 
examines the research and knowledge of radiation oncology and wound healing in 
relation to patient-to-patient variation in the severity of radiation skin reactions. 
Chapter Three details the research process including the development of new 
measures and the validity and reliability testing conducted. Chapter Four reports 
the findings of the statistical analysis commencing with descriptive statistics 
followed by testing the hypotheses on univariate and multivariate levels and 
presenting the prediction models. The final chapter includes an interpretation and 
discussion of the findings in light of previous research and literature. Clinical 
implications and future research directions are also presented. 
Theoretical Foundations and Literature Review a 
CHAPTER TWO 
THEORETICAL FOUNDATIONS ANO LITERATURE REVIEW 
The purpose of this chapter is to review the published literature and clinical 
knowledge on normal tissue reactions to ionizing radi.:ition in order to construct a 
testable model of potential predictors of severe radiation skin reactions. This review 
will show that patient-to-patient variability expressed in normal tissue reactions to 
radiation can be explained theoretically by the interplay of three groups of factors: 
radiation, genetic and personal. These factor groups form the constructs of the 
conceptual model. The proposed relationships between the constructs form a 
hypothesis to test the theoretical explanation of the variation of radiation reaction 
expressed in individual patients. The arguments supporting the hypothesis are 
based on current knowledge in radiobiology and wound management as well as a 
critical review of relevant research. 
Conceptual Framework 
The conceptual framework proposes the physiological factors that may have 
value in predicting the severity of radiation reactions in individual patients. Two 
assumptions underpin the framework: firstly that factors known to impair wound 
healing would also affect the development of skin reactions; and secondly that 
these factors have a measurable effect. 
The constructs are comprised of factors (concepts) arranged together to form 
a theoretically meaningful framework to guide empirical study. Some concepts 
overlap, finding a theoretical home within more than one construct. For example, 
skin type could be located in both the personal construct and the genetic construct, 
or chemotherapy could be located in both the personal construct and as a 
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radiosensitiser in the radiation construct The theoretical underpinnings and 
substantive evidence for the constructs and concepts of the framework are 
analysed in the following discourse Figure 2 1 presents the model used to design 
the study and guide the analysis of potential predictive factors. 
The model is also used to organise the information presented in this chapter 
The published and clinical knowledge relevant to the outcome variable, radiation 
skin reactions. will be reviewed first followed by the three constructs. The chapter 
will conclude with discussion of the hypothesised relationships between the 
constructs and the dependent variables. 
RADIATION RADIOTHERAPY GENETIC PERSONAL 
SKIN CONSTRUCT CONSTRUCT CONSTRUCT 
REACTION 
0 Age 
0 Sex ... Coexisting disease 
0 Erythema 0 Dose ... Coexisting 0 Drug therapy 
0 Itchiness ¢:: .. Absorbed dose Radiosensitive 0 Chemotherapy 
G Dry skin loss 0 Volume Disease 0 Nutrition 
0 Moist skin loss 0 Fractionation 0 Cancer prone 0 Smoking/alcohol 
0 Necrosis e Radiosensitisers Family e Scar condition 
0 Pain e Site 0 Hereditary • Skin type 
Cancer .. UV exposure 
Figure 2.1 Conceptual Framework of Radiation Skin Reaction Predictors 
Radiation Skin Reactions 
The skin forms an important function in the protective mechanisms of the 
body providing a specialised covering based on an epithelial outer layer and a 
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deeper cor .nective tissue layer The health of the skin and the body's ability to 
repair damage significantly affects the quality of life of patients undergoing 
anticancer treatment. A review of the normal anatomy and physiology of skin can 
be found in Appendix A 
Radiation Histopathology of the Skin 
Histopathologic changes of the skin range from minimal degenerative 
changes in epidermal germinal cells to total necrosis and are categorised as either 
acute or chronic. Acute reactions in normal tissues manifest damage early, that is, 
within a few weeks to a few months after irradiation. Damage to normal tissues 
exhibited months to years after irradiation is described as chronic reaction. 
However, acute reactions are the focus of this research and specifically those 
reactions occurring during the treatment period. 
An acute skin reaction develops within two to three weeks o~ irradiation as 
manifested by erythema, then dry and/or moist desquamation erosions, epilation 
and ultimately healing. The germinal epithelial cells of the skin respond to the 
effects of irradiation immediately. Damage to these cells can be dose-limiting, 
meaning that the severity of acute reactions may require time off treatment, 
potentially interfering with the effectiveness of radiotherapy in terms of tumour 
eradication. Although the skin may not always represent the critical dose-limiting 
normal tissue reaction for megavoltage radiotherapy, the skin is recognised as the 
model for other acute reacting normal-tissues, therefore knowledge of its response 
is important in understanding all normal-tissue reactions (Hamilton, et al., 1996). 
Recovery from acute effects is also variable, ranging from complete recovery 
by primary intention to healing solely by secondary intention, if healing occurs at 
all. The following points, taken from Casarett (1980, p. 94), describe the main 
sequence of histopathologic changes occurring after irradiation. 
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1. Early mitotic inhibition, degeneration and necrosis of the sensitive germinal 
cells of the epidermis, hair follicles and sebaceous glands 
2. Degenerative and inflammatory changes in the moderately sensitive fine 
vasculature. 
3. Vascular and circulatory responses with erythema and oedema. 
4. Depilation and functional and morphologic changes in the glands of the 
skin. 
5. Desquamation (dry or moist) and sloughing of the epidermis. 
6. Pigmentation. 
7. Recovery processes. 
8. Chronic and delayed or late changes including epidermal atrophy, sclerotic 
changes in underlying vessels and connective tissue, late necrosis. 
The presence of erythema indicates histopathologic changes to vascular and 
connective tissue. Erythema manifests progressively, and has been categorised 
into four phases by Casarett (1980, p. 96) as follows: 
1. The initial phase occurs within minutes or an hour or so after irradiation 
and lasts for a few hours. 
2. The second phase occurs in a day or so and lasts a day or so. 
3. The third phase (erythema proper) b~gins in the second or third week and 
lasts for several days to a week. 
4. The fourth phase (and possibly additional subsequent phases) may occur 
a month or later after irradiation. 
The first three phases are most significant to the study of acute skin 
reactions All the phases of erythema are associated with vasodilatation and 
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vascular congestion, increased permeability of the endothelium. plasmat1c 
extravasation and oedema into and/or through vessel walls as a result of the 
inflammatory response 
After subsidence of initial erythema (phases one and two), there 1s a latent 
period before phase three. Phase three includes residual oedema with thinning of 
the epidermis and reduced secretion of sebum and sweat indicating damage to 
epithelial cells and degeneration of glands. Obstructive changes in arterioles 
causing hypoxia also seem to be associated with erythema proper Consequently, 
an increased dilation and hyperaemia may occur in surviving capillaries through 
collateral channels of circulation to the area (Casarett, 1980). 
Damage to epithelial cells and degeneration of sebaceous and sweat glands 
manifests as dry desquamation during the phase of erythema proper. Temporary or 
partial permanent depilation may occur concurrently with dry desquamation If dry 
desquamation is the most acute reaction experienced, then the recovery of the 
epidermis will be functionally normal. However, the following permanent changes 
will have occurred: fibrosis of fine vessels in vasculoconnective tissue; 
hyperpigmentation in metanocytes; thinning of the epidermis; and changes to hair 
follicles and sebaceous glands. If damage to the basal cells and glands is more 
severe, moist desquamation occurs. 
Casarett (1980) described moist desquamation in terms of the consequences 
of vasculoconnective tissue changes in the epithelium. The manifestation of moist 
desquamation results from the formation of small blisters in and around the basal 
layer of the epidermis that may also extend into the more superficial layers. The 
epidermis sloughs when these blisters rupture and coalesce. denuding the dermis 
and causing permanent depilation. 
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Epithelialisation occurs after one to two weeks following sloughing of the 
epidermis if the dose has not been prohibitive and the acute vasculoconnective 
tissue damage has not been too severe Provided the blood supply is adequate. 
surviving basal cells will re-epithelialise the area. 
Doses at which moist desquamation occur vary by mode of delivery Fowler 
and Stein (1960) experimented with pigs' skins and found that similar moist 
desquamation was produced by: 20Gy in one fraction; 30Gy in five fractions over 
five consecutive days; and 50Gy in 20 fractions over 28 days The ability to 
increase the total dose through fractionation, thereby achieving more effective 
tumour eradication, without exacerbating the normal skin reaction may be a result 
of what is known as the four Rs of radiotherapy: repopulation (regeneration), 
redistribution, repair, and reoxygenation which are discussed as part of the 
radiotherapy construct. 
Furthermore, recent research by Denham. et al., (1995) suggests that the 
inflammatory response alone does not explain the patient-to-patient variability. 
Denham, et al., continue that in addition to the effect of inflammatory mediators, 
other factors such as age, gender and prior sun damage, may influence the 
reactivity of vascular tissue. 
Radiotherapy Construct 
The aim of radiotherapy is described by Perez and Brady (1992, p. 1) as 
follows: 
deliver a precisely measured dose of ionizing radiation to a defined tumour 
volume with as minimal damage as possible to surrounding healthy tissue, 
resulting in the eradication of the tumour, a high quality of life, and 
prolongation of survival at reasonable cost. 
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The importance of this objective lies in the fact that radiation affects all living cells 
both malignant and normal. A balance between the destruction of malignant cells 
and the preservation of normal cells must be maintained in order to achieve the 
best possible results for the patient with cancer. The science studying the effects of 
radiation on cells is radiobiology. 
Fletcher (1980, cited in Hilderley, 1992, p. 10) describes radiobiology as an 
essential part of radiotherapy stating "As pharmacology is to the internist, so is 
radiation biology to the radiotherapist'. Hilderley goes on to say, " ... radiobiology is 
no less important to the radiotherapy nurse" (p 10). 
Overview of Radiobiology 
The cell can be damaged by ionizing radiation directly, through immediate 
damage to DNA synthesis, or indirectly, through the production of free radicals in 
the cell. The mechanism of damage occurs at the cellular level and is intimately 
connected with the process of replication. The process of replication is similar for 
both normal and malignant cells and comprises a progression through four distinct 
phases known as the cell cycle. Figure 2.2 illustrates the phases and briefly 
outlines the functions of each phase. 
The cell is most vulnerable to direct damage from ionizing radiation during the 
phases of the cell cycle when DNA synthesis or mitosis can be disrupted. 
Specifically, radiation damage affects the following three phases: G,. when 
substances necessary for DNA synthesis are altered; G2, when protein synthesis is 
inhibited and changes occur in the chromosomes; and during mitosis, when the 
altered chromosomes lose their ability to reproduce. The mechanisms of injury to 
DNA are summarised in Table 2.1. 
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G0 = Quiescent, resting phase. Cell functions continue but the cell is unable to 
divide. 
G1 = Pre-synthetic phase. Enzymes needed for DNA synthesis are produced. 
S = DNA synthesis occurs in preparation for cell division. 
G2 = Pre-mitotic gap during which specialised proteins and RNA are synthesised in 
preparation for division. 
M = Mitotic phase. Cell divides to produce two identical daughter cells 
Figure 2.2 Phases of Cell Cycle (Holmes, 1988, p 23). 
Table 2.1 
Mechanism of direct damage to DNA from ionizing radiation 
Mechanism of injury to DNA 
• Breakage in one or both chains of the DNA 
molecule 
o Faulty crosslinking of chains after breakage 
o Damage or loss of the nitrogenous base 
o Breakage of the hydrogen bond between the two 
chains of DNA molecule 
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However. the primary cause of damage is induced by the ionization events 
derived from the indirect action of radiation, as, at the moment of irradiation, most 
cells are more likely to be in cell cycle phases other than active mitosis. The cellular 
response to radiation involves the creation of free radicals in the cell by the 
interaction of cell water and electrons ejected from atomic structures by the 
passage of radiation through the cell. Free radicals alter the atomic and molecular 
structures damaging the DNA in the cell nucleus. It is estimated that approximately 
70% of the biological damage produced by X-rays is due to the indirect action 
mediated by free radicals (Hall, 1985). The presence of oxygen acts as a sensitiser 
in the cell causing further damage to DNA through the formation of oxidising 
substances, such as hydrogen peroxide, which occurs when oxygen reacts with 
free radicals (Hildertey, 1993; Holmes, 1988). Ultimately the effects of radiation, 
whether direct or indirect, damage the cell's DNA, leading to the inhibition or failure 
of mitosis. Depending on the dose of radiation. cell death may occur immediately or 
within hours but is usually preceded by one or more cell cycles post radiation 
(Hilderfey, 1993). 
Radiation Factors 
The radiation factors associated with normal tissue reactions are well 
documented and used to advantage wherever possible in clinical practice. 
Underlying these factors is the principle of balancing tumour eradication with 
damage to surrounding normc:.. tissue. Perez and Brady (1992) call this principle 
the therapeutic ratio providing a formula thus: 
Therapeutic = 
Ratio 
% tumour control 
% major complications 
The higher the therapeutic ratio, the more efficient the particular therapy. The 
formula can be used to make comparisons between treatment protocols. It has 
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been used this way in both clinical practice and research However, Andrews 
(1981) noted that although the development of a formula was a logical step in 
decision making for optimal radiotherapy, it could not be absolute because clinical 
considerations were important. The most important of these clinical considerations 
are the interaction of total radiation do~e. the volume treated, the fractionation 
schedule and the overall treatment time 
Absorbed Radiation Dose 
The close relationship between total dose, volume of treated tissue, 
fractionation and treatment time is fundamental to predicting the severity of 
radiation skin reactions. Normal tissue tolerances, that is the point at which 
erythema, dry or moist desquamation or necrosis occur, are usually reported in 
terms of the dose of radiation received. However the dose absorbed by the body is 
affected by a number of factors which are used to enhance the efficacy and 
accuracy of radiation 
The quality {type and energy) of radiation directly affects skin reaction and is 
related to the amount of energy absorbed by the skin. The skin-sparing effect 
achieved with the megavoltage linear accelerators is somewhat diminished when 
the beams hit the body's surface at a tangent, that is, at an angle other than 90°. 
This is because penetration is lost as the beam travels more along the surface than 
straight through the body. 
Electrons are high energy, low mass particles which have only superficial 
penetration and are used to treat the skin surfaces thereby increasing the severity 
of the skin reaction. An increased dose may be desired in some treatment 
protocols such as in breast cancer where the lumpectomy scar is treated with 
electrons following treatment to the whole breast with photons. 
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The application of a tissue-equivalent material, or bolus, to the skin surface 
also increases the dose to the skin The bolus acts as tissue and the skin absorbs 
the higher dose that underlying tissue would have received; thus the use of a bolus 
increases the skin reaction. 
In an Australian study of 110 patients being treated palliatively, Denham et al 
(1995) was unable to demonstrate a dose-rate effect on the development of 
erythema in the range of 3 to 8.2 Gy. Although it is logical to assume that such an 
effect exists, the patient-to-patient variability associated with a heterogeneous 
group of patients was enough to obscure the dose-rate effect. The variables 
Denham and colleagues found that affected skin reactions were: age, gender, site 
of treatment and a history of prior sun damage. 
Volume 
From the 1940s until the 1980s it was thought that nonnal tissue tolerances 
decreased when larger volumes of tissue were treated (Perez & Brady, 1992). 
Maciejewski, Withers, Taylor and Hliniak (1990) disputed this belief in a 
retrospective study of 268 patients with head and neck cancers treated with various 
total doses and fractions. The researchers observed no difference in the acute or 
chronic effects in patients treated with large or small fields. The differences in 
conclusions from these two studies may be due to the advantages of contemporary 
techniques, in particular, megavoltage radiation. Due to the limitations of 
retrospective design, however, the findings of Maciejewski et al. must be viewed 
with caution. Thus the volume of tissue treated remains a factor that cannot be 
discounted with current empirical evidence. 
The number of fields radiated is logically linked with the total volume because 
more surface area is exposed to radiation. In some instances the dose is divided 
between the fields to ensure that nonnal tissue, particularly of vital organs, is 
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spared higher doses. In the treatment of breast cancer. however, additional fields 
usually indicate more extensiv& disease and each field has an equivalent dose 
The significance therefore. of volume of irradiated tissue lies more in the fact that 
the patient may have: reduced tolerance to the effects of radiation with the 
increased volume (a small area of skin loss is quicker and easier to heal than a 
large area); increased discomfort or skin breakdown with a larger treatment 
volume; and/or a greater variation in skin dose as the beam strikes the varying 
contours of the skin's surface 
Fractionation and Treatment Time 
Fractionation is the division of the total dose of radiation into smaller doses 
(fractions). By the 1970s, giving multiple small daily doses of radiation over a 
period of time, was found to lead to better tumour control than the large single dose 
of early treatment protocols (Kaplan, 1970). The relationship between dose and 
time is directly associated with increasing the therapeutic ratio and substantial 
research effort is currently being invested in refining fractionation schedules. The 
conventional or standard fractionation is one fraction of 2Gy given daily, five days 
per week over two to eight weeks. Fractionation is based on the four Rs of 
radiotherapy: repopulation, redistribution, repair and reoxygenation. These four 
basic factors are considered to be the mechanisms by which fractionation improves 
tumour eradication and minimises normal tissue damage (Hilderley, 1993; Withers, 
1992). 
Repopulation 
Germinal cells of the skin and mucous membranes show an early 
regenerative response through increased rates of cell proliferation. Repopulation 
may begin before the course of radiotherapy has ended and as with the 
physiological response to any trauma, the repopulation rate accelerates, creating 
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what is termed an 'avalanche effect' (Withers, 1992). In a standard course of 
treatment, where a daily fraction of 2 Gy is given five days per week, repopulation 
begins about day 28 for the skin (Turesson & Notter, 1984). 
Research by Turesson and Notter (1984) on women treated for breast cancer 
indicates that radiation-induced accelerated repopulation of the basal cells of the 
epidermis began with an abrupt onset after four weeks of standard fractionation. 
This group had a significantly more pronounced skin erythema as measured by 
reflectance spectrometry than a comparison group who received twice-a-week 
fractions of 4 Gy. 
Thus fractionation is assumed to have a protective effect on the skin. The 
assumpLon is limited however, by the fact thcit repopulation of cells may occur over 
a prolonged period (Fowler, 1979). If the overall treatment time is over-extended or 
interrupted unexpectedly, the extra time between fractions or any time off treatment 
allows regeneration of tumour cells as well as normal cells. In order to achieve 
optimal tumour eradication, additional fractions would be required resulting in a 
higher total dose. A higher total dose has implications for the overall normal tissue 
damage both in the acute and chronic phases. The optimal effect is achieved by 
planning for the overall treatment time to be as short as possible. 
Redistribution 
As stated previously, the effect on tumor eradication can be enhanced if the 
treatment is given over a shorter time. This effect is further enhanced if smaller, 
more frequent fractions are also given (accelerated hyperfractionation). Cells vary 
in their radiosensitivity as they move through the phases of the cell cycle, with the 
greatest radiosensitivity for direct damage occurring in the late S-phase and the G2 
- M. Following each fraction of radiation, surviving cells, which are in relatively 
radiation resistant phases of the cell cycle, progress to more sensitive phases. The 
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net gain in this process, in terms of tumour eradication, is that cells 'self-sensitise', 
resulting in more cells reaching the mitotic phase as the next dose is given 
(Hildertey, 1993; Withers, 1992) Protocols exploiting this phenomenon are the 
subject of current clinical trials and redistribution is the mechanism thought to be 
responsible. 
Redistribution is a phenomenon of acute-responding tissues (such as tumour, 
and normal skin, mucosa and bone marrow) and not of late-responding tissues 
(such as spinal cord, brain or kidney). Therefore hyperfractionation exacerbates 
acute effects, but reduces, theoretically, the late effects. 
Combining radiation with chemotherapeutic agents, such as methotrexate 
and hydroxyurea, is proving to be another method of exploiting redistribution 
(Hildertey, 1993). The effect of multiple modalities on skin reactions will be 
discussed in detail in a later part of the radiation construct. 
Repair 
Tile ability of the cell to repair following each fraction of radiation is the key to 
the survival of acute-responding normal tissues. Withers (1992) cites research from 
as long ago as 1959 that showed cells could be repaired following radiation given a 
few hours of normal metabolic activity. A review of the process of normal tissue 
repair can · 3 found in Appendix 8. 
Repair is initiated by the body immediately and wntinues in acute-responding 
tissues for three to four hours following each fraction of radiation. The quality and 
speed of the repair response depends on personal factors to be described in 
section on the Personal Construct. It is this aspect of the individual's capacity to 
repair damage that is the focal point of this study. 
Tumour cells also can repair between fractions, but the assumption 
underlying all radiation treatment is that less repair of radiation damage occurs in 
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tumour cells than in normal tissues In addition. reoxygenation further 
radiosensitises the tumour resulting in improved tumour kill when the next fraction 
is given. 
Reoxygenation 
As discussed in the previous section on radiobiology, oxygen is necessary for 
the production of some free radicals important in the mechanism for indirect 
damage to DNA. Hypoxia, therefore. causes the cellular response to radiation to be 
reduced (Holmes, 1988; Noll, 1992). The importance of oxygen concentration at 
the time of radiotherapy has been known for over 60 years (Hall, 1985). In the 
laboratory it has been shown that the dose required to eradicate all tumour cells 
may be doubled where just 2-3% of the cells are hypoxic (Gray, Conger, Ebert, 
Homsey & Scott, 1953; Dische, 1991). As a result, studies have been undertaken 
to identify methods to increase the radiosensitivity of hypoxic tumour cells. 
Reoxygenation occurs after each fraction of radiation as part of the normal 
tissue repair process. Fractionation optimises the reoxygenation process by 
increasing the oxygen concentration in the tumour. Cater and Silver (1960, cited in 
Perez & Brady, 1992) found that reoxygenation relates primarily to tumour cells 
and oxygen changes in normal tissues were slight or non-existent. 
The use of oxygen to deliberately sensitise tumours led to experimentation 
with hyperbaric (high-pressure) oxygen therapy. Dische (1991), in a review of the 
literature, cited research using hyperbaric oxygen to sensitise tumour cells to the 
effects of radiotherapy. He concluded that the effect of oxygen is just as great on 
normal cells as on malignant cells when the patient is subjected to hyperbaric 
oxygen therapy. Dische concluded that the therapeutic ratio (improved tumour cell 
eradication versus damage to normal tissue) is altered with hyperbaric oxygen to 
the degree that the increase in damage to normal tissue may outweigh the benefits 
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of the increased tumour eradication. As a result. the technique has largely been 
abandoned (Noll, 1992). Nevertheless, the mechanisms of injury caused by 
ionizing radiation and the substances that enhance its effects are important to 
consider when applying this knowledge to the radiohistopathology of the skin 
Radiosensitisers 
Radiosensitisers are substances that enhance the damaging effects of 
ionizing radiation. Oxygen, as discussed in the previous section, is an important 
radiosensitiser. However, more pertinent to this study are the anticancer drugs. 
The combined use of radiotherapy and some chemotherapy agents, known 
as combined modality treatment (CMT) has been well documented as potentiating 
skin reactions. A significant amount of research has been conducted on the effect 
of combining these two modalities. Although most of the research has been 
conducted in laboratories on mice, there is sufficient evidence from clinical 
research to identify specific chemotherapeutic agents that enhance cutaneous 
effects of radiotherapy (Bentzen & Overgaard, 1993; Fu, 1985; O'Rourke, 1987; 
von der Maase, 1994). 
There are three classifications of drug interactions with radiation: 
independent action, protection, and enhancement action. The radiation-drug 
interaction is said to have independent action when the drug has no effect on the 
irradiated tissue. Some experimental drugs have a protective effect on irradiated 
tissue, reducing the toxic effects on normal tissue and thereby allowing a higher 
cancerocidal dose of radiation to be delivered to the tumour (Brown et al., 1984; 
Hirshfield-Bartek, 1992). Drugs specifically used for a protection effect were not in 
use at the study site and so are not included in any further discussion. 
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Enhancement interactions. 
Enhancement interactions occur when damage to normal and tumour tissue 
is greater with the combined effect of radiation and chemotherapy than either of 
the treatments alone. Enhancement is determined by looking at the cell survival 
curves for each agent. radiation and chemotherapy, and then mathematically 
determining the theoretical amount of tumour kill (Phillips, 1980). Enhancement 
interactions are further classified as additive, superadditive and sensitising. 
Hirshfield-Bartek (1992, p. 255) explains the difference between classifications 
thus: 
Additive reactions occur if the cell killing obtained with CMT is equal to the 
cell killing produced by each modality alone (i.e., 1+1=2) ... Superadditive 
reactions occur when the amount of cell kill is greater than would be 
expected from either modality alone (i.e., 1+1=3) ... Sensitisation responses 
result when agents that are relatively nontoxic when given alone produce an 
increase in tumour kill when given with radiation. 
It is logical to assume that chemotherapeutic agents that enhance the effect 
of raaiation on tumour cells will have a similar effect on normal cells thus increasing 
the severity of normal-tissue reactions. The agents with the highest likelihood of an 
additive or superadditive effect on the skin are adriamycin, actinomycin D, 
bleomycin sulfate, hydroxyurea, 5-fluorouracil, and methotrexate (McDonald, 
1992). Fu (1985) lists six possible mechanisms to explain the interaction between 
chemotherapy and radiotherapy that result in an enhanced effect (see Table 2.2). 
Appendix C lists 15 commonly used chemotherapeutic agents along with their 
mechanism of cytotoxicity and the possible mechanism of enhancement. 
The first three mechanisms focus on preventing the tumour cells from 
repairing following each fraction of radiation. The fourth mechanism, perturbation in 
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cell kinetics, relies on the effect of redistribution The fifth and sixth mechanisms, 
the improved blood supply and increased drug delivery and uptake, rely on the 
effect of reoxygenation. The enhancing effects of CMT have positive outcomes 1n 
terms of tumour eradication but the same effects on normal cells, such as the skin, 
will impact negatively. 
Table 2.2 
Possible Mechanisms of Interaction between Chemotherapy and Radiotherapy 
Resulting in an Enhanced Effect 
Mechanism of interaction 
o Modification of the slope of the response curve 
• Decreased accumulation of or inhibition of repair of sublethal damage 
• Inhibition of recovery from potentially lethal damage 
• Perturbation in cell kinetics with an increased proportion of cells in sensitive 
cell cycle phase and proliferative state 
• Decrease in tumour bulk -l> improved blood supply -l> reoxygenation and 
recruitment -l> increased radiosensitivity and chemosensitivity 
o Increased drug delivery and uptake 
Fu, K (1985). Biological basis for the interaction of chemotherapeutic agents and 
radiation therapy. Cancer(Suppl), May 12, p. 2125. 
Site of Treatment 
The variability in skin reaction by anatomic location has been documented. 
For example, the scalp has the greatest tolerance for radiation, followed in 
decreasing order by the face, neck, trunk, ears, groin, and extremities (Dutreix, 
1986). Hamilton et al. (1996) found that anatomical site was a significant factor in 
the variation of skin reaction severity. Interestingly, the relational factor suggested 
was sun exposure. In looking at the order Dutreix documented, the face and neck 
would be expected to have had greater sun exposure than the groin. Hamilton's 
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study shows that increased sun exposure increases the early erythema rather than 
making the skin more tolerant. Thus, there is a contradiction between the findings 
of the two studies. It is important to note that the study by Hamilton et al was 
conducted in Australia, known for its high levels of Ultra Violet (UV) radiation The 
impact of chronic exposure to UV radiation is discussed in greater detail in the 
section on the Personal Construct. 
Sitton (1992) discussed differences in skin reactions at sites where there was 
appositional skin. Areas such as that found in the axilla, inframammary area, groin 
and perineum, well known clinically to have mom severe reactions, are situated 
where there is close skin-to-skin contact. There is increased moisture, warmth and 
friction along with poor aeration at these sites. The mechanism increasing the 
reaction in these areas probably relates to the stratum comeum being shed at a 
faster rate than the newly forming epithelium can maintain. Any anatomical site at 
which friction is common, whether it be due to movement or clothing, is at risk of a 
more severe reaction. Typical trouble s~ >ts are the neck, where the collars of 
clothes rub; the axilla, where clothes and movement cause friction. and the 
inframammary fold, where there can be friction from a brassiere. Obesity or tr: 0 
wearing of tight clothing can further exacerbate this problem. 
Prediction Models 
Some fair1y sophisticated models for predicting normal tissue damage have 
been proposed, including the Nominal Standard Dose (Ellis, 1969), and the 
Cumulated Radiation Effect (Kirk, Gray & Watson, 1971). Some criticisms of these 
methods are evident in the literature. Notable authors such as Peters and Withers 
(1981) suggest that no single set of correction factors can be universally applied to 
an exact relationship of dose and time and that good clinical observation and 
judgement are necessary in dealing with nonn;il tissue damage. 
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More recently, predictions of acute and chronic effects have been based on 
the Linear Quadratic Equation (LOE) (Perez & Brady, 1992) which has been used 
widely since the early 1980s However. Hamilton et al. (1996) found, in a well 
controlled clinical study of 65 patients being treated palliatively, that erythema was 
much greater at low doses of radiation than the LOE would predict. The 
researchers noted the effect of pre-treatment erythema. gender, age and site of 
treatment. Erythema was measured in the study by reflectance spectrometry. 
These findings highlight the need to complete the 'picture' of nonnal tissue 
radiation reactions by including other factors other than radiation factors alone. 
Summary of the Radiation Construct 
The principal radiation factors influencing normal tissue damage are total 
dose, dose per fraction, volume treated, overall time taken for radiotherapy to be 
completed, quality of radiation, use of tangential beams. site of treatment and the 
presence of bolus material. Although it is well known that these factors impact on 
the severity of skin reactions, their predictive value has not been calculated on an 
individual patient basis. The literature presented has also highlighted the need to 
explore individual characteristics of patients to explain more fully patient-to-patient 
variation. 
Genetic Construct 
Observation and scientific investigation into the differences in radiosensitivity 
of cells bagan in the early 1900s when the French scientist, Regaud, found that 
seminiferous epithelia became less radiosensitive as they differentiated (Regaud, 
1906 cited in Peters, 1990, p. 178). These differences in radiosensitivity were 
noted, not only in different cell types from the same person but also in the same 
cell type from different people. This led to the hypothesis that genetically based 
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radiobiologic prognostic factors or predict:ve assays were possible (Peters. 1990) 
Although the research in this area has focussed on the radiosensitivity of tumour 
cells, some extrapolation has been made to normal cells. The concept that 
individual differences can be explained by genetic diversity is supported by the 
existence of inheritable syndromes that are partislly characterised by 
hypersensitivity to radiation. The most well known of these disorders is ataxia 
telangiectasia and clinical papers have been published considering the treatment 
modifications required in the case of such striking hypersensitivity (Abidir & 
Hakami, 1983; Hart, Kimler & Evans, 1987). Although rare, other genetic 
syndromes associated with increased susceptibility to cancer and hypersensitivity 
to radiation and chemical agents are Bloom's syndrome, Fanconi's anaemia, 
retinoblastoma, Down's syndrome, basal cell naevus syndrome, progeria and 
cancer prone families (Mahon & Casperson, 1995; Peters, 1990). 
Because hypersensitivity to radiation can be observed both in tissue 
reactions, and in cell cultures derived from them, the techniques used to develop 
predictive assays have found fibroblast and keratinocyte cultures to be particularly 
useful (Geara, Peters, Ang, Wike & Brock, 1992). Thus far, the research on the 
radiosensitivity of normal tissue has concentrated mainly on the late effects of 
treatment, often using telangiectasis as a model of late normal-tissue damage 
(Burnet, Nyman, Turesson, Wurma, Yamold & Peacock, 1992; Turesson, 1989; 
Turesson, 1990; Turesson & Thames, 1989). There is little work on the acute 
effects despite a long standing assumption that the acute skin reaction influences 
the course of the radiation reaction (Jolles & Harrison, 1966; Tucker, Turesson & 
Thames, 1992) and despite clinical research suggesting that moist desquamation 
in the acute phase is highly associated with the risk of developing telangiectasia 
(Bentzen & Overgaard, 1993). 
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The research. using cell cultures. is progressing and is gradually revealing 
the relative sensitivities of cell types. For example, fibroblasts show more variation 
in radiosensitivity between individuals than keratinocytes (Geara et al., 1992) 
Geara and colleagues call for further studies using the techniques developed to 
predict normal tissue responses to radiotherapy. Burnett et al. (1992) suggest that 
these techniques may be most useful in detecting patients at the extremes of 
reaction severity. Nevertheless, Burnett et al. suggest that there are practical 
problems associated with the processes of cell culture prediction: namely that they 
are slow, they require a high level of expertise and they are labour intensive. These 
features mean that cell culture predictive assays in their present form could not be 
used in clinical practice. These practical problems will no doubt be solved as the 
research in this area continues. 
The ability to identify genetic markers capable of predicting radiosensitivity of 
both tumour and normal cells and the development of cell culture techniques to test 
radiosensitivity in individuals would at first seem to negate the need for any other 
method of predicting radiosensitivity of normal tissue. However, the extensive effort 
that has been invested in the development of predictive assays has not yet 
explained why the same cell type (whether tumour or normal) in different people 
has such variability in its radiosensitivity (Bentzen, Overgaard & Overgaard, 1993; 
Tucker, Turesson & Thames, 1992). Tucker et al. also suggest that radiosensitivity 
is not the same for all cells in an individual, contrary to the prevailing theory that 
intrinsic radiosensitivity is dominated by a genetic component common to all cells. 
Bentzen and Overgaard {1993) support this suggestion deducing from their clinical 
research that the hypothesis specifying that all normal tissues of individual patients 
have a generally high or low radiosensitivity cannot be corroborated. 
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Moreover, in an extensive review of the literature, Peters (1990) concluded 
that cellular radiosensitivity, determined by in vitro diagnosis, is but one factor 
influencing treatment outcomes. This view is supported by Tucker et al., (1992, p. 
1783) who state" ... whether these [individual} differences are dominated by 
heterogeneity in intrinsic cell sensitivity or by other factors has yet to be 
determined". The other factors which Tucker et al., suggest are personal 
characteristics, such as age and smoking. These comments regarding the interplay 
of genetically based prediction and the role of "other factors" form the foundations 
for developing the conceptual framework and hypothesis of this study. 
Hendry (1994) applies the knowledge of these relationships, suggesting the 
possibility of moderating normal tissue damage through modifying individual 
characteristics such as diet and supporting the individual's resistance to infection 
with prophylactic antibiotics. Hendry recognises the impact of surgery t.nd 
chemotherapy on the promotion of cell proliferation and suggests that appropriate 
supportive therapy in the form of fluids, electrolytes and antibiotics may positively 
affect morbidity, ultimately resulting in an ability to give higher doses of radiation. 
Hendry's conclusions are based on animal models, but it is an interesting 
proposition to suggest that not only can "other factors· affect the individual 
expression of radiation reactions, but also the modification of these factors may in 
fact moderate the impact of genetically determined radiosensitivity. The importance 
of determining the relationship between these "other factors" is clear. Such 
knowledge could lead to preventative and supportive nursing management 
approaches. 
Summary of the Genetic Construct 
Understanding the impact of genetic make-up on the variability of 
radiosensitivity between people is vital to completing the picture of individual 
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differences in radiation reactions. It is clear there is substantial support for a 
genetic basis to individual differences in radiation reactions, but at this time the 
gene markers have not been identified and a feasible clinical method of 
detenrnning prediction through cell cultures has not been developed 
'Cancer proneness' may well be an indicator of heritable radiosensitivity, but 
the relationship between individual radiosensitivity expressed as a skin reaction 
and coming from a cancer prone family or having a hereditary cancer may, at best. 
be tenuous. 
There is also support for the influence of "other factors" in the expression and 
perhaps even moderation of the genetic radiosensitivity component. The strength 
of the relationships between potential factors has not yet been determined in 
humans. The "other factors" suggested in relation to the genetic component of 
individual differences in the expression of radiation reactions are discussed as 
concepts in the Personal Construct of the conceptual framework. 
Personal Construct 
The concepts included in the Personal Construct are those which are unique 
in combination to each individual. Although some may be considered as hereditary, 
such as allergy, or due to uncontrollable environmental factors, such as exposure 
to UV radiation, their impact is expressed uniquely in each individual. A principal 
argument in this construct is that the patient-to-patient variability in the expression 
of damage to normal tissue relates to the presence in the individual of factors 
known to affect tissue repair generally. To date there has been no empirical 
research investigating the relationship between the presence of factors that impair 
normal tissue repair and normal tissue damage in radiation skin reactions. 
Many factors affect the repair of normal tissue and those most pertinent to 
radiation reactions will be described. Although specific headings have been used to 
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organise this information, it should be noted that tissue repair is often affected by 
the interplay of several factors. Each factor is considered in the light of research on 
the healing of normal tissue and radiotherapy or cancer. 
Age 
The impact of increasing age on healing is difficult to isolate because of the 
general deterioration of all body systems and the likelihood of coexisting disease 
such as diabetes. The effects of ageing on the skin are as follows. Epidermal 
turnover decreases with age resulting in extended healing times and a greater 
likelihood of secondary infection following trauma. The ageing of cell lines results in 
thinning of the epidermis, particular1y in sun exposed areas and atrophy of the 
dermis through loss of collagen and reduction in the capillary network. Elastin 
fibres thicken and fragment while the vascular bed, collagen layers and fibroblasts 
diminish. Thinning of vascular walls explains the tendency of the skin in the older 
adult to bruise. Blister formation and the susceptibility to skin tear injuries occur as 
collagen fibres lose their elasticity (Staab & Hodges, 1996). 
It is logical that sun damage to the skin would accumulate with age due to the 
time available for exposure. Lifestyle habits, anatomic site and geographic location 
of course, temper this factor (Goldfarb, Ellis & Voorhees, 1990). Sun exposure also 
causes hyperplasia of sebaceous glands with a resulting increase in cyst, 
comedone and papule formation (Ogawa, 1975; Staab & Hodges, 1996). 
The vasculoconnective damage caused by ionizing radiation, as described in 
the section on radiohistopathology, when combined with the degenerative changes 
to the epidermis and underlying structures as described above, points to an 
exacerbation of the skin reactions as age increases. 
Age also brings with it an increased risk of malnutrition {Goldfarb et al., 
1990). Exton-Smith (1971) divided the causes into primary and secondary. Primary 
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causes included ignorance. social isolation. physical disability, mental disturbance. 
iatrogenic disorder and poverty. Secondary causes were impaired appetite, 
masticatory inefficiency, malabsorption, alcoholism, and medications. As the skin is 
composed of rapidly proliferating cells, they are among the first tissues to be 
affected by nutritional deficiency. 
Obesity, which is associated with increasing age and mature onset diabetes. 
may have a negative effect on the efficiency of healing (Carville, 1995; Dealey, 
1994). Excessive adipose tissue can compromise healing principally due to the 
poor vascularity of adipose tissue. Obesity can also cause excessive wear and tear 
on skin through increased friction on movement, causing abrasion. Obesity in 
surgical patients is also a factor in increased risk of postoperative infection. 
It is estimated that 50% of cancers occur in persons over the age of 65 years 
(Strohl, 1992). With the presence of co-existing illness or conditions and the ageing 
of normal cell lines, it is accepted that increasing age limits the healing ability of 
skin. It would seem logical to assume that any skin reaction will be more severe as 
age increases. Many authors cite age as one of the probable "other factors" 
(Denham et al., 1995; Hamilton et al., 1996; Holmes 1988; Tucker et al., 1992; 
Turesson, Nyman, Holmberg & Oden, 1996). However. the reducing frequency of 
mitosis that accompanies ageing needs to be considered. Less frequent mitosis 
may reduce the severity of acute reactions because the effects of ionizing radiation 
damage become apparent on cell replication. There may, then, be a balance 
between these two mechanisms with age not making a significant contribution to 
the skin reaction. 
Coexisting Disease 
Several illnesses directly impede the healing process and others affect 
healing through medication or reduced physical mobility inhibiting nutritional intake 
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and hygiene respectively. Age is a significant factor in increasing the likelihood of 
these problems. 
Diabetes mellitus. 
Uncontrolled glycosut,a weakens the inflammatory phase and impairs 
macrophage production. n,e increased iisk of infection and the retarded healing 
that results are further comi!ilour1ed bJ/ the presence of the diabetic complicatiors 
of neuropathy and ischaemia. Ulabetes mellitus has been investigated as a 
possible factor in unusually severe reactions to radiotherapy. Kucera, 
Enzelsberger, Eppel and Weghaupt (1987) found no differences between diabetics 
and non-diabetics in any side effects although a significant increase in urinary 
complications in diabetics was suggested by Bentzen and Overgaard (1994b). In 
view of the lack of published research in this area there is insufficient evidence on 
which to draw a conclusion about the role of diabetes on radiation reactions with 
nomial tissue. 
Autoimmune diseases. 
There are two general categories of autoimmune disease: collagen diseases 
(including systemic lupus erythematosis [SLE], demiatomyositis, poly-arteritis 
nodosa, sclerodem,a and rheumatoid arthritis); and haemolytic diseases (including 
idiopathic thrombocytopoenic purpura, acquired haemolytic anaemia and 
autoimmune leucopoenia). 
Autoimmune disorders retard healing in the inflammatory phase of tissue 
repair and the risk of infection is increased due to reduced leucocyte numbers. In 
addition to these conditions predisposing the patient to problems of pain and 
immobility, which of themselves inhibit healing, treatment of autoimmune diseases 
centres on the use of steroids, anti-inflammatory drugs, and immunosuppressive 
drugs. 
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A common assertion in the literature is that patients with a collagen vascular 
disease {CVD) such as rheumatoid arthritis or SLE, dermatomyositis and 
scleroderma are at greater risk for radiation side effects (Fleck, McNeese, 
Ellerbroek, Hunter & Holmes, 1989; Teo, Tai & Choy, 1989). Although case reports 
have highlighted the differences between CVD and non-CVD patients, a study 
using a retrospective matched pair design found no difference in the incidence of 
earty or late side effects (Ross, Hussey, Mayr & Davis, 1993). 
There is convincing evidence that patients with certain genetic diseases such 
as ataxia telangiectasia (AT) differ in their radiosensitivity. These diseases have 
been discussed in the section titled, Genetic Construct. 
Stress and Depression. 
The physiological responses to stress are well documented. The primary 
biochemical response to stress is the increased production of adrenocorticotrophic 
hormone (ACTH) stimulated by the release of adrenalin. ACTH stimulates the 
adrenal cortex in the production of glucocorticoids, cortisol and hydrocortisol 
(Vander et al., 1994). Glucocorticoids break down the body's glucose stores, 
raising the blood sugar. They also suppress the inflammatory response mediated 
by the immune system by reducing the mobility of granulocytes and macrophages, 
impeding their migration to the wound. Glucocorticoids also increase protein 
breakdown and nitrogen excretion which in tum inhibits endothelial cell 
regeneration and delays collagen synthesis (Dealey, 1994). 
Stress and anxiety can also be exacerbated by pain (Hayward, 1975) and 
socioeconomic problems including social isolation and poor housing (Dealey, 
1994). Grief and depression also affect appetite and represent yet another layer of 
complexity in the interplay of factors affecting the repair of normal tissue. The 
measurement of stress and depression was not within the scope of this study. 
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Allergy and/or Skin Sensitivities. 
Skin sensitivities or allergies may have an impact on the severity of reaction. 
The response of the skin to radiotherapy can be described in the same terms as a 
response to any physical trauma. When an abrasion, a cut or a bum damages skin, 
the body responds initially with inflammation. The inflammatory response, mediated 
by the immune system, rallies the body's resources to repair tissue and prevent 
infection. Similarly, when a known allergen is brought in contact with the skin, the 
immune response is rapid and an exaggerated reaction is noted. Clinical 
observation suggests that patients who have a history of allergic reaction may 
respond to irradiation in a similarly exaggerated way, potentially exacerbating the 
radiation skin reaction. This may also include patients who have a family history of 
allergic response. 
Pruritus is a common symptom of radiation skin reaction. The principal risk 
associated with pruritus is the overwhelming urge to scratch, causing further skin 
damage including skin loss. In addition to skin allergies, there are many benign and 
malignant diseases associated with pruritus. Benign diseases include diabetes, 
hyper- and hypothyroidism, parasitic infections, multiple sclerosis, 
psychophysiological or idiopathic conditions, drug reactions, chronic renal failure, 
iron-deficiency anaemia and non-malignant obstructive biliary disease. Malignant 
conditions particularly associated with itching are lymphoma, leukemia, sarcoma 
and carcinomas of the lung, biliary tree and pancreas (McDonald, 1992). In 
addition, pruritus is known to occur in the advanced and terminal stages of many 
carcinomas (De Conno et al., 1991). 
Infection 
The presence of infection or immunosuppression may also affect normal 
tissue response to radiation (Bentzen & Overgaard, 1994b; Chak, Gill, Levine, 
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Meyer, Anselmo & Petrovich, 1988). lmmunosuppression may be part of the causal 
chain in the development of infection in radiation reactions where the integrity of 
the skin has been compromised. 
Bacteria exist as part of the natural flora of the skin and mouth and will cause 
infection, given the opportunity that epithelial loss allows. There are four levels for 
classifying infection in wounds as described by Carville (1995): 
1. Clean, where the wound is made under aseptic conditions but does not 
interfere with the integrity of mucous membranes. 
2. Clean/contaminated, where either a surgical wound does interfere with 
mucous membranes or there is contamination by resident flora of the 
cavities, but there is no host reaction. 
3. Contaminated, where bacterial contamination results in a host reaction 
but no pus formation. 
4. Infected, where the clinical signs of infection are present with increased 
leucocyte and macrophage levels. 
Contamination in an open wound does "'':It affect healing, but clinical infection 
does by prolonging the inflammatory phase and inhibiting the ability of fibroblasts 
to produce collagen (Senter & Pringle, 1985}. Healing is also affected by the 
presence of infection due to the competition for white cells and nutrients. Healing 
may be delayed until the body has dealt with the infection. In addition. systemic 
infection causes fever, raising the metabolic rate, thus increasing catabolism and 
tissue breakdown. Pain, also produced by infection. may further increase the 
metabolic rate. 
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There are also many factors that may predispose an individual to infection 
Some of these care age, obesity, diabetes (Cruse & Foord, 1973); and drugs, 
particularly immunosuppressive drugs and steroids (Bibby, Collins & Ayliffe, 1986). 
Drug Therapy 
The effect of drugs in radiation skin reactions fall into two categories. those 
that enhance the effects of ionizing radiation and those that impair healing. The 
drugs that enhance the effects of radiation, specifically the anticancer 
chemotherapy agents, have been discussed under the heading Radiosensitisers. in 
section one of the chapter. Here. the focus will be on the impact of drugs on tissue 
repair. 
Steroids and Non Steroidal Anti-inflammatory Drugs [NSAIDs]. 
Both steroids and NSAIDs are used for a range of chronic and acute 
inflammatory conditions to reduce the swelling and pain of the inflammatory 
response by blocking prostaglandin synthesis. As prostaglandins are the principal 
mediators of inflammation, both drugs impair the healing process, particularly if 
they are used over a long term (Laurence & Bennett, 1987). 
Steroids also suppress the inflammatory and reconstruction phases of the 
healing process through inhibiting fibroblast proliferation (Westaby, 1995). 
Chemotherapeutic agents. 
Chemotherapeutic agents used to destroy cancer cells are unable to 
differentiate between normal and malignant cells. The majority of drugs destroy 
DNA in replicating cells or interfere with protein synthesis, directly affecting 
fibroblast production and collagen synthesis. In addition to the direct effect of 
cytotoxic drugs on normal tissue, the side effects often cause nausea, vomiting and 
diarrhoea thereby affecting nutritional status. Alopecia caused by some cytotoxic 
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drugs may result in changes in body image that may cause or exacerbate stress 
and feelings of depression. 
It would be expected that the effect of chemotherapy on normal cells when 
given prior to. or concurrently with, radiotherapy would impair the normal processes 
of tissue repair. The body would be less able to cope with the demands on the 
healing process in response to treatment with both radiotherapy and 
chemotherapy. 
In addition to their damaging effect on normal cells, cytotoxic drugs also have 
a suppressing effect on the immune system. The principal nsks of immune 
suppression are infection and bleeding. Healing is specifically impaired by a delay 
in clearance of debris through reduced white cell activity (Laurence & Bennett. 
1987). As a result. patients receiving chemotherapy are expected to be at risk of 
infection. This would be extended to patients receiving chemotherapy as an 
adjuvant to radiotherapy thereby increasing the risk of infection in any skin reaction 
particularly where moist desquamation has occurred. 
Other drugs may cause photosensitivity reactions (see Appendix D for a list 
of these drugs). The major difficulty with photosensitivity reactions is in masking the 
severity and recovery of skin reactions. 
Nutritional Status 
A balanced diet rich in essential nutrients is necessary to provide an ideal 
environment for optimal tissue repair. Malnutrition causes delay in healing and is 
generally the result of either insufficient intake or a problem of malabsc:'"'tion. 
Several factors affect nutritional status and often their impact has a 
compound effect on healing. Age and obesity have already been discussed in the 
light of their influence on healing and nutritional status. Hospitalisation, undergoing 
medical procedures, and surgery also affect patients' nutrition. Patients who are 
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not obviously at risk of undernutrition may fail to eat adequately for optimal healing 
whilst in hospital. Brown (1993) studied medical and surgical patients considered to 
have no special dietary requirements. Due to a failure to eat the food provided. 
68% of the patients had intakes of less than 1000 kcal and large deficits in a range 
of vitamins and minerals. Many patients with cancer, having had recent 
hospitalisations for surgery, are at greater risk of malnourishment given the 
additional nutrient depletion that can occur with malignancy (Smale, Mullen, Buzby 
& Rosato, 1981). 
Malignant disease is well recognised in compromising nutritional status. 
Bruera and MacDonald (1988) discuss malnutrition as one of the most frequent 
complications of advanced cancer, alleging that the prevalence is far greater in 
patients with solid tumours, children and the elderly. From their research, they 
found 51% of patients with advanced cancer and 80% of patients with terminal 
cancer were malnourished compared with just 2.3% of patients with breast cancer 
in the early stages of the disease. In reporting other studies with a total sample of 
3,047 patients, Bruera and MacDonald revealed that weight loss ranged from 37% 
of a sample of lymphoma patients to 87% in a sample of patients with gastric or 
pancreatic carcinomas. In a study of 54 hospitalised cancer patients, almost all 
patients had loss of adipose tissue, skeletal muscle or visceral protein (Nixon, 
Heynesfield & Cohen, 1980). The use or abuse of alcohol, smoking and prescribed 
or illicit drugs may also have an impact on the nutritional status of the patient 
generally. 
Some drugs, commonly used in the treatment of cancer and associated side 
effects, affect nutritional status directly or indirectly. The following are examples of 
drugs with a direct effect on nutrition: Neomycin, used for treatment of candidiasis, 
reduces the absorption of vitamins K and D; and Methotrexate, a cytotoxic agent 
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used in the treatment of breast cancer. interferes with folic acid and vitamin 
metabolism ultimately affecting the synthesis of DNA Smoking can have a direct 
effect on nutritional status as smokers in general have been found to be deficient 1n 
vitamins B,. ~. 8 12 and C 
A number of drugs are well known to affect nuiritional status indirectly by 
decreasing appetite. lndomethacin, morphine. digoxin, and cytotoxic drugs in 
general cause anorexia and they are in common use amongst patients with cancer 
(Dealey, 1994). Nicotine and excessive amounts of alcohol also act as appetite 
suppressants. Continued smoking and alcohol use during the treatment period is 
well known to potentiate the normal tissue damage in the mouth and throat 
(Bentzen & Overgaard, 1994b; Browman et al., 1993). 
Reduced Vascularjty and Impaired Oxygenation 
Turesson et al.. (1996) tested the predictive value of several patient 
characteristics in a sarr,ple of 402 women having 45Gy to the whole breast. The 
treatment protoco!s were varied as the sample was drawn from a larger study so a 
score was specially devised to represent the "total effect (TE)" of the radiation. 
Other than the TE, hypertension and specifically a high systolic blood pressure, 
was found to be predictive of more severe erythema as measured by reflectance 
spectrometry. These two variables accounted for about 30% of the variance in 
patient-to-patient variability. This study was published after the data collection for 
the present study was well underway, so measurement of blood pressure was not 
included in the research protocol. 
A good blood supply and an adequate supply of oxygen are essential to 
healing. Impaired oxygenation can be due to a number of illnesses affecting the 
haematological, respiratory, cardiovascular and/or peripheral vascular systems. 
Although tissue hypoxia stimulates angiogenesis (Knighton, Silver & Hunt, 1981) 
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continued hypoxia impairs all metabolism and the overall growth rate (Dealey. 
1994). 
Anaemia is important in radiotherapy because of its role in the transport of 
oxygen. No studies have specifically investigated the effect of haemoglobin level 
on normal skin exposed to radiotherapy and the study of the effect on other normal 
tissues has been minimal. One group of investigators identified a significant 
correlation between high haemoglobin concentration and the risk of radiation 
myelitis and speculated that the haemoglobin concentration affected the oxygen 
concentration in the spinal cord (Dische, Saunders & Warburton, 1986; Dische, 
Warburton & Saunders, 1988). It was also suggested in the 1986 study that a 
slightly depressed haemoglobin level led to a reduction in late normal tissue 
damage. However, in these reports no allowances were made for the smoking 
habits of the subjects which would alter the oxygen unloading capacity of 
haemoglobin (Overgaard, Nielson & Grau, 1992). 
Research from the wound healing literature suggests that cigarette smoke 
contains three to six percent carbon monoxide that in tum produced 
carboxyhaemoglobin. In addition to limiting the oxygen-carrying capacity, elevated 
carboxyhaemoglobin levels have been associated with changes in the endothelium 
and increased platelet stickiness. The latter problem can add to the limitation of 
local blood flow particularly in the presence of atherosclerosis (Cohen, Diegelmann 
& Lindblad, 1992). Also, in a review of literature on the effects of smoking on 
wound healing, Siana, Frankild and Gottrup (1992), found that nicotine affected 
macrophage activity and reduced epithelialisation. 
Early research by Moseley, Finseth and Goody (1978) investigated the effect 
of nicotine alone on the healing capacity of rabbit's ears. The rate of healing in the 
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experimental group was significantly retarded up to day 10, although healing 
continued at equal rates from day 12 to day 20. 
The primary mechanism of smoking on wound healing seems to be 
cutaneous vasoconstriction. The effect may be due to one or more of the 
constituents of cigarette smoke (Cohen. Diegelmann & Lindblad, 1992). In terms of 
radiotherapy where increasing the oxygenation of tissues is associated with 
increasing radiosensitivity. smoking may seem to have a potentially protective 
effect. The degree of reduced oxygenation due to cigarette smoking is probably 
insufficient to decrease radiosensitivity. In all likelihood, however, the reduced 
oxygenation will be sufficient to reduce the body's ability to heal. 
Cigarette smoking and nicotine abuse has been studied in regard to 
radiotherapy-related morbidity. The focus of most studies has been the ear1y or late 
reactions of the mucosa in head and neck cancers. that is, anatomical sites that 
are in direct contact with the cigarette smoke (Browman et al., 1993; Oes-Rochers, 
Dische & Saunders, 1992; Rugg, Saunders & Dische, 1990}. No studies have 
specifically investigated the severity of skin reactions and smoking. In a study of 
the effects of cigarette smoking and diabetes mellitus, a greater proportion of 
smokers were found to suffer from severe irreversible side effects than the non-
smokers (Kucera, Enzelberger, Eppel & Weghaupt, 1987). Unfortunately, these 
side effects were not described in any detail. Nevertheless, the research is on 
oxygenation is conclusive that it is an important component in influencing the 
response of tumour and normal tissue to irradiation. 
Skin Colour and Condition 
There is no research available on the possible impact of the colour or 
condition of the skin in the treatment field. However, there is some anecdotal 
support to suggest that individuals with fair or pale skin have more severe skin 
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reactions. The colour of the skin is, as previously described, created by the number 
of melanocytes present, the basic yellowness of the subcutaneous fat and the 
vascularity of the area. Basic skin colour has a genetic basis but the colour is 
modified through exposure to the elements, in particular UV radiation. Melanocytes 
protect underlying structures from the effects of UV radiation and are activated 
whenever exposure occurs. The mechanisms for damage to skin cells from ionizing 
radiation and UV radiation are not the same: it may be that where the skin has 
suffered damage from chronic UV exposure its ability to heal may be impaired. 
The type of skin reaction to the sun in terms of tanning and burning, which 
individuals experience may determine the extent of UV damage. If an individual 
bums easily in the sun and does not tan readily then the probability that they have 
spent a lot of time in the sun unprotected by clothing or sunscreen is reduced. 
Individuals with a propensity to tan and not bum are more likely to spend time in 
the sun unprotected and therefore have more chronic sun damage. 
The condition of the skin, whether it is dry, normal or oily indicates the normal 
rate of desquamation of the stratum comeum. If dry skin is present in the radiation 
treatment area then the effects of the ionizing radiation may be more pronounced 
and the usual management of skin in reducing the normal rate of desquamation 
from the stratum comeum less effective. 
Exposure to Ultraviolet Radiation 
Ultraviolet (UV} radiauon, emitted by the sun, can be divided into three 
components UV-A, UV-8 and UV-C. UV radiation has some beneficial effects, such 
as its role in Vitamin D synthesis; in the treatment of neonatal jaundice; and in the 
treatment of skin conditions such as psoriasis but the effects, particularly of UV-B, 
can also be detrimental. UV-B is known for its role in mediating damaging 
photochemical reactions in the skin, including DNA damage, through the 
Theoretical Foundations and Literature Review 45 
generation of free oxygen radicals (Browder & Beers, 1993). These reactions can 
cause mutation, death or transformation in a number of cells including epidermal 
cells, with the resultant effect of causing carcinogenesis (Young, 1990). 
Most of the research in this area focuses on the development of skin cancer. 
Of relevance here, however, is that the mechanism for carcinogenesis is based on 
systemic immune suppression caused by UV-B (Jacobson & Flowers, 1996). This 
alteration to the immune system may also have a suppressing effect on the 
inflammatory phase of normal tissue repair. 
Melanocytes are activated by UV radiation to produce melanin, creating a 
protective chemical barrier against the effects of UV radiation. The effects of UV 
radiation are cumulative and, therefore, the evidence of exposure is a noticeable 
aspect of ageing skin. Chronic sun exposure thins the epidermis and atypical 
keratinocytes become more prevalent (Jacobson & Flowers, 1996). Although 
melanocytes are normally activated by UV radiation, with chronic exposure, some 
melanocytes are destroyed by UV radiation and some are stimulated. This non-
uniform reaction manifests as spotty hypopigmentation juxtaposed with areas of 
hyperpigmentation (Goldfarb et al., 1990). 
Marked changes occur to the dermis with years of UV exposure. The 
connective tissue forms irregular clumps in a process called solar elastosis. The 
first noticeable change of solar elastosis is wrinkling. Wrinkling does not c.1ccur in 
some of the most sun exposed areas such as the nose or ears, thus it seems to be 
confined to skin that is elastic (Goldfarb et al., 1990). Solar elastosis is also 
responsible for the yellowing and roughened texture of skin giving it a ... weather-
beaten" appearance (Gilchrist, 1984). 
Cutis Rhomboidalis Nuchae is a common condition in men after many years 
of sun exposure characterised by deep furrows on the back of the neck forming a 
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rhomboid pattern (Ogawa, 1975). The skin is thickened and may be yellow or red 
(Goldfarb et al., 1990). 
UV exposure is known to have a detrimental effect on the condition of the 
skin, affecting its ability to protect the body from UV radiation damage and 
impairing the healing of the skin. It seems logical to suggest, then, that the effects 
of UV radiation may also exacerbate the severity of radiation skin reactions. This 
phenomenon has received only fleeting mention in the published radiation 
oncology nursing literature (Sitton, 1992). It has, however, been noted clinically that 
the reaction observed in areas commonly exposed to UV such as the he~d. neck 
and upper chest can be dramatically worse than adjacent areas of skin that are 
less commonly exposed. 
Furthermore, work published by a radiation oncology research group in 
Australia suggests that prior sun damage increases the baseline erythema when 
measured by reflectance spectrometry (Denham et al., 1995) and increases the 
severity of early erythema. Neither of these studies specified how prior sun 
damage was assessed. Whether this phenomenon is exaggerated in Australian 
patients due to the intensity and aspect of sunlight in Australia is not known. 
Summary of the Personal Construct 
Radiation has a damaging effect on normal tissue and inhibits the process of 
tissue repair through damage to vasculoconnective tissue. The variation in 
expression of radiation skin reactions may be attributed not only to the known 
radiation factors but also to the genetic and personal factors that combine 
differenUy for each individual. 
Patients with cancer facing radiotherapy may be experiencing many of the 
factors that impair healing: anorexia-cachexia, malnutrition, anaemia, some 
metabolic alterations, impaired mobility, old age, disturbances in blood circulation, 
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strass, anxiety and neurological disorders. These conditions have the potential to 
be detrimental to the repair of the epithelium (Bruera & MacDonald, 1988; 
Jacobson & Flowers, 1996; Taylor, Moran & Jackson, 1989). In addition, such 
patients are likely to have been hospitalised for surgery and may have had, or are 
having, chemotherapy. To date, the interplay of these factors and their effect on 
radiation skin reactions has not been empirically tested. 
Relationships Between the Constructs of the Conceptual Framework 
To have a radiation skin reaction one element is essential, ionizing radiation. 
The relationship between the Radiotherapeutic Construct and the severity of the 
radiation reaction is undisputed, although the degree to which the patient-to-patient 
variation can be explained by the radiation alone is not known. When the same 
treatment protocol is used, such as in the treatment of early breast cancer, then the 
radiation becomes more constant and investigation of individual variations can be 
more clearly related to the presence of "other factors" 
Events occurring in normal tissues following irradiation, as described in the 
section on radiation histopathology, highlight the recovery or repair process as an 
esset1tial component affecting the severity of the reaction. If the individual's ability 
to repair damaged normal cells is poor, then it would be expected that the reaction 
would be more severe. Therefore, the presence of factors known to have a 
detrimental effect on wound healing such as smoking, poor nutrition, coexisting 
chronic illnesses and some drugs, would also have a detrimental effect on radiation 
reactions. 
The role of the Genetic Construct in this conceptual framework is in the 
genetic predisposition to factors which impair healing, such as chronic illness or 
factors which potentiate the effects of radiation; for example, the genetic condition, 
Ataxia Telangiectasia, known to produce a highly radiosensitive response. 
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Theoretical relationships between the constructs and the resultant radiation 
reactions formed the main hypothesis of the study: That the patient-to-patient 
variation in radiation normal tissue reactions results from the combined effect of 
some or all of the personal and genetic factors plus the radiation factors. 
This can be illustrated in the formula: 
Radiation Skin Radiation 
Reactions c: Factors 
Genetic 
+ Factors 
Personal 
+ Factors 
Measurement Issues in Operationalising the Conceptual Framework 
Dependent Variable - Radiation Skin Reactions 
Previous studies investigating skin reactions have relied on highly technical 
equipment that is not available in the average radiotherapy department; for 
example, reflectance spectrometry for measurement of erythema (e.g. Denham et 
al., 1995; Hamilton et al., 1996; Tucker et al., 1992; T1irreson & Notter, 1886; 
Turreson & Thames, 1989). However these are not available on a day to day basis 
and, more importantly, nurses are not skilled in their use. Therefore. to make the 
final instrument useful in day-to-day practice the equipment must be available to 
nurses at all times. 
A number of scales have been devised for clinical use to assess the 
progressive development of skin reactions. The most commonly used scales are 
those devised by Yasko (1983), McNally, et al. (1985) and the Radiation Therapy 
Oncology Group [RTOG] and the European Organisation for Research and 
Treatment of Cancer [EORTC] (Cox, Stetz & Pajak, 1995). There are some 
similarities in the scales in that the progression of increasing severity is 
conceptualised as an ordinal scale and each level of the scale is given a brief 
description. 
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Yasko's (1983) system has four stages (1 - 4) and follows the pattern of the 
acute skin reactions for the first three stages and then in the fourth level introduces 
chronic reactions. McNally, et al's (1985) S)'stem also has only three stages with 
each stage encompassing a broad range of possible reactions. The system is not 
specific to the skin alone, but the lack of adequate description in the stages makes 
its validity questionable. 
The scoring criteria for acute radiation reac!ions were developed by the 
RTOG/EORTC in 1985 to complement the long-standing scoring system for late 
(chronic) reactions (Cox et al., 1995). The acute scale has six levels with ·o· 
meaning an absence of radiation reaction and '5' meaning that the effects of the 
radiation led to the death of the patient. The severity of reactions is graded from 
one through four although in fact a grading of three is considered severe. 
No psychometric testing has been reported for any of these scales. The 
RTOG/EORTC, by the nature of its development by a group of expert radiation 
oncologists (Perez & Brady, 1992) and its subsequent use in many research 
studies (Dische. 1994), has established a measure of content validity. Only one 
study was found that tested clinicians' scoring of skin reactions with the 
RTOG/EORTC scale by comparing it with reflectance spectrometry. Denham et al., 
(1995) found that RTOG scores were lower than spectrometry readings in male 
patients, melanin pigmented and sun-exposed anatomical sites. Other than this 
discrepancy, the relationship between the two methods did not vary substantially 
during the development of the reaction. However, whilst a reasonable correlation 
was found between spectrometry readings and RTOG scoring, inter-rater reliability 
among clinicians was poor. The article does not indicate how many clinicians were 
involved in the observations, or if the conclusion was reached through statistical 
Theoretical Foundations and Literature Review 50 
analysis. Reliability is, however, an important aspect to consider in controlling an 
observational study based on visual assessment with the RTOG scoring system. 
Independent Variables - Predictive Factors 
Factors included in the Radiation Construct are objective items. The 
collection of this data requires only an easy-to-use method of transferring data from 
the medical record to the data collection form to ensure accuracy in documentation. 
The measurement of factors included in the Genetic Construct was not within the 
scope of this project. However, secondary measures such as a personal and/or 
family history of cancer were included. 
The Personal Construct includes the collection of some objective data, such 
as age or type of chemotherapy and some measured phenomena such as 
cumulative UV radiation exposure. Although factors which impair optimal healing 
such as age, nutrition, medications and coexisting disease are well recognised, no 
previous research in the wound care literature has attempted to quantify them. In 
other words, there is no known effect size for any of these factors. Thus, despite 
there being a logical theoretical relationship between the constructs, there is little or 
no empirical evidence to assist in overcoming the pragmatics of testing the model. 
Therefore, to determine which of the identified factors or combination of 
factors best predict the individual differences in skin reactions, an inclusive 
approach was considered appropriate. This means that as many factors as 
possible were measured to explore individual and combined effects. Also, 
wherever possible, similar characteristics (such as disease or treatment factors) 
were grouped together to provide as much control as possible over the multitude of 
potential extraneous variables. Details of the measures used to collect data for the 
Personal Construct are presented in Chapter Three. 
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Chapter Summary 
The purpose of this chapter was to review and critique the literature to 
construct a conceptual framework upon which the empirical study of factors 
impacting on the severity of skin reactions to radiation therapy could be based. The 
conceptual framework, draws together two bodies of knowledge, radiation oncology 
and wound management. The scientific research and clinical knowledge presented 
here shows that the interplay of radiation, genetic, and personal factors explains to 
some degree, patient-to-patient variability in normal tissue responses encountered 
in radiation oncology practice. 
The complexity of conducting research that considers the impact of personal 
factors on the severity of skin reactions is evident in the few studies that have been 
published. To overcome some of the difficulties, Denham et al. (1995) recommend 
that future research be confined to the study of one site and one gender. 
Management of radiation skin reactions provides a daily challenge to the 
interdisciplinary team in radiation oncology. For clinically utility it is not only 
important to determine the influence of the aforementioned concepts on patient-to-
patient variability, but also find practical measures that can be used on a day-to-
day basis. 
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CHAPTER 3 
THE RESEARCH PROCESS 
This chapter presents the methods used to collect and analyse data for the 
study. Details of the sample and setting, design, measures. procedures, analysis 
and ethical considerations are described. 
Sample 
The sample was drawn from the population of patients com.--,encing 
radiotherapy for cancer of the breast. A total of 128 women who met the following 
selection criteria were approached to join the study: 
o Adult women e 18 years old) 
e Able to verbally communicate sufficiently well in English to understand the 
purpose and nature of the study in order to give consent, and complete the 
interview. 
e Diagnosed with primary breast cancer at any stage who had undergone 
surgical removal of the breast tumour (lumpectomy) with or without axillary 
node clearance. 
o Commencing the standard post~lumpectomy radiotherapy protocol of 45 Gy to 
the whole breast delivered by two tangential fields in daily fractions of 1.8 Gy 
for 25 days, five days per week, followed by a 20 Gy electron boost (6MeV or 9 
MeV) to the lumpectomy scar delivered by one field in daily fractions of 2 Gy for 
1 O days, five days per week. 
Of the 128 women who were approached, 126 agreed to participate in the 
study. One person refused because she was too busy and the other felt too weak. 
There were no withdrawals from the study. Recruitment continued over a 12-month 
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period. The entire data collection period including a follow-up of all cases was 14 
months from May 1996 to June 1997 inclusively. 
Setting 
The setting for the study was the Radiation Oncology Department of a major 
metropolitan, public teaching hospital located in Perth, Western Australia (WA), 
hereafter known as the Department. During a 12-month period the Department 
receives over 1200 new referrals and administers approximately 1350 treatment 
courses. An average of 105 patients are treated each day. 
Design 
A prospective, descriptive correlational, repeated measures design was used 
to detemiine predictors of skin reaction severity in patients being treated with 
radiotherapy for breast cancer. This design facilitated the correlation of identified 
factors with the development of radiation reactions experienced by participants. 
The dependent variable was the severity of radiation skin reaction as measured by 
the RTOG scoring system. The independent (predictive) variables were the factors 
identified in the theoretical framework through review of the literature and clinical 
knowledge. 
Data were collected at weekly intervals over the seven weeks of treatment. In 
addition to the observation of the skin reaction at each time point, a pain score was 
recorded along with a description of the nursing interventions that had been 
instigated. Comments from participants and observers were also recorded. 
Instruments 
Operationalisation of the conceptual framework is described in this section. 
Figure 3.1 depicts the concepts and constructs that will be detailed subsequently. 
CONSTRUCT RADIATION RADIATION GENTETIC PERSONAL PERSONAL PERSONAL PERSONAL 
LEVEL SKIN FACTORS FACTORS FACTORS FACTORS FACTORS FACTORS 
REACTION (Disease related) (Treatment related) (General health) (Skin condition) 
CONCEPT a. Erythema Dose Previous Tumour histology a. Condition of scars Age Skin condition 
LEVEL cancer 
a. itchiness Fractionation Stage of disease b. Lymph drainage Chronic illness Skin allergies 
a. Dry skin Treatment Family history Time since diagnosis c. Chemotherapy for Prescribed drugs Family history 
loss length of cancer this cancer of allergies 
a. Moist skin Energy Recurrences b& Self-medication/ 
loss c Chemotherapy alternative drugs Reaction of skin 
or radiotherapy for to UV radiation 
previous cancer 
Smoking history 
b. Pain Cumulative 
Alcohol intake UV exposure 
Weight (kg) Geographic 
location 
Height (cm) 
Breast (bra) siza 
Nutritional intake I ::c Alternative diet I MEASURE- a. RTOG Radiation Participant Medical notes a. Observation Participant report Participant report 
"O 
MENT scoring prescription report I LEVEL system b. Participant report 
b. VAS- pain c. Medical notes 
Figure 3. 1 Operationalisation of the Conceptual Framework I U1 ,,.,.. 
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Dependent Variable - Severity of Radiation Skin Reactions 
As shown in Figure 3. 1. the severity of radiation skin reactions was indexed 
with two instruments, RTOG scoring system and a visual analogue scale (VAS) to 
measure pain. The breast area was divided into eight anatomical sites and a score 
recorded for each site at each observation. The sites were: midlinc chest 
(sternum); axilla; inframammary fold: nipple; and the four quadrants of the breast, 
upper outer quadrant (UOQ), upper inner quadrant (UIQ), lower outer quadrant 
(LOO). and lower inner quadrant (LIQ). The data collection form for recording 
weekly observations is presented in Appendix E. 
The RTOG Scoring System 
The RTOG Scoring System for Acute Radiation Morbidity was developed by 
groups of expert physicians as part of the RTOG over some 25 years {Dische, 
1994). The scoring has been used extensively in empirical studies {Dische) and is 
used routinely in the Department as a standard measure for documenting skin 
reactions. 
Other scoring systems have been devised; however, they have fewer 
categories and do not distinguish between acute and chronic reactions (see 
literature review}. The RTOG, therefore, was judged to have more specificity, is 
used extensively in clinical research and is accepted generally in the medical and 
nursing communities. The validity of the scoring system is based on these 
credentials as no formal psychometric testing of the RTOG has been published. 
The current form of the scoring system was published in 1995 in a special issue of 
the International Journal of Radiation Oncology Biology Physics (Cox, Stetz & 
Pajak, 1995). Descriptors for skin reactions used in the study are detailed in Table 
3.1. 
Table 3.1 
BTOG Score System for Acute Radiation Skin Reactions 
1 
RTOG· 
2 
Follicular, faint or Tender or bright 
dull erythema. erythema, patchy 
epilation, dry moist 
desquamation, desquamation, 
decreased moderate 
sweating. oedema. 
$CORES 
3 
Confluent, moist 
desquamation 
other than skin 
folds, pitting 
oedema. 
* RTOG Score of O = No change over baseline 
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4 
Ulceration, 
haemorrhage, 
necrosis. 
The RTOG system scores radiation reaction severity on an ordinal scale from 
zero to four. Zero represents no change from the baseline observation with each 
subsequent category depicting increasing severity as the score increases. 
lnterrater Reliability 
lnterrater reliability (IRR) in the use of the RTOG was tested at the 
commencement of data collection and at random times throughout the data 
collection period. Over the 14 months of data collection, 30 sets of observations 
(observation of the eight anatomical areas made one set) were included in the IRR 
testing, occurring approximately at fortnightly intervals. 
Over the study period, three people were involved in the observation of skin 
reactions, two research assistants and the researcher. All three observers were 
experienced in radiation oncology nursing. IRR was tested between two observers 
at a time because the use of three observers would have been practically difficult 
and intrusive to the patient. The researcher was always one of the two observers. 
The procedure for IRR testing was to examine a patient's skin together and then 
record the observation on separate sheets. 
IRR scores were generally high with an overall reliability of r = 0.85. The IRR 
for each observation site of the breast are detailed in Table 3.2. Discrepancies 
arose most often when the skin was changing from a RTOG 1 to RTOG 2 rating. 
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Table 3.2 
Overall lnterrater Reliability by Site on Breast over the Study Period. 
Site 
Sternum 
Axilla 
Upper Outer Quadrant 
Upper Inner Quadrant 
Lower Outer Quadrant 
Lower Inner Quadrant 
Nipple 
lnframammary Fold 
Modifications to the RTOG Scoring System 
Average IRR Coefficients (range) 
r = 0.90 (0.80 - 1.00) 
r = 0.90 (0.80 - 1.00) 
r = 0.90 (0.75 - 1.00) 
r = 0.85 (0. 70 - 1.00) 
r = 0.80 (0.70 - 1.00) 
r = 0.80 (0. 70 - 1.00) 
r = 0. 75 (0.60 - 1.00) 
r = 0.90 (0.80 - 1.00) 
After completing the data collection on the first 20 patients, a problem 
emerged in the definition of RTOG 2. There was a clear difference in the 
participant's perception of the skin reaction severity between "bright tender 
erythema", and "patchy moist desquamation". That is, patients perceived loss of 
even a small patch of skin worse than tender bright red skin. The decision was 
made to differentiate between these two reactions recording bright tender 
erythema as "2", and patchy moist desquamation as "2.5" as this would provide 
more specific information for predicting outcomes. 
A recent study (Denham et al., 1995) also found it necessary to modify the 
RTOG scoring. They split RTOG 1 rather than RTOG 2. The decision in this study 
to split RTOG 2 was based on what participants saw as a discrepancy in skin 
reaction severity scores as described by the RTOG system. 
Another modification was made due to the use of retention tape dressings to 
prevent fragile skin from breaking down. The use of retention tape dressings, such 
as Fixomull, Hypafix and Mefix) for thf' management of radiation skin reactions was 
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developed by nursing staff in the Department and was a standard feature in the 
skin care protocol (Downes, Porock & Upright, 1997). Retention tape is placed over 
areas of moist desquamation to reduce pain and the risk of infection. However, 
when the skin is assessed to be very fragile and breakdown is seen to be 
imminent, the tape is used to prevent skin loss. Retention tapes, when used as 
wound dressings, adhere to the skin and can remain intact for up to three weeks. 
Radiotherapy can continue with the tape in situ, as it is thin enough not to create a 
significant bolus effect (Downes et al.). This protocol could not be disrupted during 
the course of the study. Thus, when a retention tape was recorded, a score of 2.5 
was given to that site even when moist desquamation had not actually occurred as 
it was anticipated that had the tape not been used, the skin would have broken 
down. 
Pain is an aspect of radiation reactions that is not included on the RTOG 
scoring system other than by the term "tender" in RTOG 2. Pain was, therefore. 
measured separately using a VAS where "zero" represented no pain and "ten" 
represented the worst pain the patient could imagine. The VAS is a unidimensional 
measure of the perception of pain based on the premise that pain is what the 
patient describes it to be. Participants were asked to rate the worst pain they had 
experienced with the skin reaction during the week preceding each observation. 
The pain score was recorded on the data collection form for recording weekly 
observations of skin reactions {Appendix E). 
Independent Variables 
As indicated in the conceptual framework, and illustrated in Figure 3.1. there 
were many possible independent variables acting alone or in concert to increase 
the severity of the radiation skin reactions. The data collected and tools used to 
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measure factors from each construct are presented first, followed by a description 
of content validity and reliability testing. 
Radiotherapy Construct 
The factors identified in the conceptual framework that comprise the 
Radiotherapy Construct required careful documentation from the prescription for 
radiotherapy. At the end of the treatment period, a treatment summary was written 
by a radiation therapist from the planning section of the Department indicating the 
total dose, dose per fraction, energy used for the electron boost and the total 
number of days of treatment (including weekends and missed days). 
Genetic Construct 
The data collected for this construct were indirect indicators of personal or 
familial genetic makeup. Other tests of radiosensitivity or cancer proneness were 
beyond the scope and purpose of this study. The two items used were previous 
personal history of cancer, and a family history of any type of cancer. 
Personal Construct 
The personal construct was the largest construct and the main focus of the 
study. For ease of discussion the construct has been divided into four categories: 
disease related factors, treatment related factors, general health factors and the 
condition of the skin at commencement of radiotherapy. 
Personal Construct- Disease-Related Factors 
Data for disease-related factors were obtained from the medical record of 
each participant. Specifically, the histology and staging of the tumour were 
obtained from the pathology report after surgery. Time since diagnosis was 
calculated from the date of surgery to the start of radiotherapy. 
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Personal Construct - Treatment-Related Factors 
The two main areas of data to be collected as treatment-related factors were 
in relation to the surgical and chemotherapeutic effects of cancer treatment prior to 
commencing radiation. In addition, data from treatment with radiation or 
chemotherapy from any previous cancer treatment were documented. 
The condition of the surgical scars at the lumpectomy site and from axillary 
clearance was an important aspect in assessing the condition of the skin at the 
commencement of treatment. In consultation with a microbiologist and a clinical 
nurse consultant for wound care, an ordinal scale was developed. The scale was 
reviewed informally for content validity by four experts in surgical wounds (two 
surgical nurses and two wound care consultant nurses) and an agreement of r = 
1.00 was achieved. The scar was observed during the first week of treatment and 
recorded as follows. 
The scar: (1) is fading; (2) is inflamed (3) has haemoserous discharge (4) has 
purulent discharge 
Details of concurrent and completed chemotherapy in relation to treatment of 
the current breast cancer were taken from the participant's medical record. 
Information regarding any previous chemotherapy or radiotherapy for the treatment 
of any previous cancer was documented from the participant's self-report and 
cross-checked in the medical record. 
Personal Construct - General Health 
Data for the general health section of the Personal Construct were primarily 
collected by participant report or from the medical record (see Figure 3.1 ). 
However, several factors required more measurement as described below. 
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Nutritional intake. 
Nutritional intake was measured using a subscale of the Braden Scale for 
pressure ulcer risk prediction (Braden & Bergstrom, 1989). The Braden Scale is 
comprised of six subscales developed from the aetiology of pressure ulcers 
{Braden & Bergstrom, 1987). The nutritional intake subscale was chosen because 
its underlying assumption was identical to this study: that poor nutritional intake 
resulted in poor wound healing. 
The scale has undergone a variety of psychometric tests. Content validity 
was established by an expert panel and two studies of IRR were conducted in 
extended care facilities; r = 0.99, and r = 0.83 - 0.87 (Bergstrom, Braden, Laguzza 
& Holman, 1987). 
The nutritional intake subscale is intended to measure a person's usual food 
intake pattern rather than a temporary poor or negligible intake. If a person's intake 
has been poor over a long period and food supplements have just been 
commenced, then the rating would reflect the usual poor intak.e. Any change in 
intake should be maintained for one week before it is considered usual (Braden & 
Bergstrom, 1989). 
Personal Construct - Skin Type and Condition 
Measurement of the factors in the skin type and condition section of the 
Personal Construct required the most development, as there was little published in 
this area. 
Severity of skin allergies. 
A scale to measure the severity of skin allergies was developed with the help of 
a microbiologist and clinical nurse consultant for wound care. Scale responses 
were structured in the following manner: (1) Mild reaction {dry and peeling), (2) 
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Moderate reaction (as above plus red and itchy), (3) Severe reaction (as above 
plus blisters/oozing). 
An expert panel of four nurses as described above, reviewed the scale for 
content validity and the agreement achieved was r = 1.00. Study participants, who 
had reported skin allergy as a problem, were asked to choose a response from the 
scale that most closely fitted the severity of their skin to the presence of an 
allergen. 
Family history of skin allergies was measured using a simple "yes/no" 
question to ascertain the presence of a family history. Participants were also asked 
to record the number of family members with a skin allergy problem and their 
relationship to the participant. Only first or second-degree blood relatives were 
included in any analysis. 
Skin type. 
After review of the electronic data bases for references to non-invasive 
measures of skin type, discussion with a Consultant Dermatologist revealed a well-
known dermatology clinical scale for skin type in relation to reaction to the sun; the 
Fitzgerald scale (Harber & Bickers, 1981). The scale comprises six ordinal 
descriptors as shown in Table 3.3. Patients are asked to report their skin reaction 
to the sun following 30 to 45 minutes of unprotected sun exposure after the winter 
season or a long period of no sun exposure. 
The Fitzgerald scale correlates with more invasive measures of skin colour. 
For example, the correlation between the Fitzgerald Scale and melanin density, as 
measured by punch biopsy, is r = 0.49 (p = .001) (Dwyer, Blizzard & Ashbolt, 
1996). The scale appears to be part of the tacit knowledge of dermatology, and no 
record of its development or formal testing for validity and reliability was found. 
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Table 3.3 
The Fitzgerald Scale 
I 
II 
111 
IV 
V 
VI 
Skin Type Sunburn and Tanning History 
Always bums easily, never tans (sensitive) 
Always bums easily, tans minimally (sensitive) 
Bums moderately, tans gradually (normal) 
Bums minimally, always tans well (normal) 
Rarely bums, tans profusely (dark brown, insensitive) 
Never bums, deeply pigmented (insensitive) 
Exposure to ultraviolet (UV} radiation 
A non-invasive measurement of the cumulative effects of UV radiation was 
not located. The factors involved in exposure to the sun relate to lifestyle, such as 
sunbathing habits and use of protective measures. These are understandably 
subject to a large degree of recall bias. A small qualitative study was conducted six 
months prior to the main data collection to identify ways in which people described 
their exposure to the sun. The purpose was to find a way to capture the effect of 
lifestyle factors as potential predictive factors. The hypothesis was that a greater 
cumulative exposure to the damaging effects of UV radiation was associated with 
the development of more severe radiation skin reactions in sun exposed areas 
such as the sternum. 
After approval was gained from the hospital ethics committee, interviews with 
six patients from the Department were undertaken. A further four healthy adults 
were interviewed to identify if there were any additional factors not considered by 
patients. Data were recorded as field notes and examined for themes. Three 
themes emerged from the patient interviews and no new themes emerged from the 
additional interviews with the healthy adults. 
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The themes were: 
1. Where free time was spent - indoors, outdoors or both 
2. Where work occurfied - indoors, outdoors or both 
3. How often sun protection was used - almost always, often, sometimes, almost 
never. 
The themes were further categorised by differences in their activities and 
behaviours as children and as adults, and differences due to geographic location, 
for example living in Australia versus Britain. 
The developed scale was included in the content validity package sent to the 
original five-member panel of experts in radiation oncology. The co-efficient of 
expert agreement on content validity for this scale was r = 1.00. Study participants 
were asked to choose a response from the scale that most closely matched their 
history of sun exposure. The cut off point between childhood and adulthood at 15 
years of age was based on tha skin cancer risk factors. The complete scale is 
presented in the data collection form found on page 204, Appendix F. 
Content Validity 
The first step in developing the data collection methods was to assess the 
content validity of the factors identified in the conceptual framework. The content 
validity of the conceptual framework and tools for measuring variables was 
assessed using Lynn's (1986) method of determining agreement between 
members of an expert panel. In this method, each expert independently rates the 
items of the instrument and indicates, in their opinion, to which of four set 
categories the item belongs. The categories are: 1. Not relevant; 2. Unable to 
assess without item revision; 3. Relevant but needs minor alteration; 4. Very 
relevant and succinct. 
When the responses have been collated, percent agreement among the 
experts is calculated. The table of correlation coefficients formulated by Lynn 
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{1986), indicates the number of experts from a panel who must agree to reach 
significant agreement when oc = 0.05. The number of experts in a panel affects the 
number required to achieve significant agreement. For example, to achieve 
significance with a panel of two requires both experts to agree, whereas a panel of 
five requires four experts to agree. If a particular item is rated as ca! .gory 3 
(relevant but needs minor alteration) or 4 (very relevant and succinct), then it is 
deemed to be a valid item. Lynn {1986) also suggests that an agreement 
coefficient of over 0.80 is required before content validity is deemed established. 
The procedure for assessing content validity of the predictive factors in this 
study was as follows. Five expert radiotherapy practitioners, two nurses, two 
consultant radiation oncologists and one radiation therapist were approached by 
phone and all agreed to assist in the exercise. Each member of the panel was sent 
a letter thanking them for their assistance and instructing them in the system to 
check content validity. A copy of the abstract from the research proposal was also 
sent for their information. A table was constructed for ease of assessment where 
each item was alongside the categories as described above {Appendix G). All but 
six items achieved a content validity coefficient of greater than or equal to 0.80, 
which according to Lynn's {1986) criterion, is an acceptable level of agreement. 
Four items, age, tumour histology, recurrences, and family history of cancer 
attained a coefficient of 0.60. Two items had a coefficient of 0.40 {time since 
diagnosis and stage of disease at diagnosis). According to Lynn {1996) these six 
items should be modified or removed. However, panel experts offered no 
recommendations for modification of the items. Given the exploratory nature of the 
study, and the fact that the items were selected based on literature purporting 
relationships between these and the severity of skin reactions, all items were 
retained. Collection of data related to time since diagnosis and stage of disease 
were justified as they would be useful descriptors of the sample. 
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The expert panel was also asked to comment on the scoring of specific 
items. Minimal changes were suggested and incorporated before proceeding to the 
next phase of pilot testing. In addition to the expert panel's input, the consultant 
statistician also reviewed the instrument and commented on the scoring. The 
scoring system was found to be suitable for the analysis planned. Following this 
initial assessment of content validity, operationalisation of the factors was 
completed. 
Reliability testing 
The reliability of much of the data collection lay in the accuracy of recording. 
Random checks were made, comparing the medical notes of about 20% (26) of the 
sample and asking 5% (6) of participants to repeat the interview. No errors were 
detected. 
The process of asking six participants to repeat the interview made it possible 
to assess the reliability of several of the scales used as listed below: 
o The subscale of the Braden Scale used for nutritional intake 
o The Cumulative UV Radiation Scale 
• The Fitzgerald Skin Condition Scale 
o The Skin Allergy Severity Scale 
No differences in participants' responses to these scales were detected in this 
small group. 
Scar Condition Scale 
lnterrater reliability for the Scar Condition Scale was conducted randomly 
during the data collection period between the three observers. Approximately 10% 
(12) of the sample was tested and reliability was found to be r = 1.00. 
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Demographic Data 
In addition to the factors described, the following demographic data were 
cn!lected to test for representativeness of the sample: marital status, occupation, 
and education level completed. In the pilot study socioeconomic status was 
assessed through an item on annual family income. Participants were reluctant to 
give this information so the item was removed and two other items replaced it, 
usual accommodation, and postal area code. Socioeconomic status was then 
assessed using the Australian Bureau of Statistics' (ABS) socioeconomic listing 
developed from the National Census data (1996). 
Pilot Testing of Measures 
The final form of the data collection form can be found in Appendix F. The 
instrument was piloted on the first five participants and modifications to the order of 
the items were made. Participants reported verbally that they could understand all 
items easily. No new items were added at this stage, so these participants were 
included in the final sample. 
Training of research assistants 
Two research assistants were trained during the course of the data collection 
period in the use of the preliminary instrument prior to commencing work on the 
study to ensure that the explanations and instructions given to each participant did 
not differ significantly. Where uncertainty arose (for example in assessing the 
pathology reports) the Consultant Radiation Oncologist (adviser to the project) was 
available to answer questions and make necessary clinical decisions. 
All three observers were experienced in radiation oncology nursing and were 
familiar with use of the RTOG scoring system in the Department. Thus training for 
the measurement of the dependent variable comprised testing interrater reliability 
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and ensuring that a second opinion would be obtained from another observer, or 
the Consultant Radiation Oncologist in cases of uncertainty. 
Procedures 
Recruitment 
Patients planned for standard protocol treatment of breast cancer were 
identified from the list prepared each week by the planning section of the 
Department. From this list the researcher/research assistant liaised with the 
radiation therapists working on the linear accelerator units to ensure that identified 
patients fitted the study criteria, and noted when treatment was to start. 
Patients fitting the inclusion criteria of the study were approached to join the 
study during the first week of their treatment. To avoid any unnecessary stress, 
patients were not approached on the first day of their treatment. Prospective 
participants were approached in the waiting area in the following way: The 
researcher/research assistant introduced herself and asked if the patient had a few 
moments to discuss a research study in which they might participate. If willing, the 
patient was taken to a side room to provide the necessary privacy. The research 
was explained fully and questions answered. Formal consenting procedures were 
completed when the researcher/research assistant was sure that participants 
understood both what was involved and their rights as voluntary research subjects. 
Each participant was allocated a code number and each page of the questionm=tire 
and follow-up schedule was numbered. 
Interview - Completion of the Data Collection Form 
The interview to complete the preliminary instrument was conducted at the 
same time as consent. An interview format was used, as the preliminary instrument 
was not designed for independent completion. On a very small number of 
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occasions the interview was completed at the first follow-up. It was essential 
however, that the condition of the skin was assessed and documented on the first 
occasion to establish a baseline. 
Most items on the questionnaire were answered by patient report in the 
interview and no corroboration was sought. Information for items 1 - 5 on the 
questionnaire and the treatment details were obtained from the medical notes and 
the prescription for radiotherapy. 
Follow-up 
The follow-up procedure was facilitated by the good working relationship 
between the researcher/research assistants and the radiation therapists working on 
the linear accelerators. Once a week during the treatment period, each participant 
was examined immediately prior to or after the daily treatment so that they did not 
have to undress again for the research protocol. A list of current participants' 
names was given to the radiation therapists working on the linear accelerators who 
would then call the researcher/research assistant to the machine to see 
participants. Consent was verified verbally with the participant before the 
observation took place at each follow-up. 
Participants' data were name identified on the front page only. All the 
research documents were kept in a lever arch file and secured along with the 
medical notes in the Department. Completed consent forms were kept in a locked 
filing cabinet in the nursing office in the Department for the duration of the data 
collection period and then transferred to the research office and kept in a secured 
place. 
Closure of Study Participants 
At the end of the treatment period the participant's questionnaire and follow-
up schedule ware removed from the lever-arch file. The section at the top of the 
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first page on which was the hospital label with the name of the participant was 
removed and placed with the consent forms in the filing cabinet. The questionnaire 
and follow-up schedule, now only identified by a code number, was removed from 
the Department, taken to the research office and secured in a locked cabinet. 
Analysis Plan 
The data were analysed using the Statistical Package for the Social Sciences 
version 7.0. Data were cleaned and data entry checked by random sample of 10% 
of the questionnaires. The process of data analysis was completed in the steps set 
out below. 
1. Sample characteristics and all potential predictive factors (independent 
variables) were explored using descriptive statistics. Normality of continuous 
variables was tested graphically using a probability plot and box plot and one-
sample Kolmogarov-Smimov nonparametric test. 
2. The RTOG score {dependent variable) was explored and found to have a non-
normal distribution. Therefore the RTOG score was re-coded into a 
dichotomous variable for all eight anatomical sites and for each week thus 
{refer to Table 3.1 for definitions of RTOG scores): 
• RTOG score of O or 1, representing no reaction or a mild reaction 
became 0-RTOGO 
e RTOG score of 2 or more, representing a less manageable reaction 
became D-RTOG1. 
3. The independent variables were explored and collapsed where necessary to 
ensure the validity of chi-square testing. 
4. Chi-square testing was conducted between the dependent site-specific D-
RTOG score and each categorical independent variable. 
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5. Independent sample t-tests were conducted on the dependent site-specific 0-
RTOG score and each continuous independent variable. 
6. Nursing interventions with creams and topical ointments were tested as 
possible co-variants. 
7. On the basis of the univariate results, any relationship with a p-value of< 0.10 
was noted for inclusion in the logistic regression analysis. 
8. Stepwise logistic regression was performed on the results for week five first 
This week was the last of the radiation to the whole breast area and if a more 
severe reaction was going to occur it would most likely have occurred by week 
five. The alpha level for entry of a predictor was set at 0. 10 and removal at 
0.15 to allow for a more complete exploration of the predictors. Categorical 
variables were treated as indicator (dummy} variables with the reference group 
being the "zero" group e.g. for smoking, the never smoked group was the 
reference group with which the ex-smoker and current smoker groups were 
compared. 
9. Stepwise logistic regression was performed in the same manner on the D-
RTOG scores for weeks four and three to determine what variables might 
predict those at risk of an early reaction. 
10. The RTOG scores were described from data recording the skin reactions 
during the electron boost treatment in weeks six and seven. 
11. Univariate level relationships were tested using chi-square analysis for 
categorical variables and t-tests for continuous variables for weeks six and 
seven. 
12. Stepwise logistic regression analysis was then performed between the D-
RTOG scores in week six and seven. RTOG scores for weeks six and seven 
record the effect of the electron boost to the lumpectomy scar and the 
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diminishing skin reaction effect of the remainder of the breast following 
completion of the whole breast protocol. 
13. A prediction model for each anatomical site by week was developed providing 
an estimate of the relative risk for each predictive factor in the model. The 
Exp(B) column in the table constructed as part of the computer output is the 
logistic regression equivalent of the odds ratio or relative risk. The probability 
or likelihood that an individual may enter the more severe reaction group was 
calculated from the following formula: 
Probability (event) = ez 
1 + e2 
14. The results of the Pain VAS were described and compared with the results of 
the RTOG and D-RTOG scores. 
Ethical Considerations 
Permission to conduct this study was given by Edith Cowan University 
Committee for the Conduct of Ethical Research on July 28, 1995 and the 
Institutional Ethics Committee of the study hospital on March 22, 1996 (Appendix 
H). 
Consent 
Each participant was given an information letter detailing the purpose and 
nature of the study and informing them of their rights as research participants. 
Telephone numbers were included to provide ongoing opportunity for participants 
to ask questions or exercise their right to withdraw (Appendix I). Fully informed, 
written consent was obtained from all participants before proceeding. Consent was 
affirmed verbally at each follow-up observation. 
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The research assistants were made aware of the vulnerability of patients as 
research participants particularly as one of the research assistants was a nurse in 
the Department. The issue of ensuring participants knew their rights to ask 
questions or to withdraw from the study was specifically targeted during training 
Confidentiality and Security of the Data 
Th"! issue of confidentiality was particularly important in this study as the data 
were name identified for follow-up over seven weeks and because the research 
office was not at the study site, necessitating transportation of confidential data. 
Particular care was taken in the design of the data collection forms to make it 
possible to facilitate follow-up by name as well as to be able to completely remove 
name-identification before removing forms from the Department. This was 
achieved by making the patient identification label removable as can be seen in 
Appendix F. Once in the research office the data collection forms were stored in a 
locked area, separate from the consent forms and master-list of participants' code 
numbers. 
Risks and Benefits 
The risks to participants in the study were minimal, as there was no change 
to the care given from nursing, medical or radiation therapy staff and the weekly 
observations were timed to coincide with treatment on the linear accelerators. The 
only difference was the extra time necessary to complete the consenting 
procedures and the interview. Only one person, approached to join the study, 
refused on the grounds of time. 
Many participants commented that being in the study had reassured them. 
They felt that having their skin observed so closely meant that any adverse affect 
would be detected ear1y and they would receive the help they needed straight 
away. 
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Another serendipitous benefit from participation was the opportunity for 
participants to talk to someone who was not directly involved with the hospital 
processes, but who was knowledgeable of them. Several times the interview time 
was extendea due to the participant needing to tell the story of their diagnosis and 
other related events. Two women were referred, with their permission, to 
professional counsellors due to the distress they were suffering related to their 
diagnosis and other problems. 
The fact that there were no withdrawals from the study suggests that any 
inconvenience involved in the research process were balanced by the benefits 
perceived by participants. 
CHAPTER FOUR 
RESULTS 
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This chapter presents the results of the two principal research objectives: 
Firstly, to test the theoretical relationships between factors that may impair healing 
and the severity of radiation skin reactions; and second, to develop a model to 
predict radiation skin reactions in women being treated for breast cancer. 
The chapter is organised by these objectives following the description of the 
sample and each variable. 
Descriptive Analysis 
Demographic Variables 
The sample comprised 126 wcmen commencing the standard protocol of 
radiotherapy following surgical lumpectomy of breast cancer. The age variable was 
nonnally distributed with a mean of 53.22 years (SD = 10.64, Range= 30- 78 
years). 
Sample statistics of demographic variables are shown in Table 4.1 with 
comparative figures for the female population in Western Australia fl/'/A) from the 
1996 census (Australian Bureau of Statistics [ABS], 1997). A typical participant in 
the study would be 53 years old, married (or in a long term de facto relationship), 
with at least a high school education although their current occupation would be 
classified as home duties. The participant would own or be purchasing her 
residence and have a weekly income of $311. 
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Table 4.1 
Percent Distribution of Participants According to Sample Demographics for 
Comparison with General Population Statistics 
Demographic Item 
Marital Status 
Never married 
Married/de facto 
Separated 
Widowed 
Divorced 
Education/qualification 
Primary school 
Lower secondary 
Trade/secretarial 
Upper secondary 
Degree/diploma 
Higher degree 
Accommodation 
Own home/flat 
Rent home/flat 
Other e.g. Nursing 
home 
Mean weekly income 
Sample (n = 126) WA Population 
2.4 
79.4 
0.8 
7.1 
10.3 
3.2 
31.8 
24.6 
13.5 
20.6 
4.8 
87.3 
10.3 
$311 
} 
} 
*8.4 
*67.9 
4.8 
8.7 
10.1 
42.9 
23.2 
8.6 
66.7 
29.0 
4.3 
$307 
* The ABS figures do not include de facto relationships as a separate category. Therefore, 
some people in de facto relationships would respond as "never married" 
Occupational status was not reported in the census data in a fom, comparable 
with the study and does not appear in the table. The largest occ1.1pational group was 
"home duties' (34.1%} followed by clerical (19.8%), retired (16.7%} and professional 
(14.3%). The remaining participants classified themselves as unemployed, unskilled 
workers, students or skilled tradespeople. 
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Postal codes were used to determine the socioeconomic status of the sample 
using the 1996 census results (ABS, 1997). Results showed the sample had a mean 
weekly household income of $311 . In comparing the demographic data from the 
sample with the population statistics from WA (ABS, 1997), the sample was 
reasonably representative of the general female population on most items, including 
income. 
Radiation Construct 
The organisation of the remainder of this section is based on the conceptual 
framework. The radiation factors: dose, doses per fraction. number of fields and 
treatment techniques were identical for all participants (see Chapter Three for 
details). It was possible for only two radiation factors to vary: overall length of time 
taken to complete the course of radiotherapy and the energy used for the treatment. 
The mean number of days taken was 38 days (SD= 2.84, range= 34- 57 days). 
The mean number of days for the electron boost was 14.7 days (SD= 1.54, range= 
10 - 20 days). 
The other variation was the energy used for the treatment; 114 (95%) 
participants received their photon dose at an energy of 6MV and the remainder at 
4MV. The majority received an electron boost to the scar of 9- 16 12Meve· (Table 
4.2). 
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Table 4.2 
Percent Distribution of Participants According to Radiation Energy Levels Used for 
Electron Boost Treatment 
Energy (MeVe} 
6 
9 
12 
16 
20 
Total 
Percentage of Participants 
5.1 
28.0 
41.5 
18.6 
6.8 
100.0 
Genetic Construct 
Two items, a personal and/or a family history of cancer, represented 
secondary measures of genetic disposition to cancer and radiosensitivity. 
Personal History of Cancer 
The majority of the sample (82.5%} had not had cancer before; 15% had one 
previous epi.:-J:ide of cancer and 2.5% had more than one previous episode. The 
types of cancer reported are summarised in Table 4.3. 
Table4.3 
Frequency and Percent Distribution of Participants According to Types of Previous 
Cancer (N = 126). 
Cancer Type 
Skin C<:1ncers (including melanoma) 
GynaecologiC<:11 ( cervix, uterus) 
Breast C<:1ncer 
Other 
Total 
Frequency of Participants(%) 
13 (52%} 
7 (28%) 
3 (12%) 
2 ( 8%) 
25 (100%) 
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Overall, 21 participants reported 25 cancers. Of these, 13 participants 
reported having skin cancer including two cases of melanoma. A history of skin 
cancer was a particularly important variable on the basis that the development of 
skin cancers indicated significant sun damage to the skin. The criterion used to 
detennine a history of skin cancer was a confinned medical diagnosis and 
treatment. All of these had received treatment for skin cancer including liquid 
nitrogen, laser treatment, surgical removal and 5-Fluorouracil cream. Given the fact 
that medical treatment had been given, the diagnosis of skin cancer was taken as 
positive. There was no significant difference in age between participants with a 
history of skin cancer and those without a history of skin cancer as tested by an 
independent sample t-test. 
Family History of Cancer 
Overall, 69% of p....1rticipants reported having one or more first or second 
degree relatives with a history of cancer. More than one quarter (26.4%) reported 
having one relative with cancer and a further 25.6% reported they had two. The 
remaining 10% had had between three and ten relatives with cancer. 
Just over one third (39%) of participants reported a family history of breast 
cancer. The majority of these (67%) had one relative affected. Two participants 
reported four and five family members refipectively. 
Personal Construct - Disease-Related Factors 
All participants had undergone lumpectomy for breast cancer. Histology 
reports revealed that the majority of tumours were Infiltrating Ductal Carcinoma 
(66%). The next largest group was Lobular Carcinoma (15.9%) with two participants 
{1.6%) having both Infiltrating Ductal and Lobular Carcinoma. The remaining 
tumours were classified as Adenocarcinoma (3.1 %}, Infiltrating Cribifonn Carcinoma 
(1.6%), Medullary Carcinoma (0.8%) and Mucinous Carcinoma (0.8%). In 10.3% of 
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pathology reports specific histology typing was not reported. The recommended 
practice for the classification of histology type states that the tumour is ductal unless 
otherwise specified (Australian Cancer Network, 1997). Also, adenocarcinoma is 
listed as ductal meaning that a total of 79.4% of the tumours were ductal. Published 
figures. such as the European study of 861 describing early stage breast cancers in 
Kurtz et al (1989), suggest that 82% of breast cancers are ductal, suggesting that 
this sample was relatively typical of the breast cancer population. 
Almost three-quarters (73%) of tumours were staged at surgery as Stage I, 
and one participant was classified as tumour in-situ. The next largest group was 
Stage II with 21.4% of participants. 
Most participants (79%) began their radiotherapy within eight weeks of 
surgery. The remaining 21% were delayed in starting by: chemotherapy (13%); 
infection (1.6%); lymphocele (4.8%); one participant (0.8%) was being treated tor 
recurrence 12 months following surgery; and one (0.8%) delayed by choice. 
Personal Construct- Treatment-Related Factors 
Variables in the treatment-related factors' section of the Personal Construct 
focused on the condition of the surgical scars, axillary lymph node clearance, tr,.. 
development of a lymphocele, and chemotherapy treatment. 
Scar Condition Scale 
The condition of the lumpectomy scars of the majority of participants (97.6%) 
was classified as good with the scar healing and fading. The remaining 2.4% of 
lumpectomy scars were still inflamed. Almost one third of participants (31%) did not 
have a separate scar in the axilla from clearance of axillary lymph nodes. Of the 
remaining 87 participants, 97. 7% of the axillary scars were healing well and fading. 
The scar was still inflamed in one particioant and there was a haemoserous 
discharge from the scar of another. 
Results 81 
Axillary Lymph Node Clearance 
The majority of participants (84.9%) had one or more axillary lymph node 
removed for pathology with a mean of 9.38 nodes (SD= 5.96 nodes, Range= 0-
39). Of the 104 participants with nodes removed 20 (19.2%) had one or more nodes 
affected by cancer with a mean of 2.75 nodes affected (SD= 2.43, Range 1 - fl). 
Lymphocele Drainage 
Over half of the participants (55.6%) did not develop a lymphocele that 
required draining by needle aspiration following surgery. Table 4.4 details the 
frequency of needle aspirations. Seven participants required that straight drainage 
be re-commenced after going home due to the build-up of lymph fluid. 
Table 4.4 
Perc.ent Distribution of Participants According to the Number of Needle Aspirations 
for Lymphocele (N = 126) 
Number of Aspirations Percentage of Participants 
None 55.6 
1 9.5 
2 7.1 
3 6.3 
4 4.8 
5 5.6 
~ 6 (including those recommenced on 11 .1 
straight drainage) 
Total 100.0% 
Chemotherapy for Breast Cancer 
Participants receiving chemotherapy were classified into two groups. 
1. those who had four cycles of Etoposide and Cyclophosphamide (EC) over 
three months prior to radiotherapy and a further three cycles of 
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Cyclophosphamide, Methotrexate and 5-Fluorouracil (CMF) concurrently 
with radiotherapy; and 
2. those who had six cycles of CMF beginning at approximately the same 
time as their radiotherapy. 
An independent sample t-test analysis revaaled that those participants 
receiving chemotherapy were significantly younger than those not receiving 
chemotherapy for breast cancer (t (124) = 2.10, p = 0.038). 
Personal Construct- General Health Factors 
The variables included in the general health section of the Personal Construct 
were those specifically relating to factors known to impair wound healing. 
Chronic Illness 
More than half of the participants (52.4%) reported having current chronic 
illness with 22% reporting two or more diagnoses. In total, 21 diagnoses were 
reported but none were classified as radiosensitive conditions. The most commonly 
occurring chronic illness was osteoarthritis (16.7%) followed by hypertension 
(15.2%), followed by asthma and cardiac conditions an equal third (10.6%). 
An independent sample t-test analysis revealed, as expected, that participants 
with chronic illness were significantly older than those reporting no chronic illness (t 
(124) = -4.62, p = 0.000). An independent sample t-test analysis also revealed that 
participants with a current chronic illness were significantly higher in weight than 
those reporting no chronic illness (t (123) = -2.66, p = 0.009). 
Prescribed drugs, Self medication and Complementary medicines 
The majority of participants (62.7%) were taking prescribed medications on a 
regular basis. However, none of these drugs had a possible side effect of 
photosensitivity. Only two participants were taking drugs that could impair healing; 
these were steroids taken regularly for asthma. One fifth of participants were taking 
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Tamoxifen as part of their treatment for breast cancer. This group were significantly 
older than participants not taking Tamoxifen as tested by an indepenrtent sample t-
test (t (124) = -4.66, p= 0.000) 
Participants were asked an open-ended question to report their use of over-
the-counter pharmaceuticals and complementary medicines. To assist data 
collection. three categories were given to determine the purpose or effect of the 
medicine; for general health, to aid healing, and as an anticancer treatment 
Participants could nominate to which of these categories the medicine belonged or 
explain its use in their own words. No new categories were formed. In total, 74 
(58.7%) of participants were self-medicating or taking complementary medicines 
prescribed by a naturopath. Of these, 58 (78.4%) were taking these medicines to 
improve their general health, 15 (20.3%) were taking them to aid healing and 16 
(21.6%) were taking them as complementary anticancer treatments. 
Participants classified the reason for taking complementary medicines 
differently. For example for some taking antioxidants was for their general health 
and for others it was an anticancer treatment. Details of the complementary 
medicines taken by participants can be found in Appendix J. In addition to taking 
complementary medicines two participants were receiving acupuncture as an 
anticancer treatment concurrently with radiotherapy. 
The Relationship between Chronic Illness and Medication Use 
Chi-square analysis revealea a significant association between the chronic 
illness and the use of prescribed medications, with both the dichotomous prescribed 
medication variable (x.2 (1) = 142.48, p = .000) and the three level prescribed 
medication variable (x2 (2) = 184.32, p = .000). There was no association between 
reporting a chronic illness and taking complementary medicines, which is confirmed 
by the finding that the majority of participants were taking these medications to 
improve general health. There was, however, a significant association between 
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taking prescribed medications and complementary medicines(/ (1) = 9.52, p-= 
.002). 
Smoking History 
Just over half of the participants (521 % ) had a history of smoking. For the 
analysis, smoking history was collapsed into a three-level variable, with 45 (47.9%) 
in the never smoked group, 36 (38.3%) in the ex-smoker group, and 13 (13.8%) in 
the current smoker group. All the ex-smokers. except one, had quit more than 12 
months prior to commencing radiotherapy. Of the current smokers nine (69.2%) 
smoked 15 or less cigarettes per day, two (15.4%) smoked 20 cigarettes per day, 
and two (15.4%) smoked 40 cigarettes per day. 
Alcohol Intake 
The majority of participants (64.3%) reported that they consumed alcohol. 
However, just over half of all participants (55.6%) indicated they had decided not to 
drink during treatment 
Nutritional Status 
Nutritional status was indexed by body weight in kilograms, height in 
centimetres and by intake as assessed by the nutrition subscale of the Braden Scale 
(1992). The mean weight of the sample at commencement of radiotherapy was 
66.9kg (SD= 13.4, range= 42 -112kg). The weight variable was normally 
distributed. 
Measurement of height was taken to establish the body mass index (BMI) of 
participants. BMI was then classified into three groups for further analysis, 9.6% of 
participants were underweight (BMI < 20), 69.1% were of normal weight (BMI 20 -
25), and 21.3% were overweight (BMI > 25). 
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Important to nutritional status is any recent change in weight. The range of 
reported weight change in the sample was from -13 kg to+ 12kg although 57 4% 
had not changed their weight since diagnosis 
The majority of participants had an "excellent" intake of food (81 4 % ) 
according to the Braden Scale assessment of nutritional intake. Of the remainder. 
17% reported an "adequate" intake and only 1.6% had a "probably inadequate" 
intake. No participants were assessed as having a ·very poor" intake 
In addition to nutritional intake, participants were asked if they had changed 
their diet since being diagnosed with breast cancer. Only 9.6% reported a change in 
diet. The changes consisted of a reduced intake of fats and red meat, and an 
increased intake of fibre through fresh fruit and vegetables. 
Breast Size 
Breast size was indexed by the brassiere size and cup size. The range of 
brassiere size was size 10 to 22 with almost two thirds of the sample being size 12 
or 14. The frequencies for cup size are shown in Table 4.5. 
Table4 5 
Percent Distribution of Participants According to Brassiere Cup Size and the 
Dichotomous Breast Size Variable (N = 124) 
Cup Size Percentage of Participants 
A 13.0 
B 31.7 
C 30.1 
D 17.1 
.:: DD 8.1 
Total 100.0% 
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Personal Construct - Skin Condition Factors 
Skin Condition and Allergies 
Participants rated the skin condition in the treatment ar~a as oily. normal or 
dry. The majority (78.6%) rated their skin as normal, 19% rated it as dry and the 
remainder (2.4%) rated their skin as oily. 
Le~.s than half the sample (42.1 %) reported having skin allergies Most 
avoided contact with the allergen but rated the severity of the reaction if it did occur 
to be mild (31%), moderate (41.1%) or severe (27.7%). Participants reported allergic 
reactions to a variety of substances including foods, plants. make-up, detergents 
and jewellery. In addition. 36.5% reported a family history of skin allergies. 
Skin Reaction to UV Radiation. 
Results of participants' reports of their skin reaction to UV radiation as 
measured by the Fitzgerald Scale are shown in Table 4.6. 
Table 4.6 
Percent D1strip_ution of Participants According to Skin Reaction to UV Radiation (N = 
126). 
Fitzgerald Scale 
1 
2 
3 
4 
5 
6 
Total 
Percentage of Participants 
12.7 
18.3 
35.7 
29.4 
4.0 
0.0 
100.0% 
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Cumulative UV Radiation Exposure 
This variable was first analysed by examining frequencies for each item of the 
scale (see Table 4.7) Scores of the two items of the child exposure subscale 
(possible score range 2 - 7) and three items of the adult subscale (possible score 
range 3 - 10) were calculated and combined into a total score being the sum of the 
five items (possible score range 5 - 17). The mean of the child exposure subs ca le 
was 5.6 (SD= 1.4 range= 2 - 7) The mean of the adult exposure subscale was 5.5 
(SD= 1.5 range= 3 - 9). The mean of the total UV exposure scale was 11.2 (SD= 
2.4 range= 6 - 16). 
Table 4.7 
Percent Distribution of Participants According to Individual Items on the Cumulative 
UV Radiation Exposure Scale (N = 126) 
Item 
Free time as a child spent in: 
1. Indoor activities 
2. Indoor and outdoor activities 
3. Outdoor activities 
Sun protection as a child used 
1. Almost always 
2. Often 
3. Sometimes 
4. Almost never 
Work as an adult was {or is) mainly 
1. Indoors 
2. Both indoors and outdoors 
3. Outdoors 
Free time as an adult spent in: 
1. Indoor activities 
2. Indoor and outdoor activities 
3. Outdoor activities 
Sun protection as an adult used 
1. Almost always 
2. Often 
3. Sometimes 
4. Almost never 
Percentage of Participants 
12.7 
42.9 
44.4 
13.5 
4.0 
16.7 
65.9 
81.7 
16.7 
2.0 
18.3 
55.6 
26.3 
36.5 
23.8 
19.8 
19.8 
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The impact of the sun on the skin is dependent on the geographic location and 
residents of Australia are known to come from a wide range of countries. Therefore. 
participants were asked the predominant place they lived as a child and an adult 
More than half of the participants (52 4%) had lived in Perth as a child and as an 
adult. The next largest group were those who lived in the UK and Europe (34.3%) as 
a child, but spent most of their adult life in Australia. The mean length of time lived in 
Australia was 41 years (SD= 18 years, range= 2 - 76 years) 
Analysis of Whole Breast Radiation Treatment (Weeks One to Five) 
Description cf the RTOG Scores Weeks One to Five 
KTOG scores for the dependent variable for each anatomical area are shown 
in the following figures by week of treatment One week of treatment is equivalent to 
five daily fractions of radiation. For the first five weeks the daily dose is 1.8 Gy. 
Thus, the doses for week one were 1.8 Gy to 9 Gy; week two were 10.8 Gy to 18 
Gy; week three are 19.8 Gy to 27 Gy; week four are 28.8 Gy to 36 Gy; week five 
were 37.8 Gy to 45 Gy. Results for weeks six and seven, which are the 10 days of 
electron boost to the scar, are presented later in the chapter. 
RTOG Scores for Weeks One and Two 
In week one, no participants scored RTOG 2 or more with the vast majority 
scoring "O" for all anatomical sites except the nipple. One participant scored RTOG 2 
in week one; this was related to inflammation of the lumpectomy scar that was 
located v'9ry close to the nipple. In week two, three participants scored RTOG 2 on 
the nipple; two participants had more severe reactions on the sternum, two in the 
inframammary fold; and one in the axilla, UOQ and LIQ areas. 
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RTOG Scores for Week Three 
In week three, as expected, a number of participants showed signs of a more 
severe skin reaction Figure 4 I illustrates the RTOG scores over the eight sites for 
the third week of treatment. The more severe reactions categorised as a RTOG 2 
score or higher, were not common The site with the most frequent severe reactions 
was the sternum (17 participants). The description in the comments accompanying 
the data colle'"'tion report the sternum reactions to be follicular rashes with some 
blistering noted. The second most frequent site for severe reactions was the axilla 
with 13 participants demonstrating more severe reactions at this location. 
Site of Reaction 
IDRTOGO fil!RTOG 1 DRTOG2 I 
lnfram = lnframammary Fold 
-
-
Figure 4.1 Frequency Distribution of Participants According to RTOG Scores by 
Anatomical Site for Week Three of Treatment 
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RTOG Scores for Week Four 
The frequency of more severe radiation skin reactions increased in week four 
as expected Figure 4 2 illustrates the distribution of RTOG scores. Patchy moist 
desquamation, indicated by scores of RTOG 2.5, began to appear during week four 
of treatment The areas affected were the axilla, UOQ and the inframammary fold 
areas. Skin loss on the sternum was different to the other areas, as the blistering 
reaction, noted in week three, broke down and oozed serous fluid The reactions in 
the axilla, UOQ and inframammary fold were typical radiation moist desquamation 
reactions. 
90 
80 "" iii 
f $ 1lj ., ~ ~ 
C/l 70 " 
,. 
E f I l co fl 
.9- 60 
- ~ m :c 'jJ 0 t ·\l ~ I co 50 
---0... 
•. 
- 40 " 0 
.... ;:; Q) 
~::-
.c 30 E -,-
.... 
-
,.-
:, 
-
-
- ..... 
- -· 
·;t;; 
z 20 
- - ----
·--
i,-. 
10 ,--
-- -
,___ 
0 Im ~ 
~<$' ,'S::,'ll 00 ..:),o 00 ,o ~0 §:' ~ v V V ~q_~ 
e:,'-0 
Site of Reaction 
ID RTOG O ill RTOG 1 D RTOG 2 Ii RTOG 2.5 I 
lnfram = lnframammary Fold 
,-
-
-
-
-
'--
-
..__ 
.,,,, 
§:' 
'S:,'l> 
,~ 
Figure 4.2 Frequency Distribution of Participants According to RTOG Scores by 
Anatomical Site for Week Four of Treatment 
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RTOG Scores for Week Five 
The frequency of patchy moist desquamation (RTOG 2.5) increased again 
during week five of treatment. In addition, confluent moist desquamat,on (RTOG 3) 
was recorded for the first time in the ax1lla and UOQ reactions. Figure 4.3 illustrates 
the distribution of RTOG scores for week five. 
Patchy moist desquamation in the sternum area continued to be the result of 
the blister reaction noted in earlier weeks. The number of participants with patchy 
moist desquamation and confluent moist desquamation also increased in the axilla 
and inframammary reactions. 
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Anatomical Site for Week Five of Treatment 
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Frequency of Moist Desguamation 
Patchy moist desquamation (RTOG 2.5) occurred n four sites during the 
course of treatment: the sternum. axilla, UOQ and inframammary fold. Two of these 
sites, the axilla and UOQ. recorded the occurrence of confluent moist desquamatton 
(RTOG 3). Figure 4.4 illustrates the time trends for the development of moist 
desquamation in this sampl6 for the four sites. The figure includes the weeks of the 
electron boost to consider the pattern of moist desquamatinn over the full treatment 
time. 
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Figure 4.4 Time Trends for the Development of Patchy or Confluent Moist 
Desquamation in the Four Most Affected Sites 
The pattern that emerged was as expected with skir loss reported in all four 
sites by week four. Skin loss in the sternum began in week three, but healed by 
week seven, an understandable pattern, as electron boosts were not administered 
to the sternum. 
The axilla had the highest frequency of moist desquamation, peaking in week 
six and falling slightly in week seven. Although the axilla was a site for electron 
boost treatment, most participants had no treatment to this area in weeks six and 
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seven. TJ.,e peak. of the axilla reaction in week six probably indicates a car,y-over 
effect from the end of the whole breast treatment completed in week five. 
The frequency of moist desquamation in the UOQ showed a steaciy increase 
through weeks six and seven. This was expected given the fact that most of the 
electron boost treatments in this sample were in the UOQ. 
The development of moist desquamation in the inframammary fold site 
followed a similar pattern to that of the axilla. Again healing was noted as the 
severity of the reaction decreases during week. seven. 
Testing the Theoretical Relationships of the Conceptual Framework in Radiation 
Skin Reactions during Whole Breast Treatment 
To ensure the validity of univariate and multivariate testing, several predictor 
variables were re-coded to overcome the problem of empty cells. A standard 
approach was taken. First, a dichotomous variable was created with "O" indicating 
no and "1" indicating yes. For example if the participant did not have a history of skin 
cancer they would score "O", if they did, the score would be 'T. Further subdivision 
was tested, however, in all cases this did not reveal any further significant detail. 
Table 4.10 details the proportion of scores in re-coded variables. 
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Table 4.8 
Percent Distribution of Participants According to Re-coded Predictor Variables 
--------------------------~----·------------ --
Percentage of Part1c1pants 
Predictor Variable No Yes 
History of Cancer (not skin cancer) 82 5 17 5 
History of Skin Cancer 89.7 103 
Tumour Stage~ II 73.8 26.2 
Aspiration of Lymphocele 55.6 444 
Chemotherapy for breast cancer (overall) 87.3 12 7 
Chemotherapy commenced concurrently 89.7 10.3 
with radiation 
Chemotherapy before radiation (part or all 96.8 3.2 
of chemotherapy treatment) 
Breast s;ze ~ D cup 74.8 25.2 
Skin ty~ - Fitzgerald scale > 3 31.0 69.0 
Univariate Testing of Potential Predictive Factors during Whole Breast Treatment 
The distributions of the RTOG scores were not normal for any of the 
anatomical sites in any week. The RTOG scores were re-coded into dichotomous 
variable values (D-RTOG). A score of "O" or "1" became 0-RTOG 0, (a mild or no 
reaction) and a score of "2" or more became D-RTOG 1, (a severe reaction). Weeks 
one and two had extremely few scores in D-RTOG 1. Participants who scored D-
RTOG 1 in weeks one and two were ali found to have developed a breast infectjon. 
Therefore, the univariate testing focussed on weeks three to five only. 
For continuous variables, independent sample t-tests were performed to test 
relationships between potential predictor variables and skin raactions (D-R TOG 
scores). Table 4.9 presents the significant t-test results (ex= 0.10) for weeks three, 
four and five. Each predictive factor was tested for association with the 0-RTOG 
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scores for each anatomical site for each week of treatment. Chi-square analysis was 
performed on categorical variables (a= 0.10) (see Tables 410,411and412) 
Table 4.9 
Significant Relationships between Site and Continuous Predictor Variables for 
Weeks Three, Four and Five as Measured by t-test (p-value). 
Anatomical Site Current Dose UV child Total UV 
Weight sub-score score 
Week 3 Sternum -1.95 (.053) 
Week 3 Axilla -3.06 (.003) 
Week3 UOQ , .96 ( 053) 
Week3 UIQ 2.46 (.015) 
Week3 LOQ -1.74 (.085) 3.09 (.002) 
Week 3 Nipple -1,92 (.057) 
Week 3 lnframammary 2.52 (.013) 
Fold 
Week4Axilla -2,93 (.004) 
Week4 UOQ -2.13 (.035) 
Week 5 Axilla -4.05 (.000) 
Week5 UOQ -2.35 (.021) -3.11 (.002) 
Week5 UIQ -1.81 (.073) -4.07 (.000) 
Weeks LOQ -2.22 (.028) -3.38 (.001) 
Week5 LIQ -2.22 (.028) -3. 13 {. 002) 
Week 5 Nipple -2.46 (.015) 
Week 5 lnframammary -3.93 (.000) 
Fold 
Table4.10 
Significant Relationships in Dichotomous RTOG Scores for Week Three According to Site as Tested by Chi-square (p-value) 
Site Breast Lympho- Condition Chemo- Concurrent r-amily Chronic Smoke Stage~ II Tamoxifen Skin-type 
size cele of breast therapy chemo- history of illness 
scar befora thsrapy cancer 
radiation 
Sternum 444 ( 04) 
Axilla 6.33 (.01) 3.61 (.08) 5.94 ( 01) 3.50 (.06) 5.39 (.07) 2.99 (.08) 3.59 ( 06) 
UOQ 2.79 (.09) 10.88 (.00) 3.76 (.05) 
UIQ 5.75 (.02) 7.88 (.00) 5.53 (.02) 3 73 (.05) 3.61 (.06) 
LOQ 4.02 (.04) 9.26 (.00) 4.52 (.03) 2.98 (.08) 
LIQ 2.79 (.09) 10.68 (.05) 3.76 (.00) 
Infra- 3.35 (.07) 11.19 ( 00) 
mamma!Y_ 
History of 
skin 
cancer 
-
7.74100) 
;:o 
(T) 
Cl) 
C 
;:::; 
(/1 
tO 
CJ) 
Tabla4.11 
Significant Relationshi(,!s in Dichotomous RTOG Scores for Week Four According to Site as Tested b~ Chi-sguare (Q-value) 
Site Alcohol Breast size Chemo- Concurrent Chemo- Condition Skin-type Family History of Smoke 
intake therapy chemo- therapy of breast history of skin cancer 
therapy before scar skin 
radiation allergies 
Sternum 3.70 (.05) 15.80 ( 00) 
Axilla 15.48 (.00) 4.91 (.03) 4.80 (.03) 
uoa 8.74 (.00) 2. 79 (.09) 4.83 (.03) 
UIQ 6.23 (.04) 5.16 (.02) 3.74(05) 
LOQ 6.52 (.04) 5.53 (.02) 2.74 (09) 4.96 ( 03) 6.00 ( 05) 
LIQ 6.52 (.04) 4.96 (.02) 5.53 (.02) 2.73 ( 09) 4 96 (03) 6.00 ( 05) 
Nipple 5.52 (.06) 4.29 (.04) 2.81 ( 09) 
Infra- 3.07 (.08) 5.42 (.02) 5.26 (.02) 6.32 ( 04) 
mamm 
Tamoxifen 
599( 01) 
::0 
<l) 
1/) 
C: 
;:::;: 
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<.O 
-..j 
Table4.12 
§igniflQ:.@nt Relatlonshlgs in Dichotomous RTOG Scores for Week Five According to Site as Tested b~ Chi-sguare {12-value} 
Site Breast size Smoke History of Lymphocele History of Tamoxifen History of UV 
cancer-not skin skin cancer protection 
skin allergies used as an 
adult 
Sternum 11.24 ( 00) 6 85 ( 08) 
Axllla 5.46 (.02) 3.18 (.07) 3.21 (07) 
uoo 9.14 (.00) 4.81 (.09) 3.22 (.07) 
UIQ 5.68 (.02) 3.16 (.08) 
LOQ 7.89 (.00) 5.25 (.04) 3.30 (.07) 
LIQ 3.02 (.08) 8.95 (.01) 2 86 ( 09) 
Nipple 3.02 (.08) 8.70 (.01) 4.51 (.03) 
lnframammary 17.34 (.00} 14.10(00) 5.57 ~.01) 3.67 ( 06) 
::0 
(1) 
C/l 
C: 
cii 
U) 
OJ 
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Testing for Potential Covanates 
A potential source of covariance was the nursing interventions used as 
standard practice dunng the course of radiation therapy Particularly 1mport~nt was 
the use of creams and emollients The premise for using these products was to 
promote patient comfort. There is no empirical evidence to date that suggests that 
creams used have a significant impact on reducing the severity of the skin reaction. 
In addition. the governing principle for deciding which cream is used and how often. 
is patient preference. 
The null hypothesis that there was no significant association between using 
cream and the severity of skin reaction was tested by Chi-square analysis for weeks 
three, four and five at each site. No significant associations were detected for any of 
these tests, indicating that cream use was not associated with the severity of the 
skin reaction. 
Development of Predictive Models for Radiation Skin Reactions during Whole 
Breast Treatment 
Logistic regression analyses were conducted on the D-RTOG scores for each 
anatomical site for weeks three to five. The predictive value of all independent 
variables, identified from the conceptual framework, was tested by stepwise logistic 
regression analysis on the D-RTOG score for each site. Due to the exploratory 
nature of the study a variable entry level was set at ex: = 0.10 and removal level was 
set at ex:= 0.15 (Tabachnick and F1d8II, 1996). This prevented the premature 
deletion of variables that may be clinically significant even if not reaching the usually 
accepted oc = 0.05 level for statistical significance. This decision increased the 
likelihood of Type II errors in hypothesis testing, meaning that there could be an 
increased chance of false positive results. This is an acceptable clinical error in the 
case of radiation skin reactions as it represents a cautious approach. 
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Results from the week five reactions are presented first as week five 
represents the main effect of radiation on the skin in the treatment area during whole 
breast irradiation The results for the sternum reaction are used as a full example of 
the method of interpreting logistic regression analysis including the calculation of 
relative risk and the interpretation of confidence intervals. 
Week Five Prediction Models 
The D-RTOG scores recorded during week five represent the reactions 
experienced during the last five doses of whole breast treatment (Dose range= 28.8 
Gy - 45 Gy). In most cases, these reactions will not become any more severe 
following the last dose, except for the site of the electron boost treatment. Thus. the 
results of the stepwise logistic regression analysis for the radiation skin reactions 
observed at each site in week five represents the prediction of the worst radiation 
skin reaction experienced during whole breast irradiation. 
Week five sternum reaction results. 
Data from all 126 women were available for analysis: 74 (58.7%) had a score 
of D-RTOGO and 52 (41.3%) scored D-RTOG1. Of the variables tested, two entered 
the model: history of skin cancer and age. These two factors correctly predicted 
97.3% of cases with mild or no reactions, and 26.92% of cases with severe 
reactions giving an overall accuracy of 68.25% for the model. 
The use of a Chi-square test (Tabachnick & Fidell, 1996) determines whether 
the model is a significant improvement over the observed frequencies alone. This is 
expressed as a significantly reliable model. The model for the week five sternum 
reaction was significantly reliable when compared with the constant only model, 
x.2{2) = 14.407, p = 0.000, indicating that the predictors, as a set, reliably 
distinguished between the 0-RTOGO and 0-RTOG 1 scores. Table 4 .13 shows 
details of the regression analysis for each of the two predictors. 
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Table 4.13 
Logistic Regression Results for the Week Five Sternum Reaction 
Variables B SE Wald OF Sig R Exp{B) 95%CI 
History of 2.462 .808 9.272 1 .002 .206 11.723 2.404 -
skin cancer 57.170 
Age (per -.030 .018 2.713 1 .099 -.064 .970 .938-
year) 1.006 
{Constant2 1.020 .973 1.099 1 .294 
From these results, the relative risk of developing a more severe sternum 
reaction in week five is 11. 7 times greater in an individual with a history of skin 
cancer when compared with an individual with no history of skin cancer. 
Relative risk calculation. 
The regr ~ssion equation for calculating the probability of experiencing a more 
severe skin reaction in the sternum is: 
where 
Using the week five data, estimates of model parameters give the regression 
equation: 
z = 1.0202 + 2.4616(skin cancer) -0.0303(age) 
For example, consider an individual who has a history of skin cancer and who 
is 60 years of age. The calculation for the probability of developing a severe skin 
reaction on the sternum during week five of treatment is as follows: 
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As the individual has a history of cancer, the value of X, (where O = no history 
of cancer and 1 = history of cancer) is 1 and the.· value of X2 (age in years) 1s 60, 
then: 
= 
z = 1.020 + (.461(1) -0 030(60) = 1 6638 
The probability of a S.£!vere skin reaction is then 
ez 
1 + ez = 
e' 6638 
~~16683 
= 0.8407 
In other words this individual r.as an 84% likelihood of developing a score of 
D-PTOG = 1, that is a standard RTOG score of ::: 2, in week five of treatment. 
If the probability of me individual developing a severe reaction is 0. 841, then 
the probability of not developing a severe skin reaction is therefore: 
1 - 0.8407 = 0.1593 
Comparing these probabilities, the odds ratio (or risk) of developing a severe 
skin reaction is: 
0.8407: 0.1593 = 5.227: 1 
Therefore, this 60-year-old individual with a history of skin cancer is 5.227 
times more likely to develop a severe skin reaction than not to develop a severe skin 
reaction. 
Consider now an individual of the same age who does not have a history of 
skin cancer. The calculation for the probability of developing a severe skin reaction 
on the sternum during week five of treatment is as follows: 
As the individual has no history of cancer, the value of X, (where O = no 
history of cancer and 1 = history of cancer) Is O and the value of X2 (age In years) is 
60, then: 
z = 1.020 + 2.461(0) -0.030(60) = -.7978 
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ez e· 1g10 
= 1 + e1 = 1 + e· 19e = 0.3105 
In other words. this individual has only a 31% likelihood of developing a score 
of D-RTOG = 1, that is a standarti RTOG score of ::: .'"_2, ir. ·P ~k five of treatment 
The probability of the individual not developing a severe skin reaction is, 
therefore: 
1 - 0.3105 = 0.6895 
Comparing these probabilities, the odds ratio of the individual developing a 
severe skin reaction, or not developing a severe reaction, is: 
0.3105 : 0.6895 = 0.4503 : 1 
Therefore, a 60-year-old individual who does not have a history of skin cancer 
is only 0.4503 times more likely (meaning the individual is less than half as likely) to 
develop a severe skin reaction, than not to develop a severe skin reaction. 
The effect of the history of skin cancer is to increase the odds, or risk, of a 
severe skin reaction from 0.4503 : 1, to 5.227 : 1 
thus: 
5.227 I 0.4503 = 11.7233 
= exp (2.4616) 
The relative risk of a severe skin reaction, therefore, is 11.7233 times greater 
for an individual with a history of skin cancer. The relative risk is calculated 
automatically by the computer and can be found in the Exp(B) column of Table 4.13. 
As the stepwise logistic regression resulted in a regression equation with no 
significant interaction term, the relative risk of a history of skin cancer on developing 
a severe reaction is constant for all ages. Thus, the relative risk of 11 . 7233 applies 
for individuals of all ages, not just a 60-year-old. 
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The process is the same for calculating the impact of age on the seventy of 
the skin reaction. In this case, the inverse relationship between age and the sternum 
reaction. shown by t.'le negative B result. means that as age increases the relative 
risk of a severe skin reaction reduces. 
For example, consider an individual with no history of skin cancer who 1s 30 
years of age. The calculation for the probability of developing a severe skin reaction 
on the sternum during week five of whole breast treatment is as follows: 
As the individual has no history of cancer. the value X, (History of skin cancer) 
= 0 and the value of X2 (age)= 30, 
then: 
z = 1.0202 + 2.4616(0) - 0.0303(30) = 0.1112 
The probability of a severe skin reaction is: 
eo 1112 
= 1 + eo1112 = 05277 
In other words this individual has a 52.7% likelihood of developing a severe 
skin reaction. 
If the probability of the individual developing a severe reaction is 0.5277, then 
the probability of not developing a severe reaction is: 
1 -0.5277 = 0.4723 
Comparing these probabilities, the odds ratio or risk of devel0ping a severe 
skin reaction is: 
0.5277 : 0.4723 = 1.1173 : 1 
Consider then the individual in the previous example who was 60 years of age 
and had no history of skin cancer. Recall that the risk of developing a severe 
reaction for this individual was 0.4503: 1. 
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To compare the effect of agr between a 60-year-old and a 30-year-old the 
odds ratio, or risk. of a severe skin reaction 1s 
0 4503 I 1 1173 = 0 4030 
In the example calculating the relative risk of a severe skin reaction due to 
having a history of skin cancer, this final result would represent the relative risk, or 
Exp(B). as listed on the table (11 723). However, the calculation of the relative risk 
with a continuous variable differs from the calculation of 2n indicator (dummy) 
variable in that the relative risk accounts for the effect of one year only. This means 
that the relative risk for a specific age difference is the relative risk per year raised to 
the appropriate power. Thus to calculate the relative risk of an age difference of 30 
years (60 - 30 years) the Exp(B) must be raised to the power of 30. 
then, 
0.9701 30 = 0.4030 
This means that when no history of skin cancer is reported, the 60 year old 
individual is less than half as likely to develop a severe skin reaction in week five 
than a 30-year-old individual. 
In a similar way, each logistic regression table lists the estimates of model 
parameters specifying the regression equation enabling the ca!culation of the 
probability of a severe skin reaction for any individual. In addition, each listed value 
of the relative risk (Exp(B)) enables us to summarise the effect of each factor on the 
likelihood of developing a severe skin reaction. 
Confidence intervals. 
Confidence intervals for logistic regression analysis are calculated for the 
estimated exponential B values (Exp(B)) or relative risk. It must be remembered that 
Exp(B) values and the limits of confidence intervals are in an exponential scale 
therefore the Exp{B) value does not fall in the middle of the interval but closer to the 
Results 106 
lower limit. Also. when the estimated Exp(B) value is large, then consequently the 
confidence interval will be large. In the sternum reaction model for week five, history 
of skin cancer has a large estimated Exp(B) value and this is reflected in the wide 
range for the confidence interval. 
Other than these points, the usual rules for interpretation stand. The 
coniidence interval is testing that: 
B ~ 1 
Therefore, 1.he confidence interval should not include "1". Occasionally the 
lower limit of the confidence interval is less than 1.00 as in the case of "age" in the 
week five sternum reaction model. The,e are three potential explanations for this 
finding. A lower confidence interval limit of < 1.0·J can result from: 
1. A small estimated Exp(B) value{< 1.00). 
2. Accepting a significance level of 0.10 for entry of predictors to the model 
has weakened the statistical power for testing that predictor. 
3. The predictive factor being represented by a small number of participants 
resulting in a loss of statistical power to detect the effect of the predictor. 
The first two of these explanations apply to "age" in the sternum reaction 
model; the Exp(B) value is less than 1.00 and the significance level for age is 0.099. 
Week five axilla reaction results. 
After deletion of one case due to missing values, data from 125 women were 
available for analysis: 63 (50.4%) had a score of D-RTOGO and 62 (49.6%) scored 
D-RTOG1. Two variables entered the model: lymphocele aspirated and current 
weight. These two variables correctly predicted 76.19% of cases with mild or no ski: 1 
reactions and 69.35% of severe reactions, giving ari overall accuracy of 72.80% of 
cases overall. The model was signfficantly reliable when compared with the constant 
only model, x2(2) = 19.872, p = 0.0000, indicating that the predictors, as a set, 
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reliably distinguished between the D-RTOGO and D-RTOG1 scores Table 4 14 
shews details of the regression analysis for each of the two predictors 
Table 4.14 
Logistic Regression Results for the Week Five Axilla Reaction 
Variables B SE Wald DF Sig R Exp(B) 95%CI 
Lymphocele .788 .395 3.984 1 .046 .107 2.199 932-
aspirated 4.322 
Weight (per 063 .017 13.189 1 .000 .254 1 065 1.028 -
kilogram) 1.098 
{Constant} -4.530 1.194 14.384 1 .000 
Those participants who had developed a lymphocele requiring drainage had a 
relative risk c,f developing a more severe skin reaction 2.2 times greater than those 
who did not. The relative risk is based on the weight of the participant in kilograms, 
therefore the relative risk of developing a more severe reaction increases 1.065 
times per kilogram increase in weight. Thus the magnitude of the impact of weight 
on severity of skin reaction becomes more apparent. 
The equauon for calculating the probability of experiencing a more severe skin 
reaction in the axilla then, is: 
e -4.5301 •. 1sa2(lymphocels> • o.0626(weighl> 
1 + e -4.5301 •. 1aa2(lymphocels> • o.DE26(welQht) 
It is possible to compare the impact of these two predictors despite one being 
an indicator variable {lymphocele aspiration) and the other being continuous {weight 
in kgs), to answer the question: what weight difference corresponds with the risk 
associated with having had a lymphocele aspirated? 
The process illustrated in the calculation of relative risk for an age difference is 
also used in this example. The relative risk of a severe skin reaction is ExpB = 
1.0648 which means that the relative risk of severe skin reaction for a weight 
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difference of dkg (where d = difference in weight) 1s 1 0646d To calculate the impact 
of weight compared with the impact of lymph drainage, then the value of d must be 
calculated when 
2.1995 
That is when 
d = *In 2, 1995 / In 1 0464 = 12.6 
*In = natural log 
The effect of an increase in weight of 12.6 kg is equivalent, in risk, to an 
indh ::::ual who has had a lymphocele aspirated. That is an individual who is 72.6 kg 
in weight, but has not had a lymphocele aspirated, has the same risk of developing 
a severe skin reaction as an individual who is 60 kg in weight but has had a 
lymphocele aspirated. This calculation illustrates the magnitude of the weight 
variable on the development of severe skin reactions. 
Week five upper outer quadrant (UOQ) reaction results. 
After deletion of three cases due to missing values, data from 126 women 
were available for analysis: 86 (68.2%) had a score of D-RTOGO and 37 (31.8%) 
scored D-RTOG1. Five variables entered the model: breast size, dose group, 
lymphocele aspirated, smoking and stage. Dose was re-coded (dose group) into 
dichotomous variable values with 37.8 Gy to 43.2 Gy (fractions 1-4 in the Slh week of 
treatment) = 0, and 45 Gy (5th fraction in the 5th week of treatment) = 1. This was 
done to account for a non-normal frequency distribution for dose and the need to 
estimate risk for the highest dose received in the whole breast treatment. 
These five variables correctly predicted 88.24% of mild ~r no skin reactions 
and 42.11 % of severe skin reactions giving an accuracy of 73. 98% overall. The 
model VJas significantly reliable when compared with the constant only model, x2(6) 
= 24.463, p = 0.0004, indicating that the predictors, as a set, reliably distinguished 
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between the D-RTOGO and D-RTOG1 scores Table 4 15 shows details of the 
regression analysis for each of the five predictors 
Table 4.15 
Logistic Regression Results for the Week Five uoq Reaction 
Variables B SE Wald OF Sig R Exp(B) 95%CI 
Breast size 1.025 .478 4.610 1 .032 131 2.788 1.093-
7.112 
Dose group 1.050 .528 3.949 1 .047 .113 2.856 1.015-
8.042 
Lymphocele 1.044 .468 4.974 1 .026 .140 2.840 1.135-
aspirated 7.105 
Stage group .852 .492 3.000 1 .083 .081 2.343 .894-
6.150 
*Smoking 6.670 2 .036 .133 
Ex-smoker 0.480 .481 0.994 1 .320 .000 1.620 .630-
4.150 
Current 1.780 .692 6.615 1 .010 .174 5.930 1.530-
smoker 23.019 
{Constant} -2.491 .500 25.122 1 .0000 
*Reference group for smoking is the "never smoked" group 
For breast size, where the cup size is "D" or more, the risk of having a more 
severe reaction is almost three times greater than if the cup size is "A, 8 or C". The 
last fraction of the whole breast treatment (45 Gy), increases the risk of severity by 
almost three times. For women who have had a lymphocele aspirated one or more 
times, the relative risk of a more severe reaction is almost three times greater than if 
no drainage was performed. For those participants whose tumour was stage II or 
greater at surgery, the relative risk of developing a more severe reaction in week 
five is over twice as great than for participants who were stage I or tumour in situ. 
This result must be considered with cautioun as the confidence includes 1. The 
smoking predictor reveals a slight increase in risk for ex-smokers but a high relative 
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risk six times greater for those smoking through treatment than for those who have 
never smoked. The confidence interval includes 1 for the ex-smokers, however the 
ex-smoker group was not at significant nsk 
The lower limits of the confidence intervals for stage group and ex-smokers 
are both less than 1.00. In the case of these two predictors the explanation lies in 
the significance level being> 0.05 for entry into the model. In the case of ex-
smokers the significance level is 0.320 and is included in the model only as a level 
of the smoking variable. 
The equation for calculating the probability of experiencing a more severe skin 
reaction in the uoa is: 
e -2 .491 • 1 025{Breast :...tu) • 1 050{Dose gcoup) • 1 044 (Lymphocele) 
• 0.48Q(Ex-smoker) • 1 78Q(Current smdwr) • 0.0521Staqe) 
1 + e -2.491 + 1 025{Breasl size) + 1 050(Dos8 oroup) • , 044 (Lymphooole) 
• 0.480(fa-smolcer) • 1 780(Curref11 smelter)• 0.052(S1.lge) 
Week five upper inner quadrant (UIQ) reaction results. 
After deleting three cases due to missing values, data from 123 women were 
available for analysis: 86 (68.2%) had a score of D-RTOGO and 37 (31.8%) scored 
D-RTOG1. Three variables entered the model: breast size, dose group, and 
lymphocele aspirated. These variables correctly predicted 97.70% of mild or no 
reactions, and 25.00% of severe rractions giving an accuracy of 76.42% of cases 
overall. The model was significantly reliable when compared with the constant only 
model, x2(4) = 13.100, p = 0.0108 indicating that the predictors, as a set, reliably 
distinguished between the D-RTOGO and D-RTOG1 scores. Table 4.16 shows 
details of the regression analysis for each of the three predictors. 
The prediction model for the radiation skin reaction in the UIQ is similar to that 
of the UOQ except the factors smoking and stage did not enter the model. The 
relative risks indicate that the larger breast size is over twice as likely to have a 
more severe reaction; receiving the last fraction of treatment (45 Gy) has a relative 
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risk two times greater than the fractions given on the other four days of week five 
{i.e. 37.8 - 43.2 Gy). Lymphocele aspiration increases the relal!ve risk for this site 
by two times The confidence intervals for all three variables include 1. and 
therefore. must be viewed with caution The significance level for all three variables 
was> 0.05 and this probably explains the lower limit of the confidence levels 
Table 4.16 
Logistic Regression Results for the Week Five UIQ Reaction 
Variables B SE Wald OF Sig R Exp(B) 95%CI 
Breast size .837 .457 3.357 1 .067 .096 2 310 .943-
5.655 
Dose group .875 .501 3.050 1 .081 .084 2.398 .899-
6.399 
Lymphocele .772 .421 3.367 1 .067 .096 2.166 .949-
aspirated 4.944 
(Constant} -1.853 .379 23.888 1 .000 
The equation for calculating the probability of experiencing a more severe skin 
reaction in the UIQ is: 
e -1.eso. o.837(Bmaat sizaJ • o.s75(l)ose groupJ • o 1n<Lymphocelo> 
1+ e ·t.650• 011Ji<Brmst sizoJ • o.87S(l)osegroupJ. o.in(LJTTll)hoc:elaJ 
Week five lower outer quadrant (LOO) reaction results. 
Tnree cases ware deleted due to missing values, therefore data from 123 
women were availab:S for analysis: 91 (73.9%) had a score of 0-HTOGO and 32 
(27.1%) scored D-RTOG1. Two variables entered the model: breast size and 
smoking. These variables correctly predicted 96.67% of mild or no reactions and 
6.06% of severe reactions, giving an accuracy of 72.38% overall. The model was 
significantly reliable when compared with the constant only model, x.2(3) = 11.942. p 
= 0.0076, indicating that the predictors, as a set, reliably distinguished between the 
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D-RTOGO and D-RTOG1 scores. Table 4.17 shows details of the regression 
analysis for each of the two predictors 
The relative risk associated with a large breast size is similar to that seen 1n 
both UOO and UIQ reactions The results for smoke group indicate that there is little 
additional risk of severe reaction for ex-smokers but over four times the risk for 
current smokers. The lower limit of the confidence interval for ex-smokers is < 1 
probably because the ex-smoker group did not have a significant level of risk. 
Table 4.17 
Logistic Regression Results for the Week Five LOO Reaction 
Vanables 8 SE Wald OF Sig R Exp(B) 95%CI 
Breast size 1.092 .460 5.642 1 .018 .160 2.981 1.210 -
7.343 
*Smoking 5.327 2 .070 .097 
Ex-smoker .282 .477 .350 1 .554 .000 1.325 .551-
3.372 
Current 1.427 .621 5.286 1 .022 .152 4.165 1.234-
smoker 14.058 
{Constant) -1.641 .341 23.107 1 .000 
*Reference group for smoking is the "never smoked" group 
The equation for calculating the probability of experiencing a more severe skin 
reaction in the LOO is: 
e -1.641 + 1.092(Breast size) + 0.282(Ex-smokar) + 1 427(Cummt smoker) 
1 + e-1.641 + 1.&ri(ffuimiiiilze) + oiii2(Eic-cmolier) + 1.427(Currenhmoker) 
Week five lower inner quadrant (LIQ) reaction results 
Three cases were deleted due to missing values therefore data from 123 
women ware available for anat ·sis: 90 (73.2%) had a score of D-RTOGO and 33 
(27.8%) scored D-RTOG1. Three variables entered the model: breast size, 
Results 113 
lymphocele aspirated and smoking. These variables correctly predicted 93.26% of 
mild or no reactions. and 20.59% of severe reactions, g1v1ng an accuracy of 73 17% 
overall. The model was significantly reliable when compared with the constant only 
model, x2(4) = 19.667. p = 0.0006, indicating that the predictors. as a set, reliably 
distinguished between the D-RTOG1 and D-RTOG2 scores. Table 4.18 shows 
details of the regression analysis for each of the three predictors. 
Table 4.18 
Logistic Regression Results for the Week Five LIQ Reaction 
Variables B SE Wald OF Sig R Exp(B} 95%CI 
Breast size 1.191 .471 6.389 1 .012 .174 3.289 1.307 -
8.278 
Lymphocele .886 .476 3.468 1 .063 .101 2.426 .955-
aspirated 6.168 
*Smoking 9.569 2 .008 .196 
Ex-smoker .192 .487 .155 1 .694 .000 1.211 .466-
3.146 
Current 2.067 .679 9.284 1 .002 .224 7.904 2.091 -
smoker 29.881 
{Constant~ -2.117 .445 22.693 1 .000 
*Reference group for smoking is the "never smoked" group 
The model is similar to the LOO reaction, with a relative risk over three times 
greater for those with a larger breast size. The lymphocele group had a relative risk 
of over twice that of the no lymphocele group. It should be noted that the lower limit 
of the confidence interval < 1. Again, the ex-smokers have a small but non-
significant increase in risk of severe skin reaction, but the current smoker's risk is 
eight times that of the never smoked group. 
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The regression equation for calculating the probability of experiencing a more 
severe skin reaction in the LIQ is 
e -2 117 • I 191{Broasl Silo) • 0 886(Lymphocekl) • 0 192(Ex-smoker) • 2 067(Cuttem smolcm) 
1 + e -2 117 • I 191(B<oast sue) • 0 886{lymphocelo) • 0 192/Ex-imoker) • 2 067/Curu,nt amolu,,j 
Week five nipple reaction results. 
Data from 126 women were available for analysis: 86 (68.2%) had a score of 
0-RTOGO and 40 {32.8%) scored D-RTOG1. Only one variable entered the model: 
smoking. This model correctly predicted 92.86% of mild or no reactions and 23.81 % 
of severe reactions, giving an accuracy of 69.84% overall. The model was 
significantly reliable when compared with the constant only model, /(2) = 7.461, p = 
0_0240, indicating that the predictor ;eliably distinguished between the 0-RTOGO 
and D-RTOG1 scores. Table 4.19 shows details of the regression analysis for the 
single predictor. 
Table4.19 
1,_Q£istic Regression Results for the Week Five Nipple Reaction 
Variables B SE Wald OF Sig R Exp{B) 95%CI 
*Smoking 7.131 2 .028 .140 
Ex-smoker .399 .425 .884 1 .347 .000 1.491 .649-
3.427 
Current 1.569 .588 7.121 1 .008 .179 4.804 1.517-
smoker 15.213 
{Constant} -1_059 .282 14.144 1 .000 
*Reference group for smoking is the "never smoked" group 
The model for predicting the nipple reaction differs fmm the reactions of the 
four quadrants of the breast, in particular, in that the size of the breast did not 
predict the severity of the reaction. The ex-smokers had a slightly increa:,ed relative 
risk although again, not significant, of one and a half times that of never smokers. 
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The confidence interval reflects this. as the lower limit is < 1 The nsk is significantly 
increased for current smokers who had an almost five times greater risk of a more 
severe reaction. 
The regression equation for calculating the probability of experiencing a more 
severe skin reaction in the nipple is: 
e . f 059 • 0 399(Ex-smoker) • 1 S69(Curren1 smoker) 
1 + e -1 059 • 0 399(Ex-w>Olwr) • 1 S69(Curren1 smoker) 
Week five inframammary fold reaction results. 
Three cases were removed due to missing values therefore data from 123 
women w~re available for analysis: "'8 (63.4%) had a score of D-RTOGO and 45 
:6.6%) scored D-RTOG1. Two variables entered the model: breast size and 
smoking. This model correctly predicted 90.91% of mild or no reactions and 47.83% 
of severe reactions giving an accuracy of 74.80% overall. The model was 
significantly reliable when compared with the constant only model, /(3) = 31.080, p 
= 0.0000, ind:cating that the predictors, as a set, reliably distinguished between the 
D-RTOGO and D-RTOG1 scores. Table 4.20 shows details of the regression 
analysis for each of the two predictors. 
The relative risk of developing a more severe skin reaction in the 
inframammary fold was increased over five times with a large breast size. It is 
notable that for skin reactions in the inframammary fold, ex-smokers showed a 
significantly increased risk of severe reaction of three times over the never smoked 
group. Those participants smoking through treatment had over ten times the risk of 
the never smokers. 
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Table 4.20 
Logistic Regression Results for the Week Five lnframammary Fold Reaction 
Variables B SE Wald DF Sig R Exp(B) 95%CI 
Breast size 1.687 .482 12.282 1 .001 .252 5.406 2.104 -
13.890 
Smoke 13.479 2 .001 .241 
group 
Ex-smoker 1.142 .458 6.233 1 .013 .161 3.134 1.278-
7.681 
Current 2.316 .690 11.261 1 .001 .239 10.139 2.621 -
smoker 39.223 
{Constant~ -1.715 .351 23.907 1 .000 
*Reference group for smoking is the "never smoked" group 
The equation for calculating the probability of experiencing a more severe skin 
reaction in the inframammary fold in week five is: 
e -1.715 + 1.687(Breast size)+ U42(Ex-$1'10ker) + 2.316{Cumml smolal<) 
1 .,.. e -1.ns + 1.M?(8i'east &IZS). 1.142(Ei-srnofuirj. 2.316(Cuiren1 smoiaiij 
Week Four Prediction Models 
The reactions recorded for week four represent the dose range of 28.8 Gy -
36 Gy. A score of 0-RTOG 1 (standard RTOG > 2) during week four represents an 
early severe reaction. Thus the prediction models developed by stepwise logistic 
regression produce factors that indicate the likelihood of an earlier reaction 
occurring in an individual. Dose group was categorised in a simUar way as week 
five with 28.8 Gy - 34.2 Gy as the reference group (0) and the last dose of the 
week, 36 Gy being grouped as 1. 
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Week four sternum reaction results. 
Data from 126 women were available for analysis: 89 (70.6%) had a score of 
0-RTOGO and 37 (29 4%) scored D-RTOG1. Two variables entered the model 
dose group and history of skin cancer. These variables correctly predicted 96.63% 
of mild or no reactions and 27.03% of severe reactions, giving an accuracy of 
76.19% overall. Dose group in week four represents the last fraction of week four of 
the whole breast treatment (36 Gy). The model was significantly reliable when 
compared with the constant only model, /(2) = 18.212, p = 0.0001, indicating that 
the predictors, as a set, reliably distinguished between the 0-RTOGO and 0-RTOG 1 
scores. Table 4.21 shows details of the regression analysis for each of the two 
predictors. 
Table 4.21 
Logistic Regression Results for the Week Four Sternum Reaction 
Variables 8 SE Wald OF Sig R Exp(B) 95%CI 
Dose group .994 .493 4.068 1 .044 .116 2.701 1.028-
7.092 
History of 2.334 .705 10.960 1 .001 .242 10.322 2.592-
skin cancer 41.110 
{Constant} -1.379 .257 28.750 1 .000 
A history of skin cancer is an important predictor in the model for week four 
sternum reactions. The relative risk for a history of skin cancer is 10.3, which is very 
similar to the week five model. The difference seen here is that the dose factor, 
rather than age, entered the model in week four. The last fraction of treatment in 
week four more than doubles the relative risk of a severe skin reaction. 
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The equation for calculating the probability of experiencing a severe skin 
reaction in the sternum in week four is 
e · 1 4o56 • 0 8410{Do,w, group) • 2 4514/Slun cancer) 
1 + e -l 4656 • o 8410(Dos.o group) • 2 4514(Skln cance1> 
Week four rucilla reaction results. 
Three cases were deleted due to missing values, therefore data from 123 
women were available for analysis: 95 (77.2%) had a score of D-RTOGO and 28 
(22.8%) scored D-RTOG1. Three variables entered the model: breast size, 
chemotherapy, and lymphocele aspirated. These variables correctly predicted 
92.55% of mild or no reactions and 41.38% of severe reactions, giving an accuracy 
of 80.49% overall. The model was significantly reliable when compared with the 
constant only model, x2(3) = 18.726, p = 0.0003, indicating that the predictors, as a 
set, reliably distinguished between the D-RTOGO and D-RTOG1 scores. Table 4.22 
shows details of the regression analysis for each of the three predictors. 
Table4.22 
Logistic Regression Results for the Week Four Axilla Reaction 
Variables B SE Wald OF Sig R Exp(B) 95%CI 
Breast size 1.553 .477 10.614 1 .001 .253 4.726 1.857-
12.032 
Chemo- 1.101 .619 3.160 1 .075 .093 3.008 .893-
therapy 10.125 
Lymphocele .766 .466 2.702 1 .100 .072 2.150 .863-
aspirated 5.356 
(Constant} -2.222 .402 30.482 1 .000 
The model differs slightly from the week five model in that breast size has 
replaced weight a larger breast size increases the relative risk of a more severe 
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skin reaction by three times. Chemotherapy also entered the model, indicating that 
when having chemotherapy for breast cancer the relative risk of having a severe 
radiation skin reaction is three times as great. This result must be viewed with 
caution, as the lower limit of the confidence interval is < 1. The impact of lymphocele 
aspiration is very similar to that in the week five model at just over two times the 
relative risk. Again, it should be noted that the lower limit of the confidence interval is 
< 1. 
The equation for calculating the probability of experiencing a more severe skin 
reaction in the axilla in week four is: 
e·2.222 + 1.553(Broast size)+ 1 101(Chemolherapy) • 706{Lymphocele) 
1 + e·2.222 + 1.S53{8reasl size)+ 1 101(Chemolherapy) + 706(Lymphocele) 
Week four UOQ reaction results. 
Three cases were deleted due to missing values therefore data from 123 
women were available for analysis: 100 (81.3%) had a score of D-RTOGO and 23 
(18.7%) scored D-RTOG1. Two variables entered the model: breast size, condition 
of the breast scar. These variables correctly predicted 99.00% of mild or no 
reactions and 8. 70% of severe reaction, giving an accuracy of 82.11 % overall. The 
model was significantly reliable when compared with the constant only model, x2(2) 
= 10.315, ,) = 0.0058, indicating that the predictors, as a set, reliably distinguished 
between the D-RTOGO and D-RTOG1 scores. Table 4.23 shows details of the 
regression analysis for each of the two predictors. 
The model is quite different for UOQ reactions in week four compared with 
week five. Breast size is the only predictor that is the same; interestingly the relative 
risk also remains similar. The condition of the breast scar as a predictor indicates 
that if the lumpectomy scar is inflamed or discharging at the commencement of 
treatment, then the risk of a severe skin reaction in week four is over 1 O times 
greater. 
Results 120 
The lower limit of the confidence interval for "Condition of the breast scar" is 
less than 1. 00 and is probably due to there being only three participants with 
inflammation or infection in the scar at the commencement of radiation The high 
upper limit of the confidence interval for this predictor reflects the high relative risk 
Table 4.23 
Logistic Regression Results for the Week Four UOQ Reaction 
Variables B SE Wald OF Sig R Exp(B) 95%CI 
Breast size 1.319 .497 7.046 1 .008 .206 3.741 1.412-
9.911 
Condition of 2.315 1.295 3.194 1 .074 .100 10.122 .799-
breast scar 128.144 
{Constant} -1.988 .322 38.104 1 .000 
The equation for calculating the probability of experiencing a more severe skin 
reaction in the UOQ in week four is: 
e· 1.988 + 1.319(Breasl size)+ 2.315{Condition of br82st scar) 
1 + e· 1.988 + 1.319(8,easl size)+ 2.315{Condition of bmasl scar) 
Week four UIQ reaction results. 
Three cases were deleted due to missing values therefore data from 123 
women were available for analysis: 101 (82.1%) had a score of D-RTOGO and 22 
(17.9%) scored D-RTOG1. Two variables entered the model: breast size and 
condition of the breast scar. These variables correctly predicted 99.01% of mild or 
no reactions and 9.09% of severe reactions, giving an accuracy of 82.93% overall. 
The model was significantly reliable when compared with the constant only model, 
x2{2) = 8.809, p = 0.012, indicating that the predictors, as a set, reliably 
distinguished between the 0-RTOGO and D-RTOG1 scores. Table 4.24 shows 
details of the regression analysis for each of the four predictors. 
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Table 4.24 
Logistic Regression Results for the Week Four UIQ Reaction 
Variables B SE Wald DF Sig R Exp(B) 95%CI 
Breast size 1.171 .504 5.386 1 .020 .171 3.225 1.200-
8.669 
Condition of 3.350 1.287 3.333 1 .068 .107 10.483 .841-
breast scar 130.615 
(Constant) -1.990 .322 38.144 1 .000 
The predictors entering the model for the UIQ: breast size and condition of the 
breast scar, are the same as for the UOQ in week four. The levels of relative risk 
associated with the predictors are also very similar. Again, the confidence interval 
includes 1 for "condition of the breast scar". 
The regression equation for calculating the probability of experiencing a 
severe skin reaction in the UIQ in week four is: 
e·1.990 + 1.171(Bnlast size)+ 3.3SO(Condilion al broa$1 scar) 
1 + 0 -i .990 • 1.111{8roasl size) + J.350(Condllion a1 breast s.car> 
Week four LOQ and LIQ reaction results. 
Please note that the results for LOQ and LIQ reactions are identical. They are 
therefore presented together. Three cases were deleted due to missing values, 
therefore data from 123 women were available for analysis: 103 (83.7%) had a 
score of 0-RTOGO and 20 (16.3%) scored D-RTOG1. Three variables included in 
the model: breast size, condition of the breast scar, and smoking. These variables 
correctly predicted 96.08% of mild or no reactions and 14.29% of severe reactions, 
giving an accuracy of 82.11 % overall. The model was significantly reliable when 
compared with the constant only model, x.2(4) = 12.874, p = 0.012, indicating that 
the predictors, as a set, reliably distinguished between the 0-RTOGO and 0-RTOG 1 
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scores. Table 4.25 shows details of the regression analysis for each of the three 
predictors. 
Table 4.25 
Logistic Regression R.3sults for Week Four LOQ and LIQ Reactions 
Variables B SE Wald OF Sig R Exp(B) 95%CI 
Breast size .900 2.709 1 .095 .084 2.460 .856-
.5390 7.077 
Condition of 2.619 1.399 3.506 1 .0611 .115 13.727 .885-
breast scar 212.962 
Smoking 5.457 2 .065 .114 
Ex-smoker .665 .593 1.258 1 .262 .000 1.944 .609-
6.214 
Current 1.490 .706 5.447 1 .019 .175 5.190 1.302-
smoker 20.691 
(Constant) -2.490 .464 28.869 1 .000 
The equation for calculating the probability of experiencing a more severe skin 
reaction in the LOO and the LIQ in week four is: 
e-2.490 + .900(broozt size) + 2.61S{condition of lifcaSI &ear) + .665(ox-smoker) + 1.490(currenl smok.er) 
1 + e-2.400 + llOO(bri,ssi sizo) + 2.619(c:ondlilon of breast scar) + .66S(ox~ + 1.490(curmnl smoker) 
Week four nipple reaction results. 
Data from 126 women were available for analysis: 98 (79. 7%) had a score of 
D-RTOGO and 25 (20.3%) scored D-RTOG1. With the standardised approach to the 
logistic regression, a model that significant1y improved the prediction of severe skin 
reactions to the nipple was not found. 
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Week four inframammary fold reaction results. 
Data from 126 women were available for analysis: 98 (77 7%) had a score of 
D-RTOGO and 28 (22.3%) scored D-RTOG1. Two variables entered the model, 
chemotherapy and smoking. These variables correctly predicted 96.94% of mild or 
no reactions and 14.29% of severe reactions, giving an accuracy of 7, 57% overall 
The model was significantly reliable when compared with the constant only model. 
x.2(3) = 10.709, p = 0.0134, indicating that the predictors, as a set, reliably 
distinguished between the 0-RTOGO and D-RTOG1 scores Table 4.26 shows 
details of the regression analysis for each of the two predictors. 
Table4.26 
Logistic Regres .. ,on Results for the Week Four lnframammary Fold Reaction 
Variables B SE Wald OF Sig R Exp(B} 95%CI 
Chemo- 1.306 .584 5.006 1 .025 .150 3.692 1.176-
therapy 11.593 
Smoking 6.349 2 .042 .133 
Ex-smoker .692 .503 1.8SS 1 .169 .000 1.998 .746-
5.323 
Current 1.563 .629 6.182 ~ .~13 .177 4.773 1.392-' 
smoker 16.363 
(Constant) -1.974 .380 27.033 1 .000 
The regression equa!ion for calculating the prcl:!.9C'ility of experiencing a more 
severe skin reaction in the lnframammary Fold in week four is: 
Ef1.974 + 1~ + 0.692(Ex-cmokef) + 1.563(CUmm1 smoker) 
1 + 8 -1.s1.o • i.306(C1lemalfuipy). o.002cex-<11t101mr>. 1.563(Current iimoimr> 
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Week Three Prediction Models 
Although very few participants scored D-RTOG 1 during week three. a logistic 
regression analysis was attempted in order to determine if any predictors could be 
proposed to identify very early reactions. The reactions recorded for week three 
represent the dose range of 19.8 Gy- 27 Gy. 
Week three sternum reaction results. 
Data from 126 women were available for analysis: 109 (86 5%) had a score of 
0-RTOGO and 17 (22.4%) scored D-RTOG1. One variable was included in the 
model: history of skin cancer, and correctly predicted 100.00% of mild or no 
reactions and 0.00% of severe reactions predicted 86.51% of cases overall. The 
model was significantly reliable vlhen compared with the constant only model, /(1) 
= 5.879, p = 0.0153, indicating that this predictor reliably distinguished between the 
0-RTOGO and D-RTOG1 scores. Table 4.27 shows details of the regression 
analysis. 
Table4.27 
Logistic Regression Results for the Week Three Sternum Reaction 
Variables B SE 
History of 1.660 .647 
skin cancer 
(Constant) -2.130 .305 
Wald OF Sig 
6.590 1 .010 
48.671 1 .000 
R 
.215 
Exp(B) 95% Cl 
5.260 1.481 -
18.685 
A history of skin cancer entered the model as it did in the models of both 
weeks four and five. The relative risk is noticeably lower in this model, indicating that 
the relative risk of a severe reaction is just over six times greater in those with a 
history of skin cancer. The relative risk was calculated at 10 and 11 times greater in 
the models for weeks four and five respectively. 
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The equation for calcuiating the probability of experiencing a more severe skin 
reaction in the sternum in week three is 
e -2 130 • , 660!~ o1 •kin canoot> 
1 + e·2 1Jb. 1 •6So(Ai5tiiv a aJn cance<1 
Week Three Results for the Remainder of the Sites 
The frequency of D-RTOG 1 scores were small in week three, therefore the 
predictive models produced through logistic regression were not significantly reliable 
when compared with the constant only model for each site. 
One variable, lymphocele group, consistently appeared in the models as 
significantly related to the severity of skin reactions in week three, as detennined by 
the Wald statistic. The lymphocele group appeared in the model for reactions in the 
axilla, and all four quadrants of the breast The size of the breast variable was also 
significantly related to the severity of the skin reaction in the UIQ and LOO sites. 
Analysis of Electron Boost Treatment 
Description of RTOG Scores in Weeks during Electron Boost Treatment 
The results of the RTOG scores for weeks six and seven are displayed in 
Figures 4.5 and 4.6 respectively. 
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The highest frequency of moist desquamation (RTOG ~ 2) occurred in week 
six. 'Mlen comparing Figure 4.4 and 4.5, it can be seen that the frequency of RTOG 
O scores increase and the frequency of RTOG 1 scores decrease concurrently m 
week seven indicating that overall there was healing and recovery during the last 
week of the boost treatment 
Over half of the participants (55.6%) had their lumpectomy scar, and thus their 
boost, in the UOQ of the breast. The frequency distribution for lumpectomy scars is 
detailed in Table 4.28. 
Table4.28 
Frequency and Percent Distribution of Participants According to the Site of 
Lumpectomy Scar 
Site of Lumpectomy Scar Frequency(%) of Participants 
UOQ 70 (55.6%) 
UIQ 19 (15.1%) 
LOO 10 ( 7.9%) 
Central scars (including the nipple) 1 O { 7. 9%) 
Across both UOQ & axilla 9 ( 7 .1 % ) 
LIQ 6 ( 4.8%) 
Axilla 3 ( 2.4%) 
_ln_fra_ma_m_m_a_ry....._F_o_ld ________ 1_{...__0_.S_o/c~o).__ ________ _ 
The severity of the reaction only continues to increase at the site of the 
lumpectomy scar, where the electron boost is delivered. At the remainder of sites 
the reaction diminishes as healing progresses. Given this fact, it was not logical to 
include all sites in the analysis, as the diminishing reactions in most cases would 
confound the results. Therefore, for the purposes of analysis, only participants 
whose lumpectomy site was located in the UOQ, the UOQ and axilla, or the axilla 
were inciudad (N = 82, 65.1% of total sample). 
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Univariate Testing of Potential Predictive Factors Related to Severe Skil" Reactions 
during the Boost Treatment 
Chi-square analysis was performed on dichotomous and categorical predictor 
vanables and the D-RTOG scores for week six and seven. The analysis was 
confined to those participants with the boost treatment in the axilla and/or the UOQ 
of the breast Tables 4.29 and 4.30 present the results of the Chi-square analysis for 
weeks six and seven respectively. 
For continuous variables, t-tests were performed to test relationships between 
potential predictor variables and skin reactions {D-RTOG scores). In week six. 
participants with a more severe axilla reaction had a significantly higher mean 
weight (t (72) = -3.96, p = .000). as did participants with a more severe UOQ 
reaction (t (72) = -2.17, p = .033). 
In week seven, participants with a more severe axilla reaction had a 
significantly higher mean weight (t (75) = -2.64, p = .010). Participants with a more 
severe UOQ reaction had both a significantly higher mean weight {t (74.91) = -3.22, 
p = .002), and a significantly higher mean age {t (75) = -2.40, p = .019) than their 
counterparts with a mild skin reaction. 
Tabla4.29 
Sigaifi~nt Rel~tionshlRS in Qichotomous RTOG Scores for Week Six According to Site as Testeg by Chi-~uare (g:value} 
Site Alcohol Breast Boost Family Family Lympho- History Smoker Smoke D-RTOG 0-RTOG 
intake Size energy history of history of cele of current group Axilla UOQ 
(p-value) (p-value) (p-value) breast cancer group previous or ex- (p-value} weeks week 5 
cancer (p-value) (p-value) cancer (p-value) (p-value) (p-value) 
(p-value) <e-value) 
Week6 
Axilla 11.17 6.86 5.11 4.49 3.13 3.46 10.66) 
(.001) (.009) (.024) (.034) (.077) (.063) (.001) 
UOQ 6.81 4.09 12.68 2.71 9.76 11.51 20.83 
(.033) (.043) (.013) (.099) (.002) (.003) (.000) 
Table4.30 
Significant RelationshlQs in Dichotomous RTOG Scores for Week Seven According to Site as Tested by Chi-§Quare (~-value} 
Age Breast Boost Chronic Alcohol Hyper- Smoker Smoke Skin D-RTOG 0-RTOG 
group size energy Illness intake tension current group condi- Axilla UOQ 
or ex- (p-value) tion week6 week6 
-value 
Axilla 3.35 4.10 14.01 
(.067) (.043) ( 000) ::0 t1) 
fl) 
UOQ 7.164 9.27 5.55 3.36 6.93 7.69 5.63 5.64 C ;:; 
(.028) (.056) (.062) (.067) (.008) (.021) (.060) {.018) fl) 
..... 
I'.) 
co 
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Development of Prediction Models for Radiation Skin Reactions during Electron 
Boost Treatment 
Week Six Prediction Models 
Week six represents the first week of electron boost treatment following the 
completion of 45 Gy to the whole breast The electron boost is delivered to the 
tumour bed located under the lumpectomy scar plus a small margin of tissue 
surrounding the area. As can be seen from the description of the RTOG scores, 
those areas not included in the boost site begin to heal. 
Week six axilla reaction. 
Following the deletion of eight cases due to missing values, data from 74 
women were available for analysis: 37 (50%) had a score of D-RTOGO and 37 
(50%) scored D-RTOG1. Two variables were included in the model: lymphocele 
aspirated and current weight. These variables correctly predicted 83.78% of mild or 
no reactions and 75.68% of severe reactions, giving an accuracy of 79. 73% overall. 
The model was significantJy reliable when compared with the constant only model, 
x2(2) = 22.066, p = 0.0000, indicating that the predictors, as a set, reliably 
distinguished between the D-RTOGO and D-RTOG1 scores. Table 4.31 shows 
details of the regression analysis for each of the two predictors. 
Table4.31 
Logistic Regression Results for the Week Six Axilla Reaction 
Variables B SE Wald DF Sig R Exp(B) 95%CI 
Lymphocele 1.531 .584 6.885 1 .009 .218 4.623 1.473-
aspirated 14.506 
Current .105 .029 12.906 1 .000 .326 1.111 1.049-
weight 1.176 
(Constant) -7.487 2.010 13.880 1 .000 
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Those participants who had developed a lymphocete requiring drainage had a 
relative risk of developing a more severe skin reaction 4.6 times greater than those 
who did not. The relative risk is based on the weight of the participant in kilograms 
The relative risk value appears small but it represents an increase per kilogram 
increase. Thus the magnitude of the relative risk is quite large. 
The equation for calculating the probability of experiencing a more severe skin 
reaction in the axilla is: 
e·7.4873 + I 5130{1ymphocele) + 01050(weigh1) 
1 + e·1 asn. 1.s13b(F,,nphocele). o 1056(we1111J1> 
Week six UOQ reaction. 
Following the deletion of 8 cases due to missing values, data from 7 4 women 
were available for analysis: 41 (59.4%) had a score of 0-RTOGO and 28 (40.6%) 
scored D-RTOG1. Two variables entered the model: boost energy and skin-type. 
This model correctly predicted 90.91% of mild or no reactions and 43.33% of severe 
reactions, giving an accuracy of 71.62% overall. The model was significantly reliable 
when compared with the constant only model, x2(2) = 19.008, p = 0.0001, indicating 
that the predictors, as a set, reliably distinguished between the 0-RTOGO and D-
RTOG1 scores. The lower energy levels of the electron boost treatment (6 - 12 
MeVel were not associated with a severe reaction so "boost energy" was re-coded 
into a dichotomous variable where 6 - 12 Meve· = O and 16 - 20 Meve· = 1. Table 
4.34 shows details of the regression analysis for each of the two predictors. 
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Table 4.32 
Logistic Regression Results for the Week Six UOQ Reaction 
Variables B SE Wald OF Sig R Exp(B) 95%CI 
Boost 2.822 .848 11.059 1 .001 .301 16.802 3.186-
energy 88.621 
·Skin-type 1.858 .814 5.209 1 .023 .179 6.414 1 300-
31.645 
Constant -2.398 .795 9.108 1 .003 
*Reference group was sensitive response to the sun 
The relative risk of a severe reactions was over 16 times greater if the boost 
was at the higher energy levels. The skin-type variable predicted that those with a 
nom,al or insensitive response to UV (Fitzgerald scale = 4 - 6) had a relative risk of 
almost six times greater than participants with sun-sensitive skin (Fitzgerald scale = 
1 -2). 
The equation for calculating the probability of experiencing a more severe skin 
reaction in the axilla is: 
e· 2.398 • 2.S22(boosl enerov>. 1.s58(s1on4ype) 
1 + e· 2.398 + 2.822(boOSI energy)+ 1 858(slan-type) 
Week Seven Prediction Models 
Week seven axilla reaction. 
Following the deletion of five cases due to missing values, data from 77 
women were available for analysis: 45 (58.4%) had a score of D-RTOGO and 32 
(41.6%) scored D-RTOG1. Two variables were included in the model: lymphocele 
group and current weight This model correctly predicted 77. 78% of mild or no 
reactions and 50.00% of severe reactions, giving an accuracy of 66.23% overall. 
The model was significantly reliable when compared with the constant only model. 
x2(2) = 9.455, p = 0.0088, indicating that the predictors, as a set, reliably 
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distinguished between the 0-RTOGO and D-RTOG1 scores. Table 4.33 shows 
details of the regression analysis for each of the two predictors. 
Table 4.33 
Logistic Regression Results for the Week Seven Axilla Reaction 
Variables B SE Wald OF Sig R Exp(B) 95%CI 
Lymphocele .832 .510 2.668 1 .102 .080 2.298 .847-
aspirated 6.239 
Current .061 .023 6.941 1 .008 .217 1.063 1.016-
weight 1.112 
{Constant} -4.685 1.608 8.487 1 .004 
Those participants who had developed a lymphocele requiring drainage had a 
relative risk of developing a more severe skin reaction over two times greater than 
those who did not. It should be noted that the confidence interval includes 1 for this 
predictor. The relative risk is based on the weight of the participant in kilograms, 
therefore the relative risk of developing a more severe reaction increases slightJy per 
kilogram increase in weight 
The equation for calculating the probability of experiencing a more severe skin 
reaction in the axilla is: 
e-4.6850 + .roz2(lymphocela aspiralod) + o.0608{weigh1> 
1 + e-4.6850 + .83ti(lympfucelc aiip/raied) + o.~> 
Week seven UOQ reaction. 
Following the deletion of five cases due to missing values, data from 77 
women were available for analysis: 33 (42.8%) had a score of D-RTOGO and 44 
(57.2%) scored D-RTOG1. Only one variable was included in the model: current 
weight This model correctly predicted 51.52% of mild or no reactions and 72.73% of 
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severe reactions, giving an accuracy of 63.64% overall. The model was significantly 
reliable when compared with the constant only model, /(1) = 9.378, p = 0.0022, 
indicating that the predictor reliably distinguished between the D-RTOGO and D-
RTOG1 scores. Table 4.37 shows details of the regression analysis for the single 
predictor. 
Table 4.34 
Logistic Regression Results for the Week Seven UOQ Reaction 
Variables 
Current 
Weight 
Constant 
B SE Wald DF Sig R 
.067 .024 7.876 1 .005 .236 
-4.042 1.543 6.862 1 .009 
Exp(B) 95% Cl 
1.070 1.021 -
1.121 
The relative risk is based on the weight of the participant in kilograms. 
Therefore, the relative risk for developing a severe skin reaction in the UOQ during 
the boost treatment in week seven increases 1.070 times per kilogram increase in 
weight. 
The equation for calculating the probability of experiencing a more severe skin 
reaction in the axilla is: 
8
• 4.042 + o.001cweighl) 
1 + e· 4.642 + o.ost<wolght> 
Pain and Discomfort with Radiation Skin Reactions: Results of the VAS Pain 
Scale 
Pain was not as great a problem as anticipated during the course of the 
radiotherapy. Many participants said that what they felt was discomfort and not real 
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pain and chose to report zero on the VAS scale Table 4 35 details the frequencies 
of scores on the VAS over the seven weeks of treatment 
Table 4.35 
Percent Distribution of Participants According to VAS Pain Scores over Seven 
Weeks of Treatment 
Pain VAS 
Week 0 1 2 3 4 5 6 8 9 
1 99.2% 0.8% 
2 98.4% 0.8% 0.8% 
3 96.8% 2.4% 0.8% 
4 92.8% 0.8% 0.8% 1.6% 3.2% 0.8% 
5 87.3% 1.6% 2.4% 3.2% 1.6% 2.4% 0.8% 0.8% 
6* 83.2% 2.7% 6.0% 0.9% 1.8% 1.8% 2.7% 0.9% 
7** 88.6% 4.4% 0.9% 1.8% 1.8% 2.7% 
*N=115 **N=114 
Moderate to severe pain (VAS= 4 -10) appeared in week four with one 
participant reporting a score of eight. Week six represents the highest number of 
participants reporting pain with 16.5% (19) scoring between one and nine on the 
VAS. Figure 4.6 illustrates the similarity in pattern between the pain score over the 
weeks of treatment, and the development of radiation skin reaction and moist 
desquamation in the axilla. 
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week 7 
Figure 4.7 Comparison of Pain Scores with A>cilla D-RTOG Reactions and Moist 
Desquamation over the Seven Weeks of Treatment. 
Cross Validation of Predictive Models 
To test the validity of the predictive models two random samples of about 40% 
of the sample were taken and stepwise logistic regression perfonned using the 
same criteria as in the main analysis. A sample of cases was selected randomly by 
SPSS using the select cases facility. Random sample 1 had 54 cases and random 
sample 2 had 50 cases. The details of the logistic regression analysis for predicting 
the severity of radiation reactions in weeks four and five, for these samples, can be 
found in Appendix K. Table 4.36 lists the significant predictors from the analysis of 
the full sample and the two random samples by site for reactions in week five. Only 
week five prediction models were cross validated because with the small numbers in 
the random samples, the proportion of severe reactions would be too small to 
interpret the predictive models in a meaningful way. 
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The models developed for cross validation were very similar in the predictor 
variables to enter the models for each site. This provides an indication of the 
trustworthiness of the predictive models developed with the full sample 
Table4.36 
Comparison of Significant Factors between Analysis of Full Sample and Two 
Random Samples for Week Five Reactions 
Full Sample (N = 126) Random Sample 1 (N = 54) Random Sample 2 (N = 50) 
Sternum Sternum Sternum 
History of skin cancer History of skin cancer History of skin cancer 
Age Age 
Axilla Axilla Axilla 
Lymphocele aspirated Lymphocele aspirated Lymphocele aspirated 
Weight 
UOQ UOQ UOQ 
Breast size Breast size 
Dose 
Lymphocele aspirated Lymphocele aspirated Lymphocele aspirated 
Stage of tumour Stage of tumour 
Smoking Smoking 
!JJ.Q !JJ.Q UIQ 
Breast size 
Dose 
Lymphocele aspirated Lymphocele aspirated 
Stage of tumour 
LOQ LOQ LOQ 
Breast size 
Lymphocele aspirated 
Smoking Smoking Smoking 
!JQ !JQ !JQ 
Breast size Breast size Breast size 
Lymphocele aspirated 
Smoking Smoking Smoking 
~ Nipple Nipple 
Smoking Smoking Smoking 
lnframammaiY Fold lnframammarv Fold lnframammarv Fold 
Breast size 
Smoking Smoking 
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Summary of Chapter 
This chapter has documented the analysis and findings of data collected on 
the development of skin reactions in 126 women being treated for breast cancer with 
a standard protocol of post lumpectomy radiation. The results show that the 
theoretical relationships posed in the conceptual model could be demonstrated 
empirically on univariate and multivariate levels. Prediction models for each of eight 
anatomical areas of the breast exposed to radiation were wnstructed for skin 
reactions during the weeks of treatment to the whole breast area supporting the 
proposition that it is possible to estimate the risk of skin reactions for individual 
women facing radiotherapy. Prediction models were also constructed for the 
electron boost treatment phase for the UOQ and axilla sites. 
The validity of the prediction models for week five reactions was tested by 
cross validation with two random samples. Comparison between the predictive 
models from the full sample and the two random samples indicated a satisfactory 
level of validity. 
Pain associated with radiation skin reactions was not as severe as expected 
with many participants pl'flferring to describe the reaction as discomfort. When pain 
was reported it followed a very similar pattern to that of moist desquamation. That is, 
when skin loss had occurred, then pain, rather than discomfort, is reported. 
The findings reveal that radiation factors alone cannot predict the severity of 
radiation skin reactions. The addition of factors from the Personal Construct of the 
Conceptual Framework, particularly the impact of smoking, breast size and 
lymphocele aspiration, make the prediction model more complete. 
CHAPTER FIVE 
DISCUSSION AND CONCLUSION 
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The principle hypothesis developed and tested in this study is that knowledge 
of factors that impair wound healing will contribute to creating a more complete 
understanding of radiation skin reactions and make the prediction of individual risk 
possible. The ultimate purpose of this study was to develop an instrument for 
clinical and research use that would enable nurses to predict the severity of 
radiation skl11 reactions on an individual basis. The research focussed on women 
with breast cancer as they represented a reasonably homogenous group for 
studying such a complex and multifactorial issue. 
The development of the prediction instrument was reported in detail in this 
thesis, as follows. Chapter One presented an argument for obtaining empirically 
based knowledge about the importance of radiation skin reactions in relation to the 
preparation of women for treatment. Chapter Two traced the theoretical 
relationships between the effects of ionizing radiation on normal skin and the 
impact of factors that impair the processes of tissue healing. A model supporting 
the following hypothesis was offered: that the severity of radiation skin reactions is 
a function of radiation, genetic and personal factors. Chapter Three detailed the 
methods and procedures developed to test the hypothesis and Chapter Four 
detailed the findings of the research process. 
This chapter discussed the study findings in relation to the conceptual 
framework and identifies practice implications through the development of a 
msttlod of risk prediction for women commencing standard radiotherapy post 
lumpectomy. In addition, the chapter includes a critical reflection on measurement 
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issues arising from the study and study limitations. A summary of the findings 1s 
presented first. 
Summary of Findings 
Data from a sample of 126 women commencing standard post-lumpectomy 
radiation protocol were collected on factors that were potentially predictive of 
radiation skin reaction severity. Skin reactions of these women were documented 
over the seven weeks of treatment to detennine the relationship between the 
predictive factors and the severity of the skin reaction that developed. The sample 
was representative of the general population of women in Western Australia on a 
range of socio-demographic items. The sample was also similar to the breast 
cancer population in disease related factors such as histology of the tumour when 
compared with published figures (Kurtz et al., 1989). 
Predictive Factors 
A review of treatment-related factors revealed that at the time radiation 
therapy commenced, the women's surgical incisions at the lumpectomy and axillary 
clearance sites were in good condiiion with less than 3% having any inflammation 
or haemoserous discharge. Almost half of the sample had required the aspiration 
of a lymphocele on one or more occasions post axillary clearance. Indications for 
aspiration were: discomfort due to the collection of lymph fluid, and/or a change in 
contour of the lateral chest wall due to the accumulation of fluid thus changing the 
measurements for accurate administration of ionizing radiation. Only 16 
participants were receiving or had received chemotherapy for their breast cancer. 
In tenns of general health, over half of the sample had one or more 
concurrent diagnoses of chronic illness. None of these illnesses were 
radiosensitive and the majority were not identified as illnesses that would impair 
healing. Almost two-thirds of the sample were taking prescribed medications, this 
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being significantly related to the presence of a chronic illness. In addition, over half 
of the sample were self-medicating or taking medicines prescribed by a naturopath 
Over three-quarters of these self-medications were vitamin and mineral 
supplements and just over one fifth of the sample were taking alternative 
medicines for their anticancer properties. 
Just over half of the sample had smoked at some time. but only 13 reported 
smoking throughout treatment. Alcohol consumption during treatment was reported 
by just over half of the sample. 
The nutritional status of the participants, as assessed by the nutrition 
subscale of the Braden Scale, showed that intake was adequate or excellent in 
98% of cases. There was a considerable range in the weight of participants from 
42 to 112kg, but the majority had a body mass index in the normal range. The size 
of the breast was significantly related to weight as would be expected. The majority 
of participants had smaller breast size as defined by brassiere ·c~ cup or smaller. 
The condition of the skin was normal ir. almost 80% of cases and less than 
half reported problems with skin allergies. In relation to participants' skin responses 
to UV radiation, as measured by the Fitzgerald Scale, almost 70% reported a 
normal or insensitive response. The mid to high level scores on the Cumulative UV 
Scale showed that the sample as a whole had spent their time in the sun 
unprotected with a hat, clothing or sunscreen in both childhood and adulthood. The 
majority of participants had lived in Perth thus being exposed to the high-intensity 
UV radiation for which this area is known. 
RTOG Scores 
The patterns of skin reaction development followed the expected course, as 
described in Chapter Two, with dull erythema with or without dry desquamation 
(RTOG = 1) appearing about two weeks after the commencement of radiation. This 
was followed by a steady increase with the intensity of erythema becoming bright 
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and/or tender with or without moist desquamation (RTOG ~ 2). The reactions 
during electron boost treatment reflected the anticipated change in protocol, with 
reactions remaining high or increasing at the boost site and receding elsewhere. 
Also as anticipated, the three sites with the most severe skin reactions 
(RTOG ~ 2) were the axilla, the upper outer quadrant and the inframammary fold. 
The severity of the sternum reaction with the blister reaction was not unexpected. 
but required less nursing intervention with creams and/or dressings. The blister 
reaction is not uncommon with patients treated in the Department. but has not 
been reported in the literature. It is this type of variance to the usually reported 
reactions that suggests that the chronic sun-exposure of the sternum is 
responsible. This phenomenon requires comparison with other geographic areas. 
Also as expected, the most severe reactions were recorded during week five 
of treatment with confluent moist desquamation being noted in the axilla and upper 
outer quadrants. During the two weeks of boost treatment, the reactions generally 
began to heal in the areas that were not in the vicinity of the boost. RTOG scores 
of two or more were recorded most frequently in week six. Unless actual skin loss 
had occurred, skin reactions were not reported to be painful, but rather there was a 
heightened awareness of the breast and some discomfort. 
Similarities between Prediction Models. 
Some clear patterns emerge in the prediction models between the sites of the 
breast Table 5.1 summarises the predictors. Most notable is the similarity between 
the breast quadrants. The two lower quadrants had identical prediction models in 
week four and the same predictors with only slight variation in relative risk values in 
week five. In the two upper quadrants. the predictors that entered the models in 
week five were similar with the exception of smoking and tumour stage, which were 
not predictive in the UIQ. The small number of smokers may explain the anomaly of 
smoking not being a predictor in only one quadrant in week five. 
Table 5.1 
Patt~ms of Predictors between Sites and Over Time 
Site Week.Three 
Sternum History of skin cancer 
Axilla 
UOQ 
UIQ 
LOO 
LIQ 
Nipple 
lnframammary Fold 
Week Four 
History of skin cancer 
Dose 
Lymphocele aspirated* 
Breast size 
Chemotherapy• 
Breast size 
Condition of breast scar• 
Breast size 
Condition of breast scar• 
Breast size* 
Current smoker 
Condition of breast scar· 
Breast size* 
Current smoker 
Condition of breast scar• 
Chemotherapy 
Current smoker 
• indicates that the confidence interval included "1". 
Week Five 
History of skin cancer 
Age• 
Week six 
Lymphocele aspirated* Lymphocele aspirated 
Weight Weight 
Breast size 
Current smoker 
Lymphocele aspirated 
Stage* 
Dose 
Breast size* 
Lymphocele aspirated* 
Dose* 
Breast size 
Current smoker 
Lymphocele aspirated 
Breast size 
Current smoker 
Lymphocele aspirated* 
Current smoker 
Breast size 
Ex-smoker 
Current smoker 
Boost energy 
Skin type 
Week Seven 
Lymphocele aspirated* 
Weight 
Weight 
0 
~-
;. 
g 
.... 
J:,. 
w 
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In week five, predictive factors included in the models for all breast quadrants 
were: a larger breast size; receiving the last fraction of whole breast treatment; and 
having had a lymphocele aspirated. In week four, breast size and the condition of 
the breast scar were µredictors in all quadrants. This is of interest given that the 
majority of scars were in the upper quadrants suggesting that the impact of 
increased inflammatory response along the scar line affects the overall healing of 
the whole breast. However, this finding must be viewed with caution as the 
confidence interval included 1. 
The similarities between the models suggest that with further development, it 
may be possible to group the sites, thus making the assessment simpler for daily 
clinical practice and more practcal for educational purposes. 
Mechanisms Underlying the Relationships between Predictors and the 
Severity of Radiation Skin Reactions 
The development of models to predict the severity of radiation skin reactions 
in women with breast cancer was undertaken systematically and rigorously to 
ensure the final product would be statistically sound and clinically useful. Selection 
of potential predictors for entry into the stepwise logistic regression was based on 
the conceptual model and results of the univariate testing. In interpreting the 
findings in terms of the theoretical basis for the predictive relationships, it was clear 
that the conceptual framework could be modified to represent the findings more 
closely. The discussion that follows develops hypotheses for each predictive factor 
suggesting possible mechanisms underlying the predictive relationships. Factors 
are presented in order of frequency of occurrence in the prediction models. 
Breast Size and Weight 
Breast size was a significant predictor of severe radiation skin reactions in all 
quadrants of the breast and the inframammary fold in week five, and the axilla, all 
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quadrants of the breast and the nipple, in week four. The participant's weight was a 
significant predictor in the axilla reaction models in weeks five, six and seven. 
Breast size and weight were closely related variables as indicated by the finding of 
a significant moderate correlation between the two measures and a significantly 
higher mean weight for participants in the larger breast size group. The hypotheses 
presented to support these two factors are the same; thus the discussion is 
combined. 
There are two possible hypotheses that probably combine to explain the 
influence of the participant's breast size/weight on the severity of the radiation skin 
reaction. From a wound management perspective, increasing breast size/weight is 
an indicator of several mechanisms that may impair healing. The negative impact 
on the efficiency of healing caused by excess layers of adipose tissue or obesity 
was discussed in Chapter Two. One mechanism suggested was that the poor 
vascularity of adipose tissue compromises healing (Carville, 1995; Dealey, 1994). 
Obesity can also cause excessive wear and tear on skin through increased friction 
cm movement, causing abrasion. In surgical patients, obesity is also a factor in 
increased risk of postoperative infection. A larger breast size, even when a woman 
is not obese, can increase the risk of friction particularly if a brassiere is always 
needed for support. 
Areas such as the axilla where there is appositional skin are also more prone 
to severe skin reactions due to the increased moisture, warmth and friction along 
with poor aeration. It is well recognised that these elements can contribute to a 
'llOre severe radiation skin reaction through increasing the rate at which the 
stratum comeum sloughs (Sitton, 1992). A mainstay of radiation skin care protocols 
has lJeen to artificially maintain the stratum comeum through actions aimed at 
reducing possible friction for example by patting the skin dry rather than rubbing; 
wearing loose cotton clothing; and moisturising the skin. 
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From a radiation therapy perspective, weight can be viewed as an indication 
of increasing size of the chest area, i.e. as weight increases the area included in 
the treatment field increases. A skin-sparing effect occurs as the higher energies 
produced by megavoltage linear accelerators result in the accumulation of the dose 
deeper in the tissues. A larger (heavier) person would, therefore, require a higher 
dose of radiation to the skin surface to ensure that the tumour receives the full 
dose required for eradication. Based on the hypothesis that the heavier the person, 
or the larger the breast size, the higher is the dose required relative to the skin 
surface, then a better measure of size might be a caliper reading between the 
sternum to the lateral aspect of the torso taken for treatment planning. Another 
alternative would be to develop a method of calculating skin dose for each of the 
observations sites that could be used on a practical level by nurses. In addition, a 
larger breast size is an indication of increased tissue volume being treated. A larger 
treatment volume has been implicated as increasing the severity of reactions 
(Maciejewski et al., 1990; Perez & Brady, 1992). 
Smoking 
Smoking during treatment was a significant predictor in all models in week 
five except for the sternum and upper inner quadrant. It was also a significant 
predictor in the two lower quadrants, nipple and inframammary fold reactions in 
week four. The impact of smoking on the development of more severe skin 
reactions was an extremely interesting finding. Wound healing literature suggests 
that smoking, and nicotine in particular, delays or impairs healing through a number 
of mechanisms. These mechanisms, as presented in Chapter Two, are: 
• Cutaneous vasoconstriction as a result of one or more of the constituents of 
cigarette smoke {Cohen, et al., 1992) 
e The negative impact on the nutritional status of the patient, in particular vitamin 
and mineral depletion (Cohen, et al., 1992; Dealey, 1994) 
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• Changes to the endothelium, increased platelet stickiness, high levels of carbon 
monoxide in the blood of smokers limiting the oxygen-carrying capacity of 
haemoglobin (Cohen, et al., 1992) 
• Reduction in macrophage activity and epithelialisation (Siana, Frankild & 
Gottrup, 1992) 
The effects of smoking on mucosal reactions in the mouth and throat have 
been described on several occasions in the radiation therapy literature. The 
mechanism hypothesised to explain the increased severity in mucosa! reactions 
has been the direct contact of an irritant (cigarette smoke) with the mucosa 
{Bentzen & Overgaard, 1994b; Browman et. al., 1993; Des-Rochers, Dische & 
Saunders, 1998; Rugg, Saunders & Dische, 1990). These fi;:dings suggest that 
adverse effects result not only in relation to direct contact, but also from the 
systemic effects of smoking that have been described and tested in the wound 
management literature. 
The relative risk of the ex-smoker group was not significantly higher than the 
group who had never smoked, suggesting the possibility that encouraging patients 
to quit smoking may positively impact on the severity of the skin reaction. This 
suggestion must be tempered by the knowledge that all except one of the ex-
smokers had quit more that one year prior to diagnosis. The efficacy of a quit 
smoking intervention on reducing the severity of skin reaction would require further 
testing. 
The significant impact on the severity of the skin reaction by smoking whilst 
on treatment cannot be ignored and may help identify new patients who may be at 
particular risk for severe skin reaction. The finding also underscores the importance 
of health promotion activities, such as smoking cessation, in cancer nursing 
practice. From the findings presented here it is clear that encouraging patients to 
quit smoking during treatment is an area of research that requires further attention. 
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Aspiration of a Lymphocele 
Having had a lymphocele aspirated was predictive of a more severe skin 
reaction in the axilla and all quadrants of the breast in week five and in the axilla 
reaction in week four. Entry into the models occur.-.Jd in some instances because of 
the broader entry criteria of p = . 1 O; where the significance level was greater that 
. 50 but less than . 10, then the confidence interval included 1. Despite these 
qualifications on the interpretation of lymphocele aspiration as a predictor, there 
are significant clinical implications which support the inclusion of the variable in the 
prediction models. 
The theoretical explanation for lymphocele aspiration exacerbating the skin 
reaction is related to the role the lymphatic system plays in the physiology of 
healing. It is logical to assume that participants who required aspiration of a 
lymphocele experienced more damage to the lymphatic system in the axilla due to 
clearance of axillary lymph nodes. The mean number of lymph nodes removed was 
not significantly different between participants who had a lymphocele aspirated and 
those who did not. 
As lymph oedema of the breast increases due to an inflammatory response 
to the ionizing radiation, the congestion resulting from axillary clearance increases, 
exacerbating the skin reaction and compromising the normal healing processes. 
Those women, who have demonstrated more damage to the lymph drainage 
channels by requiring aspiration of a lymphocele, are therefore at greater risk of 
breast lymph oedema and of compromised healing. 
It is possible that as a result of having the additional trauma to the axillary 
tissue from needle aspiration, a more marked inflammatory response would follow, 
further compromising the already weakened lymphatic system in the axilla. In 
addition, the possibility that the normal flora of the skin could be introduced into 
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tissue during the procedure would suggest further heightening of the inflammatory 
response or even a low-grade infection. 
The usual channel for drainage of lymph fluid for the breast is via the axillary 
nodes. The fact that aspiration of a lymphocele was not predictive in the 
inframammary fold reaction in either week four or five supports the hypothesis of 
increased tissue damage due to impaired lymphatic drainage in the upper breast. 
as there are alternative lymph node stations to channel lymph fluid from the lower 
aspect of the breast. 
Condition of the Breast Scar 
Less than 3% of lumpectomy scars were inflamed or discharging 
haemoserous fluids. The condition of the breast scar was predictive of severe skin 
reactions in three of the breast quadrants (not upper outer quadrant) in week four. 
Although the effects of scar condition are no longer predictive in week five 
reactions, it does appear to be an important indicator of risk for early onset 
reactions. The confidence intervals indicate that these findings should be viewed 
with caution and therefore further research is required before accepting the 
condition of the breast scar as a predictor in clinical assessment. 
The theoretical explanation for the predictive influence of scar condition lies 
in the delay in the healing processes due to inflammation and/or infection. The 
presence of infection or immunosuppression may affect the normal tissue response 
to radiation as described by Bentzen and Overgaard (1994b) and Chak et al., 
(1988). As discussed in Chapter Two, immunosuppression may well be part of the 
causal chain in the development of infection in radiation reactions where the 
integrity of the skin has been compromised. 
Clinical infection delays healing by prolonging the inflammatory phase and 
inhibiting the ability of fibroblasts to produce collagen (Senter & Pringle, 1985). In 
addition, there is competition for white cells and nutrients; therefore, healing may 
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be delayed until the body has overcome the infection. Furthermore. systemic 
infection causes fever, raising the metabolic rate, thus increasing catabolism and 
tissue breakdown. Pain, also produced by infection, may further increase the 
metabolic rate. 
The small group size and the interpretation of confidence intervals indicate 
that this finding musi be viewed with caution. 
History of Skin Cancer and Skin Type 
Having a history of skin cancer was significantly related to a more severe skin 
reaction to the sternum on a univariate level and as a significant predictor in weeks 
three, four and five. Skin type (as measured by the Fitzgerald scale) was 
significantly related to the severity of the sternum reaction in weeks three and four, 
and entered the prediction model for the UOQ in week six, during the first week of 
electron boost treatment. 
History of Skin Cancer 
The most likely explanation for a history of skin cancer being a significant 
predictor is that skin cancer is a measure of skin damage from chronic UV radiation 
exposure. The effects of chronic exposure to the sun were described in Chapter 
Two. It is interesting to note that other variables indicative of sun damage were 
significantly related to the severity of the skin reaction on a univariate level. These 
were skin-type in weeks three and four and the level of protection from UV 
radiation used as an adult (as measured by the Cumulative UV Radiation Scale) in 
week five. 
Of the variables associated with sun damage, only a history of skin cancer 
remained in the predictive model for the sternum. Given that only participants with 
a confirmed medical diagnosis of skin cancer were included in the analysis, this 
factor was a very conservative measurement of damage due to UV radiation. It 
also may suggest that a more discriminating measure of cumulative sun damage 
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could provide a better understanding of the impact of sun damage to areas of 
chronic exposure. 
Another interpretation of the theoretical basis for a history of skm cancer 
predicting the severity of the skin reaction would be that an individual who 
demonstrated sensitivity to the carcinogenic effects of UV radiation may also have 
a propensity to be generally more radiosensitive. In addition, the general immune 
depletion effects of chronic exposure to UV radiation as described by Santucci 
(1996), may have resulted in some impairment of the inflammatory phase of the 
normal process of wound healing. Although logical, these two hypotheses would be 
more credible if a history of skin cancer had featured in the prediction models in the 
reactions in other areas of the breast. It should be noted however, that on a 
univariate level, a history of skin cancer was significantly related to more severe 
reactions in the two lower quadrants and the nipple in week four. Thus, it would be 
premature to disregard the alternative hypotheses of radiosensitivity or immune 
depletion. 
Skin type 
The Fitzgerald scale, used to measure skin-type, incorporates sunburn and 
tanning history in a six point ordinal scale, to indicate the individual's sensitivity to 
the effects of UV radiation from the sun. Due to missing values, the variable was 
re-coded to two levels representing participants who were sensitive to the sun and 
those who had a normal or insensitive reaction to the sun. The finding that a high 
risk was associated with participants who had a normal or insensitive reaction to 
the sun would seem initially illogical. However, experience in the sun would lead 
those with sun-sensitive skin to prevent sunburn by using a hat, clothing and/or 
sunscreen. Those with skin that tans and is classed as either normal or insensitive 
to the sun, would be more likely to spend time in the sun unprotected, thus leading 
to a greater risk for chronic UV radiation damage. 
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The Cumulative UV Radiation Scale 
The two factors. history of skin cancer and skin-type, clearly suggest the 
probability of a relationship between the cumulative effects of chronic exposure to 
UV radiation. The Cumulative UV Radiation Scale was developed from a need to 
find a non-invasive method of estimating the impact of exposure to UV radiation 
over time. Initial development was through interviewing patients in the Department 
and healthy adults to determine a 1<1eaningful way of collecting information on 
exposure to the sun. The reliability and validity testing conducted were adequate to 
continue with the scale in the research. Although it was disappointing to find that 
the scores for this scale were not significantly related to the severity of skin 
reactions, the finding that a history of skin cancer and skin type were related to the 
radiation skin reactions in the sternum and UOQ shows that there is probably merit 
in pursuing some measure of UV radiation damage. The Cumulated UV Radiation 
may provide the basis for future development in this area. 
Radiation Dose 
Dose of radiation was a significant predictor in severe reactions in all 
quadrants of the breast and the nipple in week five; the sternum, upper outer 
quadrant and inframammary fold in week four and the sternum in week three. The 
significance of dose as a predictor is obvious and certainly expected, thus the fact 
that several models do not include dose as a predictor is, in fact, a more interesting 
finding. 
For example, the dose factor, although significantly related to the sternum 
reaction on a univariate level in weeks three, four and five, and on a multivariate 
level in weeks three and four, was not included in the prediction model in week five. 
This is a noteworthy finding, as it appears to indicate that the influence of a history 
of skin cancer is greater by week five than dose of radiation alone. The relative risk 
of dose is 3.5 in the week three model and 2.8 in the week four model. It would 
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seem that the influence of dose diminishes over the weeks of treatment to be 
replaced by an increasing relative risk for a history of skin cancer of 6 1 1n week 
three, and almost 12 in weeks four and five. 
The finding that dose does not appear in the axilla predictions is interesting 
given that it is an area prone to more severe reactions, including moist 
desquamation. These results suggest that wound healing factors have a significant 
influence in predicting the risk of a severe skin reaction in the axilla. The influence 
of having a lymphocele aspirated, having chemotherapy and the size of the breast 
were better predictors than radiation dose. Both a radiation enhancement 
mechanism and a healing mechanism can explain the influence of breast size and 
chemotherapy. On balance, however, it seems that in the axilla. at least, the 
influence of impaired healing is greater than that of dose or other direct radiation 
factors. 
Chemotherapy 
It is noteworthy that chemotherapy is included in models predicting earty 
onset reactions {week four) in the axilla and the inframammary fold. These sites 
are prone to moist desquamation as indicated in the descriptive results; supporting 
clinical experience. The well established theoretical basis for chemotherapy 
exacerbating radiation skin reactions was presented in Chapter Two and centres 
on the cytotoxic properties of chemotherapy and the potential for enhancing 
radiosensitivity {Bentzen & Overgaard, 1993; Fu, 19B5; Hirshfieid-Bartek. 1992; 
O'Rourke, 1987; von der Maase, 1994). 
In addition to their damaging effect on normal cells, cytotoxic drugs also have 
a suppressing effect on the immune system and thus wound healing. The principle 
risks of immune suppression are infection and bleeding. Healing is specifically 
impaired by the delay in clearance of debns through reduced white ceH activity 
(Laurence & Bennett, 1987). As a result, patients receiving chemotherapy are 
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expected to be at risk of infection. This would be extended to patients receiving 
chemotherapy as an adjuvant to radiotherapy, thereby increasing the risk of 
infection in any skin reaction particularly where moist desquamation has occurred 
From a clinical perspective it was surprising to find that chemotherapy did not 
significantly influence the prediction of week five reactions. It is possible that the 
impact of chemotherapy occurs earlier; but overall the reaction may not be worse 
during the treatment period. This study was limited to observations of skin reactions 
during the seven weeks of treatment only. It would be useful to follow those who 
developed moist desquamation after treatment to measure the healing time 
required and determine the variables that influence healing time. 
Pedersen, Bentzen and Overgaard (1994) discussed the notion of the 
"burden of side effects" suggesting the score for the reaction at the end of 
treatment alone does not supply sufficient information to comprehend the impact of 
side effects on the patient. This suggests that the length of time a patient 
experiences the side effect, as well as the severity, is important to note. Certainly in 
preparing an individual for radiotherapy the ability to determine the likelihood of 
earlier onset side effects would be reassuring to women facing radiation therapy 
and assist in coping with the experience. 
Age 
Age is frequently cited as being a probable risk factor in the development of 
radiation skin reactions (Ber.tzen & Overgaard, 1994b; Holmes, 1988; Perez & 
Brady, 1992). However, in this r:search, age was found to be a predictor only in 
the week five sternum reaction. Furthermore, an inverse relationship was revealed. 
As age increased the probability of a more severe reaction in the sternum 
decre~sed. This finding was not anticipated as the radiation literature had indicated 
a belief, at least, that increasing age would have impacted negatively on the 
development of skin reactions. From the wound management literature, the 
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diminishing capacity of the body to heal as age increases is due to a multitude of 
physiological and social reasons that suggests recovery from ionizing radiation 
would be at least delayed if not impaired. Data from this study was contrary to the 
expected view. 
Possible explanations for this finding may lie in three areas. Firstly, it is an 
accepted practice that chemotherapy is not used as frequently with older women. 
In this study the small group of participants receiving chemotherapy were 
significantly younger than those not receiving chemotherapy. Further testing of the 
potential relationship between chemotherapy and age determined that there was 
no significant interaction, suggesting that in this sample chemotherapy was not a 
covariant in the model. However, a larger sample with a greater proportion of 
participants receiving chemotherapy may shed light on this hypothesis. 
The second explanation is that as the rate of mitosis in normal skin cells 
reduces as age increases then the cells directly and indirectly affected by ionizing 
radiation would reduce. The effect on the tumour would not be the same, as the 
rate of mitosis is higher than that of normal cells. Jacobson and Flowers (1996) 
state that there is a notable decrease in the turnover rate of the epidermis by up to 
50% in the elderly. This decrease may be sufficient to provide some protection 
against the effects of ionizing radiation in the skin. 
The third possible explanation is one of difference in lifestyle of older 
participants in relation to chronic exposure to UV radiation. It is possible that the 
older generation was more likely to have been fully clothed when in the sun both in 
their youth and even in recent years. Although this is speculation, the data did 
indicate a significant iiiverse relationship between age and the protection used as a 
child as reported in the Cumulative UV Radiation Scale. 
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Boost Energy 
The results of the logistic regression for the skin reactions recorded dunng 
the two weeks boost treatment found that boost energy was a significant predictor 
of severe reactions in UOQ reaction di iring week six of treatment (first week of the 
electron boost). The relationship between the boost energy levels and the relative 
risk was demonstrated by higher energy levels(> 16MeVe') increasing the risk of a 
more severe reaction 011~r 16 times in the UOQ. However, boost energy did not 
predict the reactions in week seven. This was a somewhat unexpected finding as it 
could have been anticipated that as more skin-sparing effect occurs as higher 
energy levels increase, the relationship should have been inverse. 
Nevertheless, boost energy, as a predictor of severe skin reactions in week 
six, is a straightforward factor for use in clinical practice as the nurse can easily 
check the energy prescribed for the electron boost. The patient can then be 
prepared appropriately and be identified for close monitoring. 
Stage of the Tumour 
The inclusion of the stage of the tumour in the predictive model for the upper 
outer quadrant was an interesting finding. The model indicated that having a stage 
II or higher more than doubled the risk of a severe skin reaction. Inclusion of stage 
in the prediction models for the upper outer quadrant of the breast only was 
probably due the majority of tumours being located in the upper breast in this 
sample. The wound management literature identifies advanced cancer as a risk for 
wound !i&aling but, only one participant was classified as stage IV. The more 
probable explanation is that more participants classified at stage 11 or higher had 
larger tumours. Thus, the surgical bed would be larger, generally resulting in more 
trauma to the surrounding tissue and increasing the risk of haematoma, entrapped 
air, infection and/or abscess. 
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Comparing the Conceptual Framework with the Empirical Evidence 
After critical reflection on the predictive factors identified in this research, 
there is substantive evidence to support the original conceptual framework 
developed theoretically in comparison with the framework that emerged empirically. 
Figure 5.1 reproduces the original framework, introduced in Chapter Two. 
RADIATION RADIATION- GENETIC PERSONAL 
SKIN CONSTRUCT CONSTRUCT CONSTRUCT 
REACTION 
.. Age 
0 Sex 0 Coexisting disease 
0 Erythema 0 Dose 0 Coexisting 0 Drug therapy 
0 Itchiness ¢= 
" 
Absorbed dose Radiosensitive 
" 
Chemott.erapy 
9 Dry skin loss 0 Volume Disease Cl Nutrition 
Cl Moist skin loss 0 Fractionation 0 Cancer prone .. Smoking/alcohol 
GI Necrosis 9 Radiosensitisers Family 0 Scar condition 
Cl Pain 0 Site 0 Hereditary cancer o Skin type 
0 Energy 0 History of cancer .. UV exposure 
Figure 5.1 Conceptual Framework of Potential Predictors of Radiation Skin 
Reactions 
In considering the hypotheses generated to explain the relationships between 
predictors and the severity of the radiation skin reaction, there appears to be 
evidence for two main constructs to represent the empirical findings of this 
research. Figure 5.2 illustrates these factors. 
Radiation Factors 
cumulative 
dose 
electron boost 
energy 
::: 16Meve· 
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Healing Factors 
current chemotherapy 
increasing weight 
breast size ::: D cup 
history of skin 
cancer 
Genetic Factors 
current smoking 
lymphocete 
aspiration ::: 1 
poor condition of 
breast scar 
decreasing age 
tumour stage ::: II 
Figure 5.2 Empirically Based Framework Developed from the Findings 
The factors that entered the predictive models during the analysis are listed 
in Figure 5.2. This empirical evidence supports the theoretical relationships with the 
severity of radiation skin reactions, but they do not represent an exclusive list. 
Replication of this work must include all factors from the original conceptual 
framework until the limitations of this sample have been addressed. Furthermore, 
development of measures for concepts such as nutritional status and exposure to 
UV radiation may contribute to understanding this phenomenon. 
Measurement Issues 
The research process included a number of measures in order to 
operationalise the conceptual framework. The complexity of the framework 
required the development of new measures for some factors. These were 
combined with data from review of medical notes and reasonably concrete 
measures such as age and weight. Furthermore, another consideration in selecting 
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and developing measures was the ease with which nurses could make 
assessments on a routine basis in the clinical setting. No measure was either too 
difficult or too expensive, either in time or equipment, to prohibit its use in practice. 
The process of establishing rudimentary psychometric properties of the new 
measures was a focal point of the development work. The results of content validity 
and interrater reliability testing, as discussed in Chapter Three, indicate that the 
instruments were able to measure reliably the concepts under investigation. 
RTOG Scoring System for Skin Reactions 
Measuring the severity of skin reactions has been an important focus in 
radiation oncology since the inception of ionizing radiation as a therapeutic 
modality. The RTOG Scoring System used in this study was developed from clinical 
practice for clinical assessment rather than research. Denham et al. (1995) 
criticised the use of the system for research asserting that reflectance spectrometry 
has more specificity and reliability when compared with the RTOG as assessed by 
a number of radiation oncologists. The study by Denham et al. Revealed, however, 
that the pattern of skin reaction development was the same using the two methods. 
In the current research, reliability was ensured through careful training of research 
assistants and regular IRR testing. The results of the IRR testing, as described in 
Chapter Three, showed a high degree of correlation between all data collectors, 
certainly within acceptable ranges. 
The RTOG scoring system was modified early in the data collection period by 
the introduction of a score to separate "tender or bright erythema~ from "patchy 
moist desquamation". Where patchy moist desquamation occurred, a score of 2.5 
instead of 2 was recorded. In the final analysis, only a few participants experienced 
any moist desquamation and even fewer experienced "confluent moist 
desquamation" (RTOG = 3). Despite this finding, there may be merit in retaining the 
differentiation between a score of 2 or 2. 5 to increase the specificity of the RTOG 
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system. Denham et al. (1995) suggested separating the RTOG = 1 category into 
two with "follicular or dull erythema" as "1" and "dry desquamation" as "1 S. It is 
likely that these modifications will improve the specificity of the RTOG particularly 
for research. Further validity testing of the modifications is essential. 
Limitations 
The limitations of the study relate to three issues. Firstly there is the 
acknowledgement that other factors may increase the explanatory power of the 
prediction models. Despite this, the prediction models were able to predict the 
severity of radiation skin reactions with an overall accuracy of between 68% and 
82%. Other factors, such as the oxygenation of the skin or its temperature, specific 
nutritional deficiencies, or the impact of psychological state, could be tested in 
future research. 
Secondly, the limitations in measurement of the independent and dependent 
variables must be considered. Measures adapted or developed for use in the study 
were subject to content validity testing and to interrater and test-retest reliability 
testing. Refinement and further testing of this exploratory work will determine the 
utility of these measures for risk assessment in clinical practice. 
Thirdly, attention should be given to the limitations of the sample. The 
recruitment of participants continued over a 12 month period. Despite the 
extremely high response rate, the final sample size was 126. The sample did show 
significant similarity on socio-demographic data and on tumour histology 
suggesting that the data from the sample is trustworthy and further research with 
larger samples would be worthwhile. 
These limitations are tempered by the strengths of the study. The study 
developed a strong theoretical foundation and considerable effort was spent on 
ensuring that the measurements and protocols conducted frequently over a long 
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period of time remained accurate so that quality data were collected. Also, the 
sampling criteria were restricted as Denham (1996) cautioned that the investigation 
of predictive factors for skin reactions was subject to considerable extraneous 
variation particularly in relation to radiation factors and gender. The use of a 
sample drawn from women only, all of whom were receiving a standard post 
lumpectomy radiation protocol for breast cancer minimised the variation so that the 
focus of the analysis could be on the influence of factors from the Personal 
Construct. 
Application of the Predictive Models of Radiation Skin Reactions to Clinical 
Practice 
Underpinning this research was the aim of developing an empirical base for 
assessing patients' risk of a more severe radiation skin reaction. This study has 
developed and presented both theoretical and empirical evidence to support this 
aim. The application of this knowledge lies not just in improving clinical assessment 
in radiation oncology, but provides the theoretical basis for introducing 
interventions to support the patient physically and psychologically throughout the 
treatment period. 
As discussed in Chapter Two, Hendry (1994) suggested the possibility of 
moderating normal tissue damage through modifying individual character.sties such 
as diet and supporting the individual's resistance to infection with prophyla<..iic 
antibiotics. Hendry recognised the impact of surgery and chemotherapy on the 
promotion of cell proliferation and suggests that appropriate supportive therapy in 
the form of fluids, electrolytes and antibiotics may positively affect morbidity, 
ultimately resulting in an ability to give higher doses of radiation. This study 
supports Hendry's conclusion that not only can "other factors" affect the individual 
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expression of radiation reactions, but that the modification of these factors may 
moderate the impact of genetically determined radiosensitivity. 
Despite this research being exploratory and further research being required 
to confirm the psychometric properties of the assessment tool, specific knowledge 
arises from these findings that can be used in practice as a result of the findings. 
For example, a practicing nurse can incorporate the knowledge that smoking during 
treatment increases the likelihood of a more severe reaction; that a patient 
receiving chemotherapy will probably manifest a severe skin reaction earlier; and 
that patients with large breast sizes are at an increased risk of severe skin reaction 
and skin loss. 
Results also indicate that the models, as they have been developed with this 
sample, are extremely accurate in predicting patients who will develop only a mild 
(RTOG = 1) reaction or no reaction (RTOG = 0). Knowing who will not have a 
severe reaction is as important in clinical practice as knowing who will. If, when 
preparing a patient for radiation at the commencement of treatment, the • 1urse can 
tell the patient that she/he is 90% sure that there will be no more than a mild 
reaction, the patient is likely to be reassured and experience a reduction in anxiety 
(Poroch, 1995). 
The lower level of accuracy in predicting those who can expect a severe 
reaction means that fewer patients than predicted will have a severe reaction; a 
greater risk of making a Type II error. This is a cautious and safe approach 
because the pre1iction of a false positive will initiate close monitoring by both the 
nurse and the patient. Logically, a reaction that is not as severe as predicted would 
be better received by the patient than one that is worse. 
The potential to assess risk on an individual basis has several benefits. For 
the patient it means knowing what to expect, and when. For the nurse, it provides 
an empirical base for prioritising care and developing individualised skin 
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management. Risk assessment may also provide additional information for 
determining the effectiveness of different skin care and dressing products on a 
day-to-day basis. 
A Rudimentary Assessment Tool 
It is possible, using the formula described in detail in Chapter Four, to 
calculate the probability of an individual's risk for developing a radiation skin 
reaction of RTOG ~ 2 in women commencing a standard protocol of post 
lumpectomy radiation for breast cancer. Appendix L presents a series of tables 
constructed for each of the eight sites observed in this study that can be used to 
estimate individual risk. These tables are rudimentary and are not intended for 
immediate clinical use, but rather to indicate a useful form through which the 
findings of the study may be applied to practice in the future. 
Future Research Directions 
This study has explored and tested the relationships between the severity of 
radiation skin reactions and radiation, genetic and personal factors. Although 
described and hypothesised in texts and other publications, these relationships had 
not been tested before in a prospective study. The benefits of applying this 
knowledge to practice have been presented. Taking into consideration the 
limitations and strengths of the research it would be worthwhile to continue to 
develop this programme of research to develop a trustworthy method of risk 
assessment in radiation skin reactions. 
The first line of future research is in the development or modification of the 
measures used for the independent variables. For example, further development of 
the non-invasive measure of sun damage, and the addition of other predictors such 
as psychological state, skin oxygenation and skin temperature. Larger samples 
from more diverse populations will confirm and clarify the prediction models found 
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thus far. The process of validation studies would also require trials of prediction 
models where the person assessing the developing skin reaction would be blinded 
to the prediction. 
The second line of future research would extend the methodology developed 
here and apply it to skin sites other than the breast area and then to other normal 
tissue damage such as gastrointestinal tract mucosae. The skin has been used as 
the model for understanding the adverse effects of ionizing radiation on normal 
tissue (Denham et al., 1996). The application of this methodology to other radiation 
side effects is a logical trajectory to follow. 
The empirical basis for decision making in radiation skin management has 
been quite limited. One of the reasons for this has been that due to the problem of 
patient-to-patient variation, large random samples are required. The findings of this 
study provide support for stratification of samples based on known predictors, for 
example, smoking, breast size and lymphocele aspiration. For example. in testing 
the effectiveness of a topical ointment or cream, sample recruitment would be 
stratified by current smoking, breast size and lymphocele aspiration. 
Finally, it may be possible to use the predictions in the process of testing the 
effectiveness of topical medications and dressing materials. Earlier work by 
Downes, Porock and Upright (1997) indicated that using retention dressing tapes, 
such as Fixomull or Hypafix, may minimise skin loss through creating an artificial 
stratum comeum. By predicting who is most likely to develop a severe skin 
reaction, selection criteria for research in this area can be more appropriately 
structured, avoiding the exposure of patients to an unnecessary intervention when 
they are unlikely to develop a severe reaction. 
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Summary and Conclusions 
This research was conducted in three stages reflecting the overall aims of the 
research. Two assumptions underscored the research process: firstly that in 
addition to the effects of ionizing radiation, factors and mechanisms known to 
impair wound healing also affect the development of radiation skin reactions 
through impainnent of the nonnal process of tissue healing; and secondly that 
these factors were measurable. 
The first stage involved identification of factors from both wound healing and 
radiation literature along with clinical knowledge and development of a conceptual 
framework that could be tested. From this framework it was hypothesised that the 
severity of radiation skin reactions was a function of some or all of the genetic and 
personal factors plus the radiation factors. 
Development of the research protocol and completion of data collection 
fanned the second stage. All measures were subject to testing for content validity. 
The research protocol was piloted which included testing for stability over time, 
using test-retest reliability. During the data collection, the three, trained observers 
were rigorously tested for interrater reliability and accuracy of transferring 
infonnation from the medical record. The psychometric properties of the tool used 
exceeded the pre-set criteria. 
The sample of 126 women, recruited over a 12-month period, was 
representative of the WA general female population on socio-demographic criteria 
and representative of the breast cancer population in tenns of histology type. 
The third phase involved testing of the theoretical relationships on a 
univariate level with chi-square and t-test statistics, and on a multivariate level 
through stepwise logistic regression analysis. Through this analytical process, a 
predictive model was developed for each of the eight sites observed for the 
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reactions recorded in weeks three to seven of standard post lumpectomy radiation 
for breast cancer. 
The final aspect of the third phase was the critical reflection on the research 
process and findings. The purpose was threefold: Firstly, to form hypotheses 
explaining the mechanisms underpinning the significant predictors; secondly, to 
interpret the findings for nurses practising in radiation oncology and; thirdly, to map 
out the logical next steps for continuing the research work in this important area. 
Despite the limitations of this exploratory study, the findings contribute to both 
the knowledge and practice of radiation oncology nursing. The theory base has 
been developed through bringing together the radiation literature and the wound 
healing literature. Testing the theoretical relationships between the severity of 
radiation skin reactions and radiation factors and personal healing factors, provides 
the empirical foundation for the creation of a tool for individualising the assessment 
of risk for a severe radiation skin reaction. A trustworthy assessment tool will 
evolve with further research and development, adding to the repertoire of skills 
used by the radiation oncology nurse to promote optimal, individualised pa+i~nt 
care. 
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Normal Skin 
The skin is the largest organ of the body accounting for approximately 15% of 
body weight and along with its appendages, hair, nails, sebaceous and sweat 
glands, forms the integumentary system. Carville (1995) describes the integument 
as a complex system that performs five major functions: protection of underlying 
structures; sensation; communication; thermoregulation and metabolic synthesis. 
The skin is di11ided i11to two layers, the epidermis and the dermis, each with a 
distinct structure and function. The epidermis is further divided into five layers and 
the dermis into two. 
Epidermis 
The innermost of the five epidermal layers is the stratum germinativum or 
basal layer where constant mitotic reproduction of squamous cells occurs. The 
second layer is the stratum spinosum and the third, the stratum granulosum. These 
three layers together are also known as the Malphygian layer. The thickness of the 
Malphygian layer varies throughout the body and is related to the amount of friction 
occurring in each area. The fourth layer, stratum lucidum, is only present in the 
thick skin of the soles and palms. The cells of the fifth and outermost layer, the 
stratum comeum, are dead, having been converted to a water-repellent protein 
called keratin. This layer sheds (desquamates) continually. 
The epidermis is avascular; the capillary beds in the upper layer of the dermis 
supply nutrition through the thin basement membrane between the dermis and the 
epidermis. Interstitial fluid infiltrates the intercellular spaces of the stratum 
genninativum from the capillaries in the underlying dermis. 
About 10% of the human epidermis undergoes mitosis daily (Breathnach & 
Wolff, 1979) and it has been estimated that the basal cells of the skin take eight 
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hours to replicate (Withers, Peters, Thames & Fletcher, 1992). Frequency of 
mitosis in the stratum germinativum varies directly with the rate of desquamation at 
the epidermal surface. Under normal conditions the rate of mitosis in the basal 
layer is able to maintain the supply of these overlying non-dividing squamous cells. 
The cells of the stratum germinativum are vegetative intermitotic cells relatively 
sensitive to radiation (Casarett, 1980). 
Cells other than those in the germinal layer are primarily fixed postmitotic 
squamous cells. These are first cylindrical, and subsequently polyhedral. They then 
differentiate to become flattened, anucleated, keratinised. superficial skin layers 
that are extremely refractory to radiation and are highly radioresistant (Casarett, 
1980; McDonald, 1992). 
Other structures found in the epidermis are melanocytes. hair, and 
sebaceous and sweat glands all of which are composed of specialised epithelial 
cells continuou~ with the stratum germinat,vum of the epidermis. 
Melanocytes 
Melanocytes are found at the junction of the pigmented basal layer of the 
stratum germinativum and the dermis. Melanocytes determine the colour of the skin 
along with the inherent yellow colour of the skin and the vasculature of the dermis. 
Melanin production is stimulated by ultraviolet radiation (UV) as a fine granular 
substance that is passed through the cell layers of the epidermis showing at the 
surface as hyperpigmentation. Melanocytes are probably reverting postmitotic cells 
and are relatively radiosensitive (Casarett, 1980; McDonald, 1992). 
Hair. 
The hair consists of the visible hair shaft and the root situated in the hair 
follicle which is a continuation of the stratum germinativum. Approximately 85-90% 
of hair follicles on the scalp are in the active growing (anagen) phase at any one 
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time. The root of the hair divides rapidly, pushing the previously produced cells up 
the shaft After the talogen (resting) phase. the hair 1s shed as the new growth 
starts in the hair follicle. 
Due to its active reproduction the hair 1s relatively rajiosensit1ve with more 
rapidly growing hair having higher radiosensitivity. Lacassagne and Gncouroff 
( 1956, cited in McDonald. 1992) ranked the radiosensit1vity of hair in decreasing 
order thus: scalp hair. male beard, eyebrows, axilla. pubis and last. fine body hair 
Sebaceous glands. 
Sebaceous glands secrete oil for the hair and skin as a natural moisturiser 
preventing excessive water evaporation from the skin and water absorption through 
the skin. The presence of sebum on the surface of the skin conserves heat loss 
from the body. Sebaceous glands are classified as holocrine glands. Secretions 
produced by holocrine glands consist of the disintegrated cells of the gland. 
Secretion of sebum is followed by mitotic regeneration of the secretory cells. These 
regenerating cells are vegetative intermitotic cells and are relatively radiosensitive. 
The epithelial cells not involved in secretion. are fixed postmitotic cells and are 
relatively radioresistant (Casarett, 1980; McDonald, 1992). 
The radiosensitivity of sebaceous glands is approximately equivalent to hair 
follicles (Casarett, 1980). After a dose of radiation high enough to cause depilation, 
a reduction in secretion of sebaceous glands begins within a week. After a month. 
few glands persist and in those that do, degenerative changes are apparent. 
Sweat glands. 
Sweat glands are small but numerous in the body performing an important 
part in maintaining homeostasis of fluid and electrolytes and body temperature. 
Sweat glands are classified as merocrine glands. Merocrine glands produce their 
secretion within the cells and are not destroyed in the process. This makes them 
Appendix A 182 
less vulnerable to damage as the frequency of mitosis required to repair or replace 
sweat glands is less than for sebaceous glands The epithelial cells that hne this 
simple, coiled tubular gland are reverting postmitot1c cells and are. therefore. 
relatively radioresistant (Casarett. ·1 980: McDonald. 1992) 
Dermis 
The dermis ,s divided into two layers. the dermis and the hypoderrms or 
subcutaneous layer. The dermis is a very vascular layer also containing nerve 
endings, lymphatics. connective tissue and collagen fibres (Bryant. 1987). The 
components of the dermis are principally responsible for tissue repair. The 
hypodermis is a layer of loose connective tissue with variable amounts of adipose 
tissue. Its principal function is in connecting the dermis to underlying fascia or 
periosteum. 
In radiation skin reactions, damage to the dermis. either in the acute or 
chronic phases, is rarely seen with modern radiotherapy techniques, therefore. the 
epidermal layer is of primary concern (McDonald, 1992) . 
• 
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Normal Tissue Repair 
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Repair of Normal Tissue 
A background to radiotherapy and the effects of ionizing radiation on 
normal tissues would not be complete without some information on the 
mechanisms involved and the factors affecting the repair of epithelial tissue. Many 
factors influence the progress of healing, whether the cause of the tissue damage 
is from ionizing radiation or any other trauma. These factors are essential to 
understanding the theoretical underpinnings of the proposed model The factors 
are described and discussed in the second section of this chapter in relation to 
their potential impact on the severity of radiation reactions. Although the 
mechanism by which radiation causes trauma to normal tissue is different from 
other injury, meaning that radiation reactions cannot be strictly defined as a wound, 
the process and mechanisms of healing are the same in principle. The differences. 
due to the permanent damage caused by radiation, are described in detail in the 
section on radiohistopathology. 
The healing process of damaged tissue is usually described as occurring by 
first or second intention. Healing by primary intention is the union of the edges of a 
wound, progressing to complete healing without scar formation or granulation. 
Healing by secondary intention is wound closure in which the edges are separated, 
granulation tissue develops to fill the gap and epithelium grows over the 
granulations, producing a scar (Mosby, 1990). 
Phases of Tissue Repair 
Inflammatory phase. 
Tissue damage initiates the inflammatory response where a cascade effect 
leads to the release of histamine along with other vasoactive chemicals causing 
vasodilation in surrounding tissue. As more blood flows to the area, erythema, 
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oedema. heat and discomfort ensue. The inflammatory response includes the 
arrival of polymorphonuclear leucocytes (polymorphs/neutrophtls), to protect the 
wound from bacterial invasion, and macrophages. to clear the wound of debris 
Reconstruction phase. 
A primary mechanism in the reconstruction phase occurs through the 
attraction of fibroblasts to the wound as a result of growth factors produced by 
macrop~·.ages. Growth factors stimulate fibroblasts to produce collagen and to form 
new blood vessels {angiogenesis) which are then capable of bringing oxygen to the 
wound. 
Epithelialisation phase. 
Epithelialisation is an important phase in the healing of radiation skin ar 
mucosal reactions and is the phase where skin loss is repaired by renewal of 
epithelial cells. Squamous cells at wound margins and around hair follicle remnants 
proliferate and migrate over the wound surface in a leap-frog fashion {Dealey, 
1994). Migration stops when cells meet. either in the centre of the wound forming 
islets of cells, or at the edges. This is known as contact inhibition. Epithelial cells 
can only migrate where the tissue is viable and the wound environment is moist 
(Winter, 1962). 
Maturation phase. 
Maturation occurs over a long period often taking more than a year. The 
mechanisms involved are reduction in vascularity, re-organisation of collagen fibres 
and remodelling of scar tissue. During the maturation phase, tensile strength 
increases and the ability of the wound to resist friction and breakdown increases 
commensurately. 
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Appendix C 
Mechanisms of Radiation Enhancement with Cytotoxic Agents 
Mechanism of Cytotoxicity and Possible Mechanism of Enhancement of Radiation Effects in 15 Commonly Used Chemotherapeutic Drugs 
Drug Mechanism of Cytotoxicity Po ... ,sible mechanism of radiation enhancement 
Dactinomycin 
Adriamycin 
(doxorubicin) 
Bleomycin 
BCNU,CCNU 
Cisplatin 
Cyclophosphamide 
Cytosine arabinoside 
5-Fluorouracil 
Hydroxyurea 
Intercalates DNA and inhibits DNA and RNA synthesis; 
causes single-strand breaks in DNA 
lntercalcates DNA and inhibits DNA. RNA, and protein 
synthesis 
Causes single- and double-strand breaks in DNA. inhibits 
DNA synthesis, preferencially kills cells in G2 and M phases. 
Causes DNA strand breaks and crosslinks by alkylation and 
inhibits DNA. RNA, and protein synthesis 
Causes DNA intrastrand crosslinks and changes in DNA 
conformation and inhibits DNA. RNA. and protien synthesis 
Causes DNA crosslinks by alkylation and inhibits DNA 
synthesis 
Inhibits DNA synthesis, selectively kills cells in the S phase 
Binds and inhibits thymidylate synthetase and inhibits RNA 
processing and function 
Inhibits ribonucleoside diphosphate reductase and DNA 
synthesis, selectively kills cells in the S pha~_ ~~-
i slope of radiation dose response curves . .J.. SLD and PLO 
repair 
Additive cytotoxicity, ,.. accumulation of SLD. " PLO repair 
? .J. of repair of drig damage by radiation. ? perturbations 1n 
cell kinetics 
Additive cytotoxicity. ? .J.. of SLD repair. ? perturbations in 
cell kinetics 
,i. SLD and PLO repair. i slope of hypoxic cell radiation dose 
response curves 
Additive cytotoxicity 
,i. PLO repair. ? ... SLD repair. perturbations in cell kinetics 
t slope of radiation dose response curve postdrug exposure. 
? perturbations in cell kinetics 
Perturbations in cell kinetics 
}> 
"C 
~ 
:::, 
C. 
x· 
0 
_. 
0:, 
-...J 
Drug Mechanism of Cytotoxicity Possible mechanism of radiation enhancement 
Methotrexate Inhibits dihydrofolate reductase and synthesis of thymidylate 7 perturbations in cell kinetics 
and purine nucleotide 
Mitomycin C Causes intrastrand and interstrand crosslinks in DNA by Additive cytotoxicity 
alkylation and inhibits DNA synthesis 
Nitrogen mustard Causes single-strand breaks and crosslinks in DNA by Additive cytotoxicity 
alkylation and inhibits DNA, RNA, and protein synthesis 
Vin~stine; vinblastine Binds tubulin. poisons the mitotic spindle and causes mitotic ?perturbations in cell kinetics 
arrest 
SLD = sublethal damage; PLO = potentially lethal damage 
From Fu, K (1985). Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer (Suppl). May 12. p 2127. 
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Appendix D 
Agents That May Cause Photosensitivity Reactions 
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Agents That May Cause Photosensitivity Reactions 
Chemotherapy 
• Decarbazine 
Fluorouracil 
Methotrexate 
Procarbazine 
Vinblastine 
Adiamycin 
Antidepressants 
lmipramine 
Amitryptyline 
Amoxapine 
Desiprarnine 
Doxepin 
Maprotiline 
lsocarboxazid 
Nortriptyline 
Protriptyline 
Trimipramine 
Antihistamines 
Cyproheptadine 
Diphenhydramine 
Antimicrobials 
Demeclocycline 
Doxycycline 
Griseofulvin 
Methacycline 
Minocycline 
*Nalidizic 
Oxytetracycline 
Sulfacytine 
Sulfamethazine 
Sulfamethazole 
Sulfamethoxazole-trimethoprim 
Sulfasalazine 
Sulfathiazole 
Sulfisoxazole 
Tetracycline 
Antiparasitic Drugs 
*Bithionol 
Pyrvinium pamoate 
Quinine 
Antlpsychotic Drugs 
Chlorpromazine 
Chlorprothixine 
Fluphenazine 
Haloperidol 
Perphenazine 
Promethazine 
Piµer ::icetazine 
Promethazine 
fhioridazine 
T rifluoperazine 
Thiothixene 
Triflupromazine 
Trimeprazine 
Diuretics 
Acetazolamide 
Ch loroth iazide 
Furosemide 
Hydrochlorothiazide 
Hypoglycemics 
Chloropropamide 
Glyburide 
Nonsteroidal Anti-inflammatory 
Ketoprofen 
Naproxen 
Phenylbutazone 
Piroxicam 
Sulindac 
Sunscreens 
Benzophenones (Aramis. Clinique) 
Cinnamates (Aramis, Estee Lauder) 
Oxybenzone (Eclipse, PreSun) 
PABA and PABA esters (Block Out. 
Sea & Ski) 
Miscellaneous Drugs 
*Amiodarone 
*Bergarnot oil, oils of citron, lavender, 
lime, sandalwood, cedar 
Carbamazapine 
Contraceptives 
Disopyramine 
* Reactions occur frequently {McDonald, 1992). 
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Appendix E 
Weekly Skin Reaction Observation Record 
weeklv skin reaction observation record 
DATE SITE RTOG 
WEEK R/L SCORE 
week l midline chest wall 
ax.ilia 
upper outer quadrant 
upper inner quadrant 
lower outer quadrant 
lower inner quadrant 
nioole 
inframammary fold 
week2 midline chest wall 
axilla 
upper outer quadrant 
upper inner quadrant 
lower outer quadrant 
lower inner quadrant 
nioole 
inframammart' fold 
week 3 midline chest wall 
axilla 
upper outer quadrant 
upper inner quadrant 
lower outer quadrant 
lower inner quadrant 
nioole 
inframammary fold 
I[) 
DOSE TOPICAL Rx DRESSING PAIN COMMENl~ 
DATE SCORE 
-
-
)> 
i 
:, 
a. 
x 
m 
.... 
U) 
N 
klv sk· r b 
DATE SITE 
WEEK R/L 
week4 midline chest wall 
axilla 
uooer outer quadrant 
uooer inner quadrant 
lower outer quadrant 
lower inner quadrant 
nipple 
inframammary fold 
weeks midline chest wall 
axilla 
uooer outer quadrant 
upper inner quadrant 
lower outer quadrant 
lower inner quadrant 
nioole 
inframammary fold 
week6 midline chest wall 
axilla 
upper outer quadrant 
upper inner quadrant 
lower outer quadrant 
lower inner quadrant 
nipple 
inframammary fold 
t' d . ed 
RTOG DOSE TOPICAL Rx DRESSING 
SCORE DATE 
ID 
PAIN COMMENTS 
SCORE 
·-
)> 
"O 
1il 
:, 
a. 
x 
m 
~ 
m 
w 
kly sk 
DATE SITE 
WEEK R/L 
week 7 midline chest wall 
axilla 
unner outer Quadrant 
unner inner Quadrant 
lower outer quadrant 
lower inner Quadrant 
nipple 
inframammary fold 
Spare midline chest wall 
axilla 
unner outer Quadrant 
unner inner quadrant 
lower outer Quadrant 
lower inner Quadrant 
nipple 
inframammary fold 
Spare midline chest wall 
axilla 
unoer outer Quadrant 
uoner inner quadrant 
lower outer ouadrant 
lower inner Quadrant 
nipple 
inframammary fold 
RTOG DOSE TOPICAL Rx DRESSING PAIN 
SCORE DATE SCORE 
COMMENT\ 
-
> 
"t, 
i 
::, 
a. ;r 
m 
..... 
(!) 
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Appendix F 
Data Collection Form for Predictive Factors 
URMN sticker 
'.}<:-------------------------------------------------------------------
PRIVATE AND CONFIDENTIAL 
Predicting the severity of skin reactions in patients receiving 
radiotherapy for cancer. 
Data Collection Form - Breast Patients 
ID code 
l. Age (in years at last birthday) 
Diagnosis and Treatment 
2. Diagnosis/Histology _______________ _ 
3. Time since diagnosis(weeks, months,years) 
Reasons for oelay 
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'.}<:-------------------------------------------------------------------
... a. Stage at diagnosis 
Stage 0 Tis NO MO 0 
Stage I Tl NO MO 
Stage IIA TO NI MO 2 
Tl Nl MO 
T2 NO MO 
Stage IIB T2 NI MO 3 
T3 NO MO 
Stage IIIA TO N2 MO 4 
Tl N2 MO 
T2 N2 MO 
T3 NI.N2 MO 
Stage IIIB T4 AnyN MO 5 
AnyT N3 MO 
Stage IV AnyT AnyN Ml 6 
b. Recurrences 
No 0 
Yes, number of times 
PRJV ATE AND CONFIDENTIAL 
If found please return immediately to the Radiotherapy Department 
Sir Charles Gairdner Hospital 
ID 
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-----------------~-~----·-· 
Combined Treatment Modality Details 
5. a. Condition of Hrcast Scar 
Yes. scar fading 
Y i:s. intlami:d 
Y cs. hacmoscrous discharge 
Y cs. purulent discharge 
b. Axilla scar 
No axillary clearance 
Yes. scar fading 
Yes. inflamed 
Y cs. haemoserous discharge 
Yes. purulent discharge 
c. Lymphoce!e requiring drainage 
No 
If yes, approximate number of times 
6. a. Chemotherapy (Combined Modality Treatment) 
No (go to# 7) 
Yes 
2 
1 
4 
0 
I 
2 
3 
4 
0 
0 
Regimen _____________________ _ 
If yes, go on to part b. 
b. Chemotherapy commenced before radiotherap) 
No (go to# 7) 
Yes 
c. Chemotherapy completed before radiotherapy commenced 
No 
Yes 
0 
0 
PRIVATE AND CONFIDENTIAL 
If found please return immediately to the Radiotherapy Department 
Sir Charles Gairdner Hospital 
ID 
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-------------------· -----------···---- -------·--------. 
Personal and Family Cancer History 
7. a. Previous cancer 
No () 
Yes. how many times 
Please specify--------------------
8. a. Chemotherapy for Previous Cancer 
No 
Yes 
b. Type and how long ago? 
9. a. Radiothera::,y for Previous Cancer 
0 
No 0 
Yes, but not at same site 
Yes, includes some or all of current treatment site 2 
b. How long ago? 
10. a. Family history of cancer (1st and 2nd degree relatives only) 
No 0 
Yes, how many family members 
Specify type of cancer and relationship 
----------
PRIVATE AND CONFIDENTIAL 
If found please return immediately to the Radiotherapy Department 
Sir Charles Gairdncr I fospital 
ID 
General health 
11. Co-existing chronic disease 
No 
Yes. not known radioscnsitivc disease 
Yes. known radiosensitivc disea~e 
12. a. Prescribed medications 
No 
yes. drugs not known to adversely affect healing 
yes. drugs known to adversely affect healing 
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() 
0 
b. Other medications (over the counter/complementary/alternative 
therapies) 
No 
general health 
ii aid healing 
iii anticancer 
0 
I 
PRIVATE AND CONFIDENTIAL 
lf found please return immediately to the Radiotherapy Department 
Sir Charles Gairdner Hospital 
ID 
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13. Smoking 
a. Ha,·e you ever smoked regularly? 
No (go to 4uestion 15) 
Yes 
b. if yes, when did you start smoking'? 
c. Average, number of cigarettes did/do you smoke each day? 
d. Do you smoke now'! 
i) if no. when did you quit'? 
ii) if yes. how many per day? 
(J 
I 
19 
19 
14. Alcohol 
15. 
a. Have you ever drunk alcohol regularly? 
No (go to question 16) 
Yes 
b. if yes, when did you start drinking regularly? 
c. Average, standard drinks did/do have each time? 
d. Do you drink now? 
i) if no, when did you stop 
ii) if yes, once or twice per month or less 
Yes, about once per week 
Yes, 2-3 times per week 
Yes, 4-6 times per week 
Yes, everyday 
a. Current weight 
b. Usual weight 
c. Lowest v.,eight during this illness 
d. Height 
i) did 
ii) do 
19 
19 
0 
l 
l 
2 
3 
4 
5 
___ kg 
___ kg 
___ kg 
cm 
PRIVATE AND CONFIDENTIAL 
If found please return immediately to the Radiotherapy Department 
Sir Charles Gairdner Hospital 
10 
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16. Bra/cup sii:c 
a. dress size 
10 12 14 16 18 20 22 24 ·24 
b. cup 
A 
B 
C 
D 
DD 
>DD 
2 
3 
4 
5 
6 
17. a. Nutritional intake 
Excellent: 
Eats most of every meal. Never refuses a meal. 
Usually eats a total of 4 or more servings of proteins. 
Occasionally eats between meals. Does not require supplementation. 
Adequate: 2 
Eats over half of most meals. 
Eats a total of 4 servings of proteins each day. 
Occasionally will refuse a meal. but will take a supplement if offered. 
OR 
Is on adequate tube feeding or TPN regimen 
Probably inadequate: 3 
Rarely eats a complete meal and generally eats on I /2 of any food offered. 
Protein intake only 3 servings per day. 
Occasionally will take dietary supplement. 
OR 
Receives less than optimum amount of liquid diet or tube feeding 
~rypoo~ 4 
Never eats a complete meal, Rarely eats more than a I /3 of any food 
offered. 
Eats 2 servings or less of protein each day. 
Takes fluids poorly. Does not take a liquid diet supplement. 
OR 
Is nil by mouth and/or maintained on clear liquids 
or IV's for more than five days. 
18. f. Alternative/Complementary Diet 
PRIVATE AND CONFIDENTIAL 
If found please return immediately to the Radiotherapy Department 
Sir Charles Gairdner Hospital 
ID 
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Skin Type and Condition 
19. Skin type 
20. 
Aways hums casil). never tans ( sensitive J 
Always bums. tans minimally ( sen.sit ive) 2 
Burns moderately. tans gradually ( light brown. normal) 1 
Bums minimally. always tans well (modcratdy brown, normal) 4 
Rarely burns. tans profusely (dark hrown. insensitive) 5 
Never burns. deeply pigmentt:d (insensitive) 6 
Skin type in treatment area 
Oily 
Normal 
Dry 
() 
1 
2 
2 t. Skin allergy problems eg contact dermatitis, eczema etc. 
No (go to question 20) 
If yes. please specif} 
a. Frequency 
Occasional problem(.:::: 4 times per year) 
Frequent problem (once per month) 
Constant problem (virtually always present) 
b. Severity 
Mild ( dry and peeling) 
Moderate reaction (as above plus red, itchy) 
Severe reaction (as above plus blisters/oozing) 
c. Family History (1st and 2nd degree relatives only) 
No 
Yes, how many family members 
0 
2 
3 
2 
3 
0 
PRIVATE AND CONFIDENTIAL 
If found please return immediately to the Radiotherapy Department 
Sir Charles Gairdner Hospital 
ID 
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Accumulative UV Exposure 
22. a. How long have you lived in Australia'! (years) 
h. Predominant place you have lived up to the age of 15'! 
City/ lo\\11 .... . . __ . _ ( ·ountry 
c. Predominant place you have lived after the age of 15'! 
l'ityffown Country 
23. Cumulath·c UV ex(Josurc scale 
iVhich o( rhe .fc,/lowin~ sra1emenrs hest descrihes your exposure to the .mn 
up to the age cf 15: 
a. Did you spend most of your free time ... 
in indoor activities I 
in both indoor and outdoor activities 2 
in outdoor activities 3 
b. When outdoors, bow much did you protect yourself from the sun with a hat, 
clothing and/or sunscreen ... 
almost always I 
often 2 
sometimes 3 
almost never 4 
Which of the following sta/ements best describes your exposure to the sun 
after the age of 15: 
c. Was or is your work mainly ... 
indoors 
both indoors and outdoors 2 
outdoors 3 
d. Did/do you spend most of your free time ... 
in indoor activities 
in both indoor and outdoor activities 
in outdoor activities 
2 
3 
e. When outdoors, bow much did/do you protect yourself from the sun with a bat, 
clothing and/or sunscreen ... 
ahnost always 
often 2 
sometimes 
ahnost never 
3 
4 
PRIVATE AND CONFIDENTIAL 
If found please return immediately to the Radiotherapy Department 
Sir Charles Gairdnr.r Hospital 
ID 
------------- ----
24. Demographics 
a. Marital status 
never married 
permanent relationship married/de facto 
separated 
widowed 
divorced 
b. occupation 
unemployed 
retired 
home duties 
skilled trade 
professional 
W1Skilled 
clerical 
student 
c. education completed 
primary school (years l - 7) 
lower secondary school (years 8 - 10) 
upper secondary school 
trade/ secretarial training 
undergraduate diploma/degree 
higher degree 
d. usual accomodation 
own home/flat 
rent home/flat 
Appendix F 20 'i 
') 
3 
4 
5 
2 
3 
4 
5 
6 
7 
8 
2 
3 
4 
5 
6 
") 
nursing home 3 
~~ 4 
other, specify ________________ 5 
OFFICE USE ONLY 
f. area code (from addressograph) 
PRIVATE AND CONFIDENTIAL 
If found please return immediately to the Radiotherapy Department 
Sir Charles Gairdner Hospital 
ID 
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OFFICE USE ONLY 
Treatment Details 
25. F.lectrons site 
energy ---------
Overall length of whole breast treatment (in days) 
Overall length of electron boost treatment (in days) 
Comments 
PRIVATE AND CONFIDENTIAL 
If found please return immediately to the Radiotherapy Department 
Sir Charles Gairdner Hospital 
ID 
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Ap.,e11dix G 
Content Validity Check List 
Content Validity Check 
This set of questions relate to basic demographics and diagnosis and treatment details 
Variable and Scoring 1. Not 2. Unable 3. 4. Very 
relevant to assess Relevant relevant 
without but needs and 
item minor succinct. 
revision alteration 
1. Age ___ (in years at last birthday) 
3. Histology 
4. Time since diagnosis 
5. TNM Staging. 
7. Recurrence 
9. Chemotherapy regimen 
Chemo commenced with XRT 
Chemo commenced before XRT 
How many cycles? 
Comments on clarity, 
scoring etc. 
)> 
"C 
~ 
0. ;:r 
G) 
N 
0 
OJ 
Diagnosis and treatment details continued 
Variable and Scoring I. Not 2. Unable 
relevant to assess 
without 
item 
revision 
10. Chemotherapy for previous cancer 
The next set of questions relate to cancer 'proneness' 
Variable and Scoring 1. 2. 
11 a. Has patient had cancer before ? 
b. Family history of cancer 
3. 4. Very 
Relevam relevant 
but needs and 
minor succinct. 
alteration 
3. 4. 
Comments on clarity, 
scoring etc. 
Comments on clarity, 
scorint? etc. 
f 
:, 
C. 
x 
C) 
I'.) 
0 
<D 
This set of questions relate to the patient's general state of health 
. 
Variable and Scoring 1. 2. 
12. Co-existing disease 
13. Prescribed medications 
Nwnber of medications 
List medications 
14. Smoking habits 
Cigarette years ___ 
Current smoker 
If yes (how many per day?) 
---
15. Alcohol intake 
-
3. 4. Comments on clarity, 
scoring etc. 
l> 
-0 
i 
:, 
a. 
>(. 
G) 
l'V 
...... 
0 
General health continued 
Variable and Scoring 
16. Nutritional intake 
Weight 
Height 
Excellent: 
Eats most of every meal. Never refuses a 
meal. Usually eats a total of 4 or more 
servings of proteins. Occasionally eats 
between meals. Does not require 
suoolementation 
Adequate: 
Eats over half of most meals. Eats a total of 
4 servings of prc,teins each day. Occasionally 
will refuse a meal, but will take a supplement 
if offered. OR Is on adequate tube feeding or 
TPN regimen 
Probably inadequate: 
Rarely eats a complete meal and generally 
eats only 1/2 of any food offered. Protein 
intake only 3 servings per day. Occasionally 
will take dietary supplemt.'t.OR Receives 
less than optimum amount ot liquid diet or 
tube feeding 
J. 2. 3. 4. Comment~ on clarity. 
scorinl! etc. 
)> 
"C 
~ 
a. )( 
C) 
N 
.... 
....... 
General health continued 
Variable and Scoring 1. 
Very poor: 
Never eats a complete meal, Rarely eats 
more than a 1/3 of any food offered. Eats 2. 
servings or less of protein each day. Takes 
fluids poorly. Does not take a liquid diet 
supplement.OR Is nil by mouth and/or 
maintained on clear liquids or IV's for more 
than five days. 
The following Items relate to skin type and condition 
Variable and Scoring }. 
17. Skin type 
Always burns easily, never tans 
(sensitive) l 
Always burns. tans minimally 
(sensitive) 2 
Burns moderately, tans gradually 
(light brown, normal) 3 
Bums minimally, always tans well 
(moderately brown, normal) 4 
Rarely burns, tans profusely 
( dark brown, insensitive) 5 
Never burns, deeply pigmented 
(insensitive) 6 
2. 3. 4. 
2. 3. 4. 
Comments on clarity, 
scorinK etc. 
Comments on clarity. 
scorinl( etc. 
)> 
"'O 
i 
::, 
C. ;:;;· 
G) 
"-> 
..... 
N 
Skin type and condition conflnued 
Variable and Scoring 
18. Skin allergy problems eg contact 
dermatitis, eczema etc. 
a. Frequency 
Nil 0 
Occasional problem 
(:S 4 times per year) 1 
Frequent problem 
(once per month) 2 
Constant problem 
(virtually always present) 3 
b. Severity 
Nil 0 
Mild/moderate reaction 
(red, itchy dry and peeling) 1 
Severe reaction 
(as above plus blisters/oozing) 2 
c. Family History 
No 0 
Number of family members 
-
1. 2. 3. 4. Comments on clarity, 
scoring etc. 
)> 
"O j 
::, 
C. 
x 
G) 
"' ..... 
(.,) 
Skin condition - Ultmvlolet exposure 
Variable and Scoring 
19. UV exposure 
a. Number of years in Australia 
b. Predominant place lived in under 15 
years of age 
c. Predominant place after 15 years of 
aee 
20. Accumulative UV exposure 
Which of the fo!lowing statements best 
describes your exposure to the sun area up 
to the age of 15 years? 
I spent most of my free time in 
IndoOi: activities I 
And outdoor activities 2 
Outdoor activities 3 
I went out in the sun without the protection 
of a hat, clothing and/or sunscreen 
almonst never I 
Sometimes 2 
Often 3 
Almost always 4 
1. 2. 3. 4. Comments on clarity, 
scoring etc. 
)> 
~ 
:, 
a. 
x· 
C) 
N 
_. 
A 
Skin condition • Ultraviolet exposure continued 
Variable and Scoring 1. 
Which of the following statements best 
describes your exposure to the sun during 
your adult life: 
I mainly had jobs that were 
Indoors 1 
Both indoors and outdoors 2 
Outdoors 3 
I spent most of my free time in 
Indoor activities 1 
And outdoor activities 2 
outdoor activities 3 
I went out in the sun without the protection 
of a hat, clothing and/or sunscreen 
almonst never 1 
Sometimes 2 
Often 3 
almost always 4 
2. 3. 4. Comments on clarity, 
scorine etc. 
)> ,, 
~ 
:::, 
C. 
x 
G) 
N 
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Appendix H 
Approval Letters from Ethics Committees 
Committee for the Conduct of Ethical Research 
\b Da, 1na Puw,:k 
Dear \Is Porock 
Code: 
Re: Ethics Appmval 
95-10-
[ D I T I! CO\ V 1\ :< 
LI \! I V L l< S l TY 
;..,, ~ .. ·,, IJ; , . : ;, r; ; ••.. ' • ,. ,. 
'.,•' .~•'.r·= ;.:f, ·,;,!,ir' .'. 
;,,·,1:','.' ,··-:..-' •• ., .• -:· 
//1··.•1,•· ; •• ·••• l ',l •,,' ': 
·I".·•·:,··.·-: :, 
Project Title: Pr~Jidin's rhe severir;: of skin und orul rrwco1al reaciwn1 tr. inJr,iJ:1,-l, 
pmien;s receiving raJiorherapy for cancer. 
This project was considered by the Committee for the Conduct of Ethical Research at its 
meeting on 28 July 1995. 
I am pleased to advise that the project complies with the provisions contained in the 
l.Jni versity's policy for the conduct of ethical research. and has been cleartd ior 
implementation. 
Period of approval is from 3 l July 1995 to 30 June 1998. 
Yours sincerely 
ROD CRITTHERS 
Executive Officer 
31 July 1995 
Please note: Srudents conduaing approved research are required co submit an erhics report 
as an addendum to that which they submit to their Faculry's Higher Degrees Commirtee. 
cc: Dr Patricia Percival, Supervisor 
tvtrs Genie Sherratt. Facultv Admin Officer 
A/Prof S. Bame. Doctor.ii Studies Commmee 
JOONOALUP CAMPUS 
Joonclalup Orive. Jooru!alup 
Western Australia 6027 
Te!epllone (091 400 5555 
MOUNT LAWLEY CAMPUS 
2 Bradlonl S1reet. Mount Lawley 
Western Australia 6050 
Telepnone (09) 370 6111 
CHURCHLANDS CAMPUS 
Pearson Street. Cnurcnianas 
Western Australia 6018 
Telepnone (09l 273 8333 
CLAREMONT CAMPUS 
Goldswortny Road. ClJremonr 
Western Australia 6010 
Te1epnone i09) .w2 1333 
BUNSUR~ .;.i.MPoS 
Rooertson Qrf11e 9urcur·, 
western .\ustr1ha 5230 
Tereoncne 109;1 50 ~~~-
-=:'l..,r '81 
'<cur rer 
t~CUifl€S ~O 
Date 
Sir Charles Gairdner Hospital 
FS/pt16 7 /letpJm/5005 
Ext. 2684 
22 March 1996 
Ms Davina Porock 
Dear Ms Poree!-<. 
The research proposal "Predicting the Severity of Skin & Oral Mucosa Reactions in 
Individuals receiving Radiotherapy for Cancer" was considered at the Nursing Research 
and Ethical Review Committee meeting on 12 March 1996. 
Your proposal has been approved for implementation. 
Please contact Linda Murray, Co-Director (Nursing}, Heart & Lung CSU on 346 1828 for 
further information. 
Yours sincerely 
CHAIRMAN 
NURSING RESEARCH AND ETHICAL REVIEW COMMITTEE 
cc: Di Twigg, NExecutive Director of Nursing Services 
WP ref. d:\doa\Jttt=lptl 67 .doc 
File ref: S001 
The Queen Elizabeth II Medical Centre • Verdun Stroet. Nedlands. Western Australia 6W • Telephone (09) 389 3333 
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Participant's Information Letter and Consent Form 
Research Title: 
Researcher: 
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Predicting the degree of skin reaction in patients 
receiving radiotherapy 
Davina Porock, RN MSc(Curtin) PhD (Candidate), 
Schoof of Nursing, Edith Cowan University 
Skin reaction is a fairly common side effect of radiotherapy and individual 
patients react to the treatment in different ways. Primarily the degree of 
skin reaction patients will experience depends on the dose of radiation 
they receive. However, previous research and clinical experience has 
shown that the skin reaction varies from person to person even when the 
same dose is given. This research project aims to develop a method of 
accurately predicting the degree of skin reaction to be expected. The 
benefits to future patients from this research will be in individualised 
education to prepare for this side effect and individualised skin care 
management. 
You are invited to take part in this research project. It will involve 
completing a questionnaire now that details personal information about 
you and you.- skin and then a weekly check by me or a research nurse to 
document any skin reaction you experience. No risks are envisaged during 
this research. Your name will be kept on the data collection forms to assist 
following your progress through treatment These details will be kept 
confidential along with the normal medical record and your name will not 
be used in any report or publication from this research. 
You are free to choose whether you take part in this research and to 
withdraw from the study at a later date should you so wish. Naturally, your 
decision will not affect the treatment you receive from the radiotherapy 
department in any way. If you should have any questions now or later, 
please do not hesitate to discuss them with my research assistants Marie 
Downes and Louise Good or contact me, Davina Porock on 273 8623 or 
my supervisors, Dr Sue Nikoletti at the University on 273 8593 or Dr Fiona 
Cameron in the Radiotherapy Department on 346 4900. 
Thank you for your consideration 
Davina Porock 
PhD (Candidate) 
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Consent Form 
I ............................................................. (print name) agree to take part in 
the research project being conducted by Davina Porock entitled 
"Predicting the degree of skin reaction in patients receiving radiotherapy" 
The study has been fully explained and I understand what is involved in 
taking part. I know that I am free to withdraw from the research at any 
time. I have been given the opportunity to ask questions now and given 
details for contacting the researcher at any time. 
Patient's signature 
.......................................................... date ........................ . 
Witness' signature 
.......................................................... date .......................... . 
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Appendix J 
Self-medication and Complementary Therapies Used Regularly by 
Participants 
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Self-medication and ComQlementa!Y Medicines Used Regularll{ bl£ Part1c1Qants 
------- ------
Medicine General Aid Healing Anticancer 
Health 
Echinacea 2 
Multivitamins 7 5 
Vitamin C 6 7 
Iron 1 
Calcium 2 
Sandomycin 1 
Garlic 1 3 
Phenergrick 1 
Vitamin A 1 1 
Selenium 1 
Vitamin B 3 5 
Vitamin E 3 3 
Cod liver oil / fish oil 2 2 
Evening Primrose Oil 2 3 
Cote a cola leaves 1 
Bioace 1 
Magnesium 1 
Silicone Calcium Fluoride (SCF) 1 
Lactoacid tablets 1 
Zinc Silica Calcium 2 
Celery Salt 1 
Ginko Biloba 3 
Corclio Silva 1 
Antioxidants / Betacarotene 7 
Chinese herbs {naturopaths own 2 
prescription) 
Naturopaths tonic 2 
Manchuria I Kambucha tea 2 
combination of wormwood, black 1 
walnut drops and ground clove 
tablets 
Jungle Juice 1 
Flower essence tea 1 
Native Cuppa 1 
~20TX 1 
Appendix K 224 
Appendix K 
Cross Validation Results 
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Cross Validation Results 
Random Sample 1 - 40% of total sample 
Random sampling by SPSS produced a subset of 54 cases for this analysis 
Logistic Regression Results for the Week Five Sternum Reaction 
Data from 54 cases were available for analysis· 30 (55 6%) had a scores of 
D-RTOGO and 24 (44.4%) scored D··RTOG1. Two variables entered the mode. 
history of skin cancer and age. These variables correctly predicted 80.00% of cases 
with mild or no reaction. and 41.67% of cases with a severe reaction giving an 
overall accuracy of 62.96% for the model. The model is significantly reliable when 
compared with the constant only model. ,.2(2) = 11.135, p = 0.0035. 
Variables B SE Wald DF Sig R Exp(B) 95%CI 
History of 2.941 1.166 6.364 1 012 .242 18.934 1.927 -
skin cancer 186.050 
Age -.059 .032 3.421 1 0644 -.138 .943 866-
1.004 
{Constant} 2.582 1.696 2.318 1 .128 
Logistic Regression Results for the Week Five Axilla Reaction 
Due to missing values, data from 53 cases were available for analysis: 28 
(52.8%) had a score of 0-RTOGO and 25 (47.2%) scored D-RTOG1. One variable 
entered the model: lymphocele aspiration. This variable correctly predicted 71.43% 
of cases with mild or no skin reactions and 52.00% of severe reactions. giving an 
overall accuracy of 62.26% of cases overall. The model was significantly reliable 
when compared with the constant only model, /(1) = 3.053, p = 0.0806. 
Variables B 
Lymphocele .996 
aspirated 
(Constant) - 511 
SE 
579 
365 
Wald DF Sig R 
2.961 1 085 115 
1.957 162 
Logistic Regression Results for the Week Five UOQ Reaction 
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Exp(B) 95% Cl 
2 708 871 -
8 425 
Due to missing values, data from 53 cases were available for analysis. 34 
(64.1%) had a score of D-RTOGO and 19 (35.9%) scored D-RTOG1. Three 
variables entered the model: breast size, lymphocele aspirated and smoking. These 
variables correctly predicted 79.41 % of mild or no skin reactions and 52.63% of 
severe skin reactions giving an accuracy of 69.81 % overall. The model was 
significantly reliable when compared with the constant only model, :/(4) = 13 179. p 
= 0.0104. 
Variables B SE Wald OF Sig R Exp(B) 95%CI 
Breast size 1.378 .743 3.439 1 .064 .144 3.967 .925-
17.017 
Lymphocele 1.306 .679 3.698 1 .055 .157 3.693 .975-
aspirated 13.982 
*Smoking 4.302 2 .116 .066 
Ex-smoker 1.092 .714 2.344 1 .126 .071 2.982 .736-
12.073 
Current 1.827 .994 3.378 1 .066 .141 6.213 .886-
smoker 43.584 
(Constant) -2.193 .650 11.387 1 .001 
*Reference group for smoking is the ·never smoked" group 
• 
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Logistic Regression Results for the Week Five LOO Reaction 
Due to missing values, data from 53 cases were available for analysis 38 
(71.7%) had a score of D-RTOGO and 15 (28.3%) scored D-RTOG1. One variable 
entered the model: smoking. This variable correctly predicted 92.11 % of mild or no 
reactions and 26.67% of severe reactions, giving an accuracy of 73.58% ov~rall 
The model was significantly reliable when compared with the constant only model. 
/(2) = 6.569, p = 0.0375. 
Variables 8 SE Wald DF Sig R Exp(B) 95%CI 
*Smoking 5.916 2 .052 .174 
Ex-smoker 1.339 .725 3.414 1 .06S .150 3.186 .922-
15.796 
Current 2.079 .935 4.940 1 .026 .216 7.996 1.278 -
smoker 50.006 
{Constant} -1.791 .540 11.005 1 .001 
*Reference group for smoking is the ·never smoked" group 
Logistic Regression Results for the Week Five LIQ Reaction 
Due to missing values, data from 53 cases were available for analysis: 38 
(71.7%) had a score of D-RTOGO and 15 (28.3%) scored D-RTOG1. Two variables 
entered the model: breast size and smoking. These variables correctly predicted 
92.11 % of mild or no reactions, and 66.67% of severe reactions. giving an accuracy 
of 84.91% overall. The model was significantly reliable when compared with the 
constant only model, x2(3) = 13.515, p = 0.0036. 
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Variables B SE Wald DF Sig R Exp(B) 95% Cl 
Breast size 1.609 .760 4.489 1 .034 .199 4.998 1.128 -
22143 
"Smoking 7.197 2 .027 .225 
Ex-smoker .915 .778 1.383 1 .240 .000 2.498 .543-
11.483 
Current 2.801 1.046 7.165 1 .007 .286 16.462 2.117 -
smoker 127.989 
(Constant} -2.224 .625 12.661 1 .000 
*Reference group for smoking is the "never smoked" group 
Logistic Regression Results for the Week Five Nipple Reaction 
Due to missing values. data from 53 cases were available for analysis: 38 
(71.7%} had a score of D-RTOGO and 15 (28.3%) scored D-RTOG1. One variable 
entered the model: smoking. This model correctly predicted 97.37% of mild or no 
reactions and 26.67% of severe reactions, giving an accuracy of 77.36% overall. 
The model was significantly reliable when compared with the constant only model, 
/(2) = 12.465, p = 0.0059. 
Variables B SE Wald OF Sig R Exp(B) 95%CI 
*Smoking 8.089 2 .018 .255 
Ex-smoker 1.217 .752 2.621 1 .106 .099 3.379 .774-
14.751 
Current 3.407 1.238 7.581 1 .006 .297 30.185 2.670-
smoker 341.320 
{Constant} -1.676 .545 9.466 1 .002 
*Reference group for smoking is the "never smoked" group 
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Random Sample 2 - 40% of tctal sample 
Random sampling by SPSS produced a subset of 50 cases for this analysis 
Logistic Regression Results for the Week Five Sternum Reaction 
Data from 50 cases were available for analysis: 42 (84 0%) had a scores of 
D-RTOGO and 8 (16.0%) scored D-RTOG1. Only one variable entered the mode 
history of skin cancer. This variable correctly predicted 96.55% of cases with mild or 
no reaction. and 33.33% of cases with a severe reaction giving an overall accuracy 
of 70.0% for the model. The model is significantly reliable when compared with the 
constant only model. /(1) = 8.534. p = 0.0035. 
Variables B SE Wald DF Sig R Exp(B) 95% Cl 
History of 2.638 1.118 5.571 1 .018 .229 13.981 1.564-
skin cancer 124.960 
(Constant) -.693 .327 4.484 1 .034 
Logistic Regression Results for the Week Five Axilla Reaction 
Data from 50 cases were available for analysis: 31 (62.0%) had a score of D-
RTOGO and 19 (38.0%) scored D-RTOG1. One variable entered the model: 
lymphocele aspirated. This variable correctly predicted 72.41 % of cases with mild or 
no skin reactions and 52.38% of severe reactions, giving an overall accuracy of 
64.00% of cases overall. The model was significantly reliable when compared with 
the constant only model, :l(1) = 3.180, p = 0.0746. 
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Variables B SE Wald OF Sig R Exp{BJ 95%CI 
Lymphocele 1.060 .603 3.093 1 .079 .079 2.888 .986-
aspirated 9 412 
{Constant~ -.742 .384 3.729 1 .0535 
Logistic Regression Results for the Week Five UOQ Reaction 
Data from 50 cases were available for analysis: 46 (92 0%) had a score of D-
RTOGO and 4 (8.0%) scored D-RTOG1. Two variables entered the model· 
lymphocele aspirated and stage. These two variables correctly predicted 96 97% of 
mild or no skin reactions and 17.65% of severe skin reactions giving an accuracy of 
70.00% overall. The model was significantly reliable when compared with the 
constant only model, /(2) = 8.182. p = 0.0167. 
Variables B SE Wald DF Sig R Exp(B) 95%CI 
Lymphocele 1.617 .692 5.460 1 .020 .023 5.036 1.298-
aspirated 19.541 
Stage 1.335 .735 3.298 1 .069 .142 3.801 .900-
16.057 
~Constant} -1.767 .568 9.6728 1 .CO2 
Logistic Regression Results for the Week Five UIQ Reaction 
Data from 50 cases were available for analysis: 46 (92.0%) had a score of 0-
RTOGO and 4 (8.0%) scored D-RTOG1. Two variables entered the model: 
lymphocele aspirated and stage. These variables correctly predicted 97 .22% of mild 
or no reactions, and 21.43% of severe reactions giving an accuracy of 76.00% of 
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cases overall. The model was significantly reliable when compared with the constant 
only model, x2(2) = 5 961. p = 0.0508. 
Variables B SE Wald OF Sig R Exp(B) 95%Cl 
Lymphocele 1.350 .703 3.685 1 .055 .169 3.857 .972-
aspirated 15.305 
Stage group 1.255 .736 2.908 1 .088 .1238 3.508 .829-
14.845 
{Constant) -1.938 .592 10.703 1 .0011 
Logistic Regressior. Results for the Week Five LOQ Reaction 
Data from 50 cases were available for analysis: 42 (84.0%) had a score of 0-
RTOGO and 8 ("16.0%) scored O-RTOG1. One variable entered the model: smoking. 
This variable correctly predicted 89.19% of mild or no reactions and 30.77% oi 
severe reactions, giving an accuracy of 74.00% overall. The model was significantly 
reliable when compared with the constant only model, x2(2) = 6.449, p = 0.0398. 
Variables B SE Wald OF Sig R Exp(B) 95%CI 
*Smoking 5.611 2 .061 .168 
Ex-smoker 1.526 .802 3.619 1 .057 .168 4.600 .955-
22.160 
Current 2.037 .936 4.732 1 .030 .216 7.667 1.223-
smoker 46.046 
(Constant} -2.037 .414 11.011 1 .001 
*Reference group for smoking is the ·never smokeda group 
I 
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Logistic Regression Results for the Week Five LIQ Reaction 
Due to missing values. data from 48 cases were available for analysis: 36 
(75.0%) had a score of 0-RTOGO and 12 (25.0%) scored D-RTOG1. Two variables 
entered the model breast size and smoking. These variables correctly predicted 
91.43% of mild or no reactions. and 69.23% of severe reactions. giving an accuracy 
of 85.42% overall. The model was significantly reliable when compared with the 
constant only model. x2(3) = 14.561, p = 0.002. 
Variables B SE Wald OF Sig R Exp(B) 95%CI 
Breast size 1.918 .870 4.856 1 .028 .226 6.804 1.236 -
37.449 
*Smoking 7.122 2 .028 .236 
Ex-smoker .882 .84 .995 1 .319 .000 2.416 .427 -
13.668 
Current 2.929 1.098 7.111 1 .008 .312 18.700 2.173-
smoker 160.917 
(Constant} -2.389 .695 11.836 1 .001 
*Reference group for smoking is the "never smoked" group 
L99istic Regression Results for the Week Five Nipple Reaction 
Data from 50 cases were available for analysis: 42 (84.0%) had a score of 0-
RTOGO and 8 (16.0%} scored D-RTOG1. Only one variable entered the model: 
smoking. This model correctly predicted 91.89% of mild or no reactions and 38.46% 
of severe reactions, giving an accuracy of 78.00% overall. The model was 
significantly reliable when compared with the constant only model, x2(2} = 8.249, p = 
0.0162. 
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Variables 8 SE Wald OF S1g R Exp(B) 95% Cl 
*Smoking 7.205 2 .027 .237 
Ex-smoker 1.248 .817 2.334 1 127 .076 3485 703-
17.288 
Current 2.548 .954 7.132 1 .008 .300 12.778 1.970 -
smoker 82.892 
{Constanti -2.037 .614 11.011 1 .001 
*Reference group for smoking is the "never smoked" group 
logistic Regression Results for the Week Five lnframammary Fold Reaction 
Data from 50 cases were available for analysis: 42 (84.0%) had a score of 0-
RTOGO and 8 (16.0%) scored D-RTOG1. One variable entered the model: current 
smoking. This variable was constructed combining those not currently smoking 
(never smoked and ex-smokers) in one group and current smokers in the other 
group. This model correctly predicted 90.63% of mild or no reactions and 27.78% of 
severe reactions giving an accuracy of 68.00% overall. The model was significantly 
reliable when compared with the constant only model, /(1) = 2.784. p = 0.0952. 
Variables 
Current 
smoker 
B SE 
1.313 .803 
Wald OF Sig 
2.675 1 .102 
(Constant) -.802 .334 5.779 1 .016 
R 
.102 
Exp(B) 95% Cl 
3.718 .771 -
17.938 
"Reference group for smoking is the "never smoked and ex-smokers" group 
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Appendix L 
Rudimentary Assessment Tool for Radiation Skin Reactions 
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Probability Estimates for Sternum Reactions during Week Five 
No History of Skin Cancer History of Skm Cancer 
Age (in 5 year Probability of skin Age (in 5 year Probability of skin 
increments) reaction JRTOG 2 increments) reaction )RTOG 2 
20 60% 20 95% 
25 56% 25 94% 
30 53% 30 93% 
35 49% 35 92% 
40 45% 40 91% 
45 42% 45 89% 
50 38% 50 88% 
55 34% 55 86% 
60 31% 60 84% 
65 28% 65 82% 
70 25% 70 80% 
75 22% 75 77% 
80 20% 80 74% 
85 17% 85 71% 
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Probability Estimates for Axilla Reactions during Week 5 
No Aspirations for Lymphocele One or Mora Aspirations for 
Lymphocele 
Weight (in 5kg Probability of skin Weight (in 5kg Probability of skrn 
increments} reaction ! RTOG 2 increments} reaction ! RTOG 2 
45 15% 45 28% 
50 19% 50 35% 
55 25% 55 42% 
60 32% 60 50% 
65 39% 65 58% 
70 46% 70 66% 
75 54% 75 72% 
80 62% 80 78% 
85 69% 85 83% 
90 75% 90 87% 
95 80% 95 90% 
100 85% 100 92% 
105 88% 105 94% 
Probability Estimates for Upper Outer Quadrant Reactions at 45 Gy if Never 
Smoked 
Brassiere cup size Aspirations for Stage~ II Probability of skin 
>D L:tmehocele reaction > RTOG 2 
X X X 19% 
X X .,/ 35% 
X .,/ X 40% 
X .,/ .,/ 61% 
.,/ X X 39% 
.,/ X .,/ 60% 
.,/ .,/ X 65% 
.,/ .,/ .,/ 81% 
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Probability Estimates for Upper Outer Quadrant Reactions at 45 Gy if Ex-
Smoker 
Brassiere cup size Aspirations for Stage~ II Probability of skin 
>D Llm~hocele reaction ,:: RTOG 2 
X X X 27% 
X X ,/ 47% 
X ,/ X 52% 
X ,/ ,/ 71% 
,I X X 52% 
,/ X ,/ 71% 
,/ ,/ X 75% 
,/ ,/ ,/ 87% 
Probability Estimates for Upper Outer Qu~drant Reactions at 45 Gy if 
Currert Smoker 
Brassiere cup size Aspirations for Stage~ II Probability of skin 
>D Llm~hocele reaction .::, RTOG 2 
X X X 58% 
X X ,/ 77% 
X ,/ X 80% 
X ,/ ,/ 90% 
,/ X X 80% 
,/ X ,/ 90% 
,/ ,/ X 92% 
,/ ,/ ,/ 96% 
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Probability Estimates for Upper Inner Quadrant Reactions at 45 Gy 
Brassiere cup size ~ D Aspirations for Probability of skin reaction 
L:tmQhocele > RTOG 2 
X X 27% 
X ,/ 45% 
,/ X 46% 
,/ ,/ 65% 
Probability Estimates for Lower Outer Quadrant Reactions 
Brassiere cup Never Smoked Ex-Smoker Current Probability of 
size~ D Smoker skin reaction 
> RTOG 2 
X ,/ X X 16% 
X X ,/ X 20% 
X X X ,/ 45% 
,/ ,/ X X 36% 
,/ X ,/ X 43% 
,/ X X ,/ 70% 
Probability Estimates for Lower Inner Quadrant Reactions at 45 Gy if Never 
Smoked 
Brassiere cup size ~ D 
X 
X 
,/ 
,/ 
Aspirations for 
Lymphocele 
X 
,/ 
X 
,/ 
Probability of skin reaction 
> RTOG 2 
11% 
22% 
28% 
48% 
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Probability Estimates for Lower Inner Quadrant Reactions at 45 Gy if Ex-
Smoker 
-~--
Brassiere cup size ?: O Aspirations for Probability of skm reaction 
L :tmehocele > RTOG 2 
X X 13% 
X ,I 26% 
,I X 32% 
,I ,I 53% 
Probability Estimates for Lower Inner Quadrant Reactions at 45 Gy if Current 
Smoker 
Brassiere cup size ?: D 
X 
X 
Aspirations for 
Lymphocele 
X 
,I 
X 
Probability of skin reaction 
~ RTOG 2 
49% 
69% 
76% 
88% 
Probability Estimates for Nipple Reactions at 45 Gy 
Probability of skin reaction Probability of skin reaction Probability of skin reaction 
~ RTOG 2 if Never ?: RTOG 2 if Ex-Smoker ?: RTOG 2 if Current 
Smoked Smoker 
26% 34% 62% 
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Probability Estimates for lnframammary Fold Reactions during Week Five 
--------
Brassiere cup Never Smoked Ex-Smoker Current Probability of 
size~ D Smoker skin reaction 
> RTOG 2 
X ,/ X X 15% 
X X ,/ X 36% 
X X X ,/ 64% 
,/ ,/ X X 49% 
,/ X ,/ X 75% 
,/ X X ,/ 91% 
